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Analyzing the Role of ER Membrane Biogenesis in Mitotic Fidelity 
Holly Elizabeth Merta 
2021 
In cell division, chromosomes align and attach to the mitotic spindle with high 
fidelity in order to limit missegregation of chromosomes that form individual 
nuclei, termed micronuclei. During cell division, membrane-bound organelles are 
cleared to the periphery of the cell; lack of clearance of membranes from 
chromosomes leads to chromosome missegregation. Cells regulate the 
biogenesis of their membranes throughout the cell cycle. Cancer cells frequently 
have upregulation of membrane lipid synthesis and micronuclei, but a connection 
between membrane biogenesis and chromosome missegregation leading to 
formation of micronuclei has not been established.  
In my thesis work, I show that the protein phosphatase CTDNEP1 regulates 
membrane biogenesis and indirectly the formation of micronuclei in human cell 
lines. I elucidate how CTDNEP1 controls synthesis of ER membranes through its 
dephosphorylation and activation of the phosphatidic acid phosphatase lipin 1. I 
show that ER membrane abundance is increased in mitotic cells lacking 
CTDNEP1, and endoplasmic reticulum (ER) membranes are less cleared in 
prometaphase to metaphase.  I show that CTDNEP1 has conserved functions for 
restricting membranes to the surface of the nuclear envelope during nuclear 
envelope assembly and for maintaining nuclear morphology. Using quantification 
of mitotic cells in a fixed asynchronous population, I corroborate the results of 
  
previous studies showing that CTDNEP1 is necessary for correct timing of mitotic 
progression.  
Errors in attachment to the mitotic spindle (that may or not be surveilled by 
the spindle assembly checkpoint) lead to chromosome missegregation that 
results in formation of micronuclei. Inhibition of the spindle assembly checkpoint 
in synchronized cells leads to a small increase in micronuclei in CTDNEP1-
depleted cells. In contrast, transient spindle disassembly that causes unbalanced 
attachment errors not sensed by the spindle assembly checkpoint results in 
severely micronucleated nuclei in CTDNEP1-depleted cells, showing that 
micronuclei in CTDNEP1-depleted cells form through decreased mitotic error 
correction.  
Lipidomic analysis of total cellular lipids in CTDNEP1-depleted cells reveals 
that phosphatidylcholine/phosphatidylethanolamine are increased with loss of 
CTDNEP1. I show that inhibition of fatty acid synthesis suppresses ER 
membrane expansion in CTDNEP1-depleted cells. I observe that depletion of the 
fatty acid transcriptional regulators sterol regulatory element binding proteins 1 
and 2 and stearoyl Co-A desaturase partially suppress ER membrane expansion, 
illuminating the role of fatty acid synthesis gene upregulation in expansion of ER 
membranes in CTDNEP1-depleted cells. Inhibiting fatty acid synthesis rescues 
severe micronucleation after transient spindle disassembly and the incidence of 
micronuclei in untreated CTDNEP1-depleted cells. These data elucidate the 
mechanism for how CTDNEP1 controls ER lipid synthesis in human cells. 
Together, these data support the conclusion that increased fatty acid synthesis 
  
leads to excess ER membranes that interfere with chromosome segregation in 
mitosis, leading to formation of micronuclei. This study provides the first 
connection to misregulation of lipid synthesis to formation of micronuclei, two 
events that are common in cancer cells. This study thus provides a link between 
regulation of lipid synthesis and chromosome segregation and informing our 
understanding of how they are altered in cancer.  
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Chapter 1: General Introduction  
 
 2 
Cell and organelle membranes 
Cells are the fundamental unit of living things, and they rely on faithful 
division to propagate all of life. The idea that living things are made of cells was 
formed in the 1600s-1800s thanks to the invention of light microscopy 
(Mazzarello, 1999; Ribatti, 2018). Further light and electron microscopy studies 
identified organelles, or membrane-bound compartments with distinct makeups 
and functions that are common to all eukaryotic cells (Golgi, 1898; Palade, 1952, 
1956; Porter et al., 1945). Organelles were later found to compartmentalize 
cellular functions, and they have specific populations of proteins to support these 
functions. Many organelles are encapsulated by membranes with distinct lipid 
compositions that also support their functions. 
Membranes in cells consist primarily of lipids, molecules with hydrocarbon 
chains or rings that impart hydrophobicity. The hydrophobic nature of lipids 
causes lipids to self-aggregate within the hydrophilic environment of the cell. 
Further, the qualities of cellular lipids allow for the formation of different 
structures. Polar lipids, such as glycerophospholipids, self-aggregate in such a 
way as to form membranes, which allow the cell to compartmentalize its 
organelles and to separate itself from its environment. 
In cells, membranes take the form of mostly polar lipid bilayers (Nicolson, 
2014). The structure of cell membranes has been well described as a fluid 
mosaic, wherein proteins can span (completely or partially) and diffuse within the 
lipid bilayer (Nicolson, 2014; Singer and Nicolson, 1975). The lipid makeup of the 
lipid bilayers has shown to be important for cell physiology, including membrane 
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properties and cell differentiation (Harayama and Riezman, 2018; Levental et al., 
2017). 
Types of membrane lipids 
The main types of lipids in cells include fatty acids, glycerolipids, 
sphingolipids, and sterols (Figure 1.1). Within each type of lipid (except for 
sterols), there are classes defined by their headgroups, and within each class 
exists hundreds of different possible lipid species based on fatty acid composition 
(Harayama and Riezman, 2018). 
Fatty acids are made up of a carboxylic acid with a hydrocarbon chain 
typically around 16-22 carbons in length in mammalian cells (Figure 1.1) 
(Yamashita et al., 2014). These hydrocarbon chains can be saturated (having no 
double bonds) or unsaturated (having double bonds). The length and saturation 
of fatty acids within membrane lipids is highly important for the biophysical 
properties of the membrane (van Meer et al., 2008). Unsaturated fatty acids 
impart more fluidity to membranes due to less lipid packing (relatively more 
space between adjacent lipids) (Bigay and Antonny, 2012; van Meer et al., 
2008). Longer fatty acids in one leaflet of a bilayer have the potential to 
interdigitate with the fatty acids of the other leaflet, increasing lipid packing 
(Murate and Kobayashi, 2016).  
Glycerolipids consist of a glycerol backbone, fatty acids connected to the 
glycerol backbone by an ester linkage, and a head group (in the case of 
glycerophospholipids) (Figure 1.1). Diacylglycerol (DAG) and triacylglycerol 
(TAG) consist of the glycerol backbone and 2 or 3 fatty acid chains, respectively. 
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Glycerophospholipids, such as phosphatidic acid (PA), phosphatidylcholine (PC), 
phosphatidylethanolamine (PE), phosphatidylserine (PS), and 
phosphatidylinositol (PI), have two fatty acid chains and a head group on the 
glycerol backbone connected by a phosphate group. Although their compositions 
appear similar, the charges and shapes of glycerophospholipids can help or 
hinder the stabilization membrane curvature and the ability of proteins to 
associate with the membrane (Harayama and Riezman, 2018). In contrast to 
glycerolipids, sphingolipids are less saturated and have longer hydrocarbon 
chains that contribute to a taller profile compared to glycerolipids (van Meer et 
al., 2008). Sterols, like cholesterol, maintain membrane fluidity at lower 
temperatures but permit lipid packing to stabilize membranes at higher 
temperatures as well (Dufourc, 2008). The lipid-condensing effect of cholesterol 
and long saturated acyl chains of sphingolipids allows them to form relatively-
more-solid microdomains of distinct lipid composition within membranes, called 
lipid rafts, that can preferentially sequester or change the conformation of 
proteins for signaling purposes (Sezgin et al., 2017). The properties of 
membrane lipids enable organelles of different lipid compositions to support 
diverse populations of proteins for different cellular functions. 
Organelle membrane lipid compositions 
The membranes of organelles have distinct lipid makeups that play a role 
in organelle morphology, membrane activities and protein localization, and 
organelle identity.  Strides in biochemical and mass spectrometry analysis have 
generated key insights about how lipid composition of organelle membranes 
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contribute to their functions. Future analyses making use of lipid probes, species-
specific degradation of leaflets, and more sophisticated purification techniques 
will improve our understanding of organelle composition (Ballweg et al., 2020; 
Harayama and Riezman, 2018; Lorent et al., 2020; Romanauska and Köhler, 
2018).  
Generally, the lipid makeup of cells’ organelles has been thought to follow 
a gradient of their involvement in the secretory pathway (Bigay and Antonny, 
2012). Most of the cell’s lipids are made in the endoplasmic reticulum (ER) 
(Jacquemyn et al., 2017) (Figure 1.3). The ER consists of mostly PC and PE, PI 
and PS to a lesser extent, and then very small amounts of sphingolipids and 
cholesterol (van Meer et al., 2008; Vance, 2015). The nuclear envelope is 
thought to be similar in composition to the ER, but interconnected nature of the 
nuclear envelope and ER confounds lipid composition analyses utilizing 
organelle purification (Bahmanyar and Schlieker, 2020). Recent studies using 
lipid probes indicate the inner nuclear membrane could have a distinct 
composition from the ER (Romanauska and Köhler, 2018). In contrast to the ER, 
the plasma membrane has relatively less PC and greater amounts of PS, 
sphingolipids, and abundant cholesterol (Horvath and Daum, 2013). The cis 
Golgi is more similar in composition and physical properties to the ER, whereas 
the trans Golgi and endosomes are more similar in composition and physical 
properties to the cytoplasmic leaflet of the plasma membrane, reflecting how 
lipids are trafficked from the ER to the plasma membrane and other organelles 
(Bigay and Antonny, 2012). Organelles’ distinct lipid compositions are 
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established in part by delivery of lipids that are synthesized by the endoplasmic 
reticulum and contiguous nuclear envelope.  
The nuclear envelope and endoplasmic reticulum 
The nuclear envelope and endoplasmic reticulum make up a contiguous 
membrane structure with domains supporting different functions (Watson, 1955) 
(Figure 1.2). Their structures and functions are outlined below. 
The endoplasmic reticulum (ER) 
The ER was first identified by electron microscopy as a contiguous 
structure consisting of perinuclear ribosome-studded “rough ER” sheets and 
peripheral “smooth ER” tubules (Palade, 1956) (Figure 1.2). We now know that 
the ultrastructure of the ER in live cells also includes small peripheral sheets with 
embedded nanoholes (Schroeder et al., 2018). The structure of the ER is 
supported by ER shaping proteins and interactions with the cytoskeleton (Figure 
1.2). Reticulons are tubule-stabilizing proteins that insert a hairpin structure 
partially into the ER membrane to support membrane curvature (Hu et al., 2008; 
Voeltz et al., 2006) including inside ER nanoholes (Schroeder et al., 2018). ER 
sheets are stabilized by ribosomes/translocons and CLIMP-63, which spans the 
ER lumen in dimers to stabilize a defined lumen width (Klopfenstein et al., 2001; 
Shibata et al., 2010). Interphase ER structure is also defined by the availability of 
GTPases that can facilitate ER tubule fusion, such as atlastin and Rab10 
(English and Voeltz, 2013; Orso et al., 2009). The fusion activity of atlastin and 
tubule-stabilizing functions of reticulons and lunapark cooperate to form an 
extended network of ER tubules (Wang et al., 2016b). The maintenance and 
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dynamics of peripheral ER structure are also supported by interactions between 
ER-resident proteins and microtubules (Bola and Allan, 2009; Waterman-Storer 
and Salmon, 1998). STIM1 on ER tubules interacts with EB1 on microtubule plus 
ends, leading to ER tubules tracking plus-end microtubule growth (Grigoriev et 
al., 2008). In general, peripheral ER tubules co-align with microtubules 
(Waterman-Storer and Salmon, 1998). Movement of organelles to which the ER 
is tethered also determines its localization and movement (Friedman et al., 
2013). The abundance of ribosomes on rough ER and extensive network of the 
smooth ER support the ER’s functions to help maintain other organelles. 
The ER performs functions in translation and modification of 
transmembrane and secreted/luminal proteins and in lipid synthesis. It connects 
with other organelles to deliver proteins, lipids, and function in signaling.  
Early electron microscopy and biochemical studies identified that proteins 
can be synthesized in the ER and trafficked to other organelles or secreted (Caro 
and Palade, 1964; Palade and Siekevitz, 1956; Siekevitz and Palade, 1960). 
Transmembrane proteins and proteins destined for secretion or localization to 
organelle lumens are translated partially in the cytosol before being targeted to 
translocons in the ER membrane, where the protein is translated while being 
shunted into the ER lumen through the translocon (or embedded in the ER 
membrane) (Rapoport, 2007; Schwarz and Blower, 2015). ER chaperones can 
assist in folding these proteins, and some posttranslational modifications are also 
performed in the ER, such as signal peptide cleavage, N-linked glycosylation, 
and disulfide bond formation (Braakman and Hebert, 2013). The ER also 
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synthesizes lipids—fatty acids, cholesterol, triglycerides, sphingolipid precursors, 
and most glycerophospholipids—for the cell. 
The ER is also highly interconnected with mitochondria, endosomes, the 
Golgi apparatus, and the plasma membrane; ER contacts cover up to 5% of 
mitochondrial and endosomal outer membranes (Phillips and Voeltz, 2015). It is 
now known that ER contact sites are responsible for exchanging proteins, lipids, 
and ER-stored Ca2+, and ER contact sites are important for organelle 
maintenance, such as in endosome maturation (Csordás et al., 2006; Friedman 
et al., 2013; Phillips and Voeltz, 2015). Finally, the ER is also responsible for 
organelle biogenesis of peroxisomes and lipid droplets (Hoepfner et al., 2005; 
Joshi et al., 2017). The ER’s structures throughout the cell therefore facilitate its 
functions in protein and lipid synthesis and delivery of these molecules to other 
organelles without relying on relatively slow vesicular transport. 
The nuclear envelope 
 The nuclear envelope is a double membrane sheet that encases the nucleus 
(Figure 1.2). The nuclear envelope was first identified to have a double lipid 
bilayer by electron microscopy of extracted membranes from Xenopus laevis 
oocyte nuclei (Callan and Tomlin, 1950). These bilayers have since been termed 
the outer (ONM) and inner (INM) nuclear membranes. Subsequent microscopy 
studies have identified connections between the outer nuclear membrane and 
ER (Watson, 1955) as well as invaginations of inner (type I) or outer/inner (type 
II) nuclear envelope membranes termed nucleoplasmic reticuli (Drozdz and 
Vaux, 2017). The nuclear envelope contains nuclear pore complexes (NPCs), 
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~100 nm ring-shaped protein assemblies consisting of nucleoporins (Nups) that 
span both layers of the nuclear envelope (Bahr and Beermann, 1954; Beck et al., 
2004; D’Angelo and Hetzer, 2008; Hetzer, 2010). The structure of the nuclear 
envelope is supported by a meshwork of intermediate filament-type proteins 
(lamins) underneath the inner nuclear membrane called the nuclear lamina 
(Leeuw et al., 2018). The nuclear lamina is connected to the cytoskeleton 
through LINC complexes that span the nuclear envelope and interact with lamins 
as well as with actin filaments or microtubules in the cytosol (Sosa et al., 2013). 
The nuclear envelope’s functions largely entail its protection of the nuclear 
contents. The nuclear envelope is a semipermeable barrier for the nucleus owing 
to the nuclear pore complexes’ selective permeability. Molecules of size <30-40 
kDa can pass through the nuclear pore complexes by diffusion, while large 
proteins require interaction with importins/exportins to enter and leave the 
nucleus (Capelson et al., 2010; Hetzer, 2010). This barrier allows the cell to 
partition transcription from translation, adding a layer of regulation to protein 
synthesis (Orphanides and Reinberg, 2002). Compartmentalizing the cell’s 
genome allows the nuclear envelope to protect DNA from cytosolic nucleases 
and the innate immune signaling pathways that allow the cell to detect and rid 
itself of viral nucleic acids (Ma et al., 2020; Paludan and Bowie, 2013; Semenova 
et al., 2019). The nuclear envelope also plays an important role in 
mechanotransduction, as alterations in force applied to a cell lead to nucleus-
mediated changes in gene expression (Kaminski et al., 2014).  
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Though they are contiguous, nuclear envelope functions are thought to be 
removed from ER functions; however, emergent evidence implicates the nuclear 
envelope in regulation of lipid synthesis. Studies using nuclear-localized lipid 
sensors in budding yeast show that the inner nuclear membrane has a distinct 
lipid composition and that lipid synthesizing enzymes localize to the inner nuclear 
membrane (Romanauska and Köhler, 2018). In human cells, the nuclear 
envelope protein lamin B receptor (LBR) catalyzes an intermediate step in 
cholesterol synthesis from lanosterol and is required for human cell growth in 
cholesterol-deficient media (Tsai et al., 2016). Nucleoplasmic reticuli have shown 
to originate from newly synthesized glycerophospholipid incorporation into reticuli 
at the inner nuclear membrane during interphase (Drozdz et al., 2017; 
Goulbourne et al., 2011). Nuclear lipid droplets are droplets of mostly 
triacylglycerol and cholesterol that appear to originate from the ER lumen, 
nuclear envelope lumen, the inner nuclear membrane, or type I nucleoplasmic 
reticuli (Lagrutta et al., 2017; Layerenza et al., 2013; Ohsaki et al., 2016; 
Romanauska and Köhler, 2018; Sołtysik et al., 2019). Altering lipid synthesis at 
the INM controls nuclear lipid droplet formation in yeast (Romanauska and 
Köhler, 2018). Recent work showed for the first time that formation of nuclear 
lipid droplets is conserved in human cells. However, in contrast to budding yeast, 
they form in the absence of the triglyceride-sequestering lipid droplet maturation 
protein seipin, indicating that the mechanism of nuclear lipid droplet formation 
differs from that of ER-derived lipid droplets (Sołtysik et al., 2020; Wang et al., 
2016a; Zoni et al., 2020). While the function of nuclear lipid droplets is not fully 
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known, evidence has implicated them in hepatocyte (liver) lipid homeostasis 
(Lagrutta et al., 2017; Ohsaki et al., 2016). The nuclear envelope is thus an 
active player in regulating and performing lipid synthesis in spite of its continuity 
with the ER. 
Many lipid synthesis-regulating functions of the nuclear envelope involve 
CTP:phosphocholine cytidyltransferase α (CCTα). CCTα localizes to the inner 
nuclear envelope and catalyzes the synthesis of CDP-choline, which is the rate 
limiting step of phosphatidylcholine (the most abundant structural 
glycerophospholipid in metazoan cells) synthesis (Cornell and Antonny, 2018). 
CCTα does not constitutively localize to the inner nuclear membrane, however. In 
response to curvature elastic stress of the inner nuclear membrane, the M 
helices of CCTα move away from an autoinhibitory conformation to insert into the 
surface of the lipid bilayer, and linkers facilitate close apposition of the catalytic 
domain to the membrane to provide an anhydrous milieu for its activity (Haider et 
al., 2018; Knowles et al., 2019; Ramezanpour et al., 2018). Recent evidence 
suggests that hepatocyte nuclear lipid droplets recruit CCTα to membranes, 
perhaps in response to bilayer stress (Ohsaki et al., 2016; Sołtysik et al., 2019). 
Acute induction of nucleoplasmic reticuli formation also depends on the 
localization and activity of CCTα (Gehrig et al., 2008; Goulbourne et al., 2011). 
Recent evidence suggests CCTα’s localization is regulated posttranslationally, as 
phosphorylation of CCTα’s membrane binding domain limits its localization to the 
INM and nuclear lipid droplets (Yue et al., 2020). Given its functions in sensing 
lipid composition of the INM and nuclear lipid droplets, CCTα links the lipid 
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composition of the nuclear envelope to regulation of lipid synthesis. How the 
nuclear envelope regulates lipid synthesis through mechanisms other than CCTα 
has yet to be fully elucidated.  
Lipid synthesis in the endoplasmic reticulum 
Lipid synthesis pathways in the ER 
The bulk of membrane lipids are synthesized in the ER, and this process 
is controlled by nutritional inputs and uses substrates of nutrient metabolism 
(Figure 1.3). All lipids that are made in the ER de novo are made from acetyl-
Coenzyme A (acetyl-CoA), which is produced by conversion of citrate from the 
Krebs cycle, breakdown of fatty acids, or breakdown of amino acids (Pietrocola 
et al., 2015). Glycerolipids additionally require glycerol-3-phosphate, which is 
made from glycerol derived from glyceraldehyde-3-phosphate made during 
glycolysis (Lunt and Vander Heiden, 2011) or glycerol from glyceroneogenesis 
(Hanson and Reshef, 2003). In mammalian cells, the decision to synthesize 
membrane lipids is controlled by pro-growth signaling that is largely controlled by 
mammalian target of rapamycin (mTOR) (Ben-Sahra and Manning, 2017). 
Nutrients such as amino acids, glucose, and growth factors lead to downstream 
mTORC1 activation, which leads to activation of sterol regulatory element 
binding proteins (SREBPs), transcription factors that lead to upregulation of fatty 
acid and cholesterol synthesis genes through an unknown mechanism (Ben-
Sahra and Manning, 2017). In yeast, transcription of fatty acid synthesis genes 
mediated by the transcription factors Ino2 and Ino4 occurs during exponential 
growth and under nutrient conditions that lead to increased ER PA 
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concentrations (by sequestering the transcriptional repressor Opi1, which binds 
PA) (Henry et al., 2012; Hofbauer et al., 2018; Loewen et al., 2004). Increased 
fatty acid synthesis leads to increased de novo lipid synthesis in these pro-
growth contexts to support cell proliferation.  
Additional signals for ER lipid synthesis are changes in intracellular 
membrane physical properties, such as packing (Jacquemyn et al., 2017). CCTα 
localizes to the surface of the inner nuclear membrane in response to packing 
defects to perform the rate-limiting step for PC synthesis (Cornell and Antonny, 
2018). The PA phosphatase lipin localizes to membranes more readily with 
increased PA and PE concentration (Eaton et al., 2013; Karanasios et al., 2010). 
In yeast, membrane saturation is sensed by Mag2 and controls transcription of 
the fatty acid desaturase gene Ole1 (Ballweg et al., 2020). SREBPs are 
additionally regulated by cholesterol in ER membranes (which is usually scarce 
to begin with); low cholesterol leads to increased SREBP processing that 
generates mature, functional SREBPs (Shimano and Sato, 2017). Lipid synthesis 
in the ER thus takes nutrient availability and membrane properties as signaling 
inputs for generating lipids for cell growth and maintenance. 
 ER-derived lipids all start from acetyl-CoA (Holthuis and Menon, 2014) 
(Figure 1.3). Acetyl-CoA is then converted to either malonyl-CoA in the 
committed step for fatty acid synthesis (feeding into glycerolipid or sphingolipid 
synthesis) or acetoacetyl-CoA in the committed step for cholesterol synthesis 
(Holthuis and Menon, 2014; Tong, 2005) (Figure 1.3). In cholesterol synthesis, 
sequential steps lengthen and cyclize intermediates into cholesterol in ER 
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membranes. In fatty acid synthesis, malonyl-CoA is elongated by fatty acid 
synthase into the fatty acid palmitate, which can be elongated and desaturated 
into other fatty acyl-CoA species (Figure 1.3). For sphingolipid synthesis, fatty 
acids are formed into long chain bases, then are additionally acylated to form 
ceramides, and these can be additionally processed in the Golgi to form other 
sphingolipids such as sphingomyelin (Breslow, 2013) (Figure 1.3).  
 Committed glycerolipid synthesis begins with formation of lysophosphatidic 
acid (LPA) from fatty acyl Co-A and glycerol-3-phosphate (Jacquemyn et al., 
2017). LPA can be additionally acylated to form PA. In metazoans, PA can form 
phosphatidylinositol through the CDP-DAG pathway, or it can be 
dephosphorylated to form diacylglycerol by phosphatidic acid phosphatases 
(PAPs), including lipins (Zhang and Reue, 2017). DAG can form PC or PE or 
triglycerides through the Kennedy pathway (Gibellini and Smith, 2010; Kennedy 
and Weiss, 1956). The synthesis of either PA- or DAG-derived lipids depends on 
PA phosphatase activity, which is mediated by lipins in mammalian cells. 
CTDNEP1 and lipin 1 control of ER lipid synthesis 
The phosphatidic acid phosphatase lipin 1 (Pah1 in budding yeast; Ned1 
in fission yeast; LPIN-1 in nematodes) and its phosphatase C terminal domain 
nuclear envelope phosphatase 1 (CTDNEP1) (Nem1 in budding and fission 
yeast; CNEP-1 in nematodes) regulate the synthesis of PA- and DAG-derived 
lipids (Figure 2.1A). Lipin is conserved from yeast to humans, and isoforms of 
lipin are known to be phosphoregulated in yeast, nematodes, flies, mice, and 
humans (Bahmanyar et al., 2014; Eaton et al., 2013; Grimsey et al., 2008; Harris 
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et al., 2007; O’Hara et al., 2006; Santos-Rosa et al., 2005; Tange et al., 2002). In 
budding yeast, Pah1 was found to be a Mg2+-dependent phosphatidic acid 
phosphatase (PAP) that dephosphorylates PA to form DAG (Han et al., 2006). 
Nem1 was found to be a haloacid dehalogenase (HAD) superfamily phosphatase 
that dephosphorylates lipin to activate it (Kim et al., 2007; O’Hara et al., 2006; 
Santos-Rosa et al., 2005). In mouse cells, the nutrient-sensing kinase complex 
mTORC1 phosphorylates lipin (Peterson et al., 2011). Because other 
glycerophospholipid species can be formed from PA and DAG (Figure 2.1A), the 
activation state of lipin regulated by Nem1/CNEP-1/CTDNEP1 determines which 
glycerolipid species are made in the ER. 
Depletion of Nem1/CNEP-1 in budding yeast and C. elegans alters cellular 
lipid composition and ER and nuclear envelope membrane structures 
(Bahmanyar et al., 2014; Siniossoglou et al., 1998). In budding and fission yeast, 
loss of lipin catalytic activity leads to a proliferation of nuclear envelope and ER 
membranes, drastically altering the nucleus’ shape from round to lobed 
(Siniossoglou et al., 1998; Tange et al., 2002). In LPIN-1- or CNEP-1-deficient C. 
elegans early embryos, PA and PI are increased, resulting in an increase in ER 
sheets and deficient nuclear envelope breakdown (Bahmanyar et al., 2014; 
Golden et al., 2009; Gorjánácz and Mattaj, 2009). Cultured mouse cell nuclei 
become oblong rather than round when exposed to conditions causing lipin 
dephosphorylation (Peterson et al., 2011). In mice, active lipin is also thought to 
negatively regulate transcriptional regulation of fatty acid synthesis and positively 
regulate lipid breakdown and adipocyte maturation, and these mechanisms may 
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occur through local PA concentration changes or in some cases lipin interaction 
with transcriptional regulators (Finck et al., 2006; Péterfy et al., 2005; Peterson et 
al., 2011; Phan et al., 2004; Zhang et al., 2012). The functions of lipin 1 and 
CTDNEP1 in regulating lipid synthesis in human cells are not well understood. 
Key features of human diseases involving loss of function of lipin 1 or CTDNEP1 
are not seen in mouse models of lipin 1 deficiency, so studies of human 
CTDNEP1/lipin 1 are warranted (Jones et al., 2012; Pelosi et al., 2017).  In what 
is known so far in all organisms, however, lipin and CTDNEP1 generally act to 
limit membrane glycerolipid synthesis and abundance. 
Lipid synthesis alterations in cancer 
 Cancer is a disease is caused and aggravated by genetic or epigenetic 
changes to a cell’s DNA that cause a cell to divide continuously in an 
uncontrolled manner. Cancer is often characterized by hallmarks, common 
characteristics that facilitate transformation of benign cells into malignant cells 
and that make malignant cells even more so, all at the expense of surrounding 
healthy cells (Fouad and Aanei, 2016). Recently redefined hallmarks include 
alterations within the cell— advantages for growth and proliferation, survival-
promoting stress responses, and adaptive metabolic alterations— along with 
others involving tumor interaction with surrounding tissue to promote metastasis, 
or spreading to other tissues (Fouad and Aanei, 2016). Changes in lipid 
synthesis are part of the adaptive metabolic alterations that support growth and 
proliferation in cancer cells. 
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 Lipid synthesis is necessary for cell division. Cells accumulate membrane 
lipids prior to mitosis to supply membranes for organelles for both daughter cells 
(Jackowski, 1994). Cancer cells frequently show increased lipid synthesis to 
support increased cell proliferation (Currie et al., 2013). Consistent with their role 
upstream of sphingolipid and glycerolipid synthesis, the components of fatty acid 
synthesis are highly upregulated in cancer (Cheng et al., 2018). SREBPs, 
SREBP processing components, and SREBP target genes are all upregulated in 
a variety of tumors, as are proteins responsible for generating acetyl-CoA, such 
as ATP citrate lyase and acetyl-CoA synthetases (Cheng et al., 2018). SREBP1 
targets fatty acid synthase and stearoyl-CoA desaturase are especially known to 
be upregulated in cancer (Igal, 2010; Kuhajda et al., 1994). Upregulation of these 
fatty acid synthesis pathway components bypasses the pro-growth signaling that 
works through mTOR to lead to SREBP activation and target gene upregulation, 
all in support of uncontrolled cell proliferation. Because the complex functions 
and dynamics of organelles are all supported by lipid synthesis, the total impact 
of increased lipid synthesis in cancer cells is not understood. 
Nuclear envelope and endoplasmic reticulum dynamics during cell division 
In open mitosis in mammalian cells, the nuclear envelope breaks down; its 
membranes are absorbed into the ER, while nuclear envelope-resident proteins 
distribute throughout the ER (if transmembrane) or cytosol (if soluble) (Figure 
1.4). During mitotic exit, nuclear envelope membranes are reassembled from ER 
membranes (Figure 1.4). In this section, nuclear envelope and ER dynamics in 
mitosis will be discussed. 
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Nuclear envelope breakdown 
In nuclear envelope breakdown, the nuclear pore complexes, nuclear 
lamina, DNA-associated proteins, and inner nuclear membrane proteins are 
phosphorylated by mitotic kinases, and nuclear envelope membranes 
disassemble (Ungricht and Kutay, 2017). Nuclear envelope breakdown begins 
with phosphorylation and disassembly of nuclear pore complexes in a sequential 
manner that leads to slow initial inward diffusion of cytosolic molecules (Dultz et 
al., 2008; Lénárt et al., 2003; Terasaki et al., 2001). Cyclin dependent kinase 1 
(Cdk1), Polo-like kinase 1, and NIMA-related kinase 1 phosphorylate the FG 
(soluble) nucleoporin Nup98 leading it to be disassociated from the nuclear pore 
complexes first, facilitating disassembly of other Nups in protein complexes 
(Dultz et al., 2008; Laurell et al., 2011; Macaulay et al., 1995). The nuclear 
lamina is then phosphorylated by protein kinase C (PKC) and Cdk1-cyclin B, 
leading to its disintegration (Goss et al., 1994; Mall et al., 2012; Ottaviano and 
Gerace, 1985; Peter et al., 1990). Dynein pulling forces from the nascent mitotic 
spindle forming under mammalian cell nuclei also contribute to breakdown of the 
lamina (Beaudouin et al., 2002). Phosphorylation of proteins that link DNA and 
the lamina to the inner nuclear membrane leads to dissociation of chromosomes 
from the nuclear envelope (Hirota et al., 2005; Molitor and Traktman, 2014; 
Tseng and Chen, 2011).  
Nuclear envelope clearance from mitotic spindle and chromosomes 
After disassembly of nuclear envelope-associated proteins by mitotic 
phosphorylation, the nuclear envelope membranes are removed from the vicinity 
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of chromosomes to ensure that the assembling mitotic spindle can access 
chromosomes. Multiple mechanisms appear to play a role in removing 
membranes from chromatin. Depletion of LINC complex components or NudE/EL 
(which promotes dynein association to the nuclear envelope during mitotic entry) 
reduces the removal of nuclear envelope membranes from chromatin (Turgay et 
al., 2014). ER-associated proteins REEP3/REEP4 also limit membranes from 
being associated with mitotic chromosomes (Schlaitz et al., 2013). Nuclear 
envelope breakdown is also influenced by mitotic ER structure or ER/nuclear 
envelope membrane composition. Maintenance of mitotic ER structure by 
reticulon expression or expression of the membrane fusion GTPase Rab5 is 
required for proper nuclear envelope breakdown in the C. elegans early embryo 
(Audhya et al., 2007). Depletion of lipin or CNEP-1/CTDNEP1 in C. elegans and 
human cells leads to defective or delayed nuclear envelope breakdown 
(Bahmanyar et al., 2014; Golden et al., 2009; Gorjánácz and Mattaj, 2009; Mall 
et al., 2012). After nuclear envelope breakdown and removal of membranes from 
chromatin, the nuclear envelope membranes are absorbed into ER membranes 
(Yang et al., 1997). The nuclear envelope and ER in mitosis are a contiguous 
membrane system, with nuclear envelope transmembrane proteins being 
distributed throughout the ER (Ellenberg et al., 1997; Yang et al., 1997). 
ER and endomembrane exclusion from mitotic spindle and chromosomes 
During prometaphase through mitotic exit, the mitotic ER localizes 
primarily to the cell cortex, and this localization is important for mitotic fidelity. In 
Drosophila S2 cells, the membranes are thought to form a “spindle matrix” that 
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concentrates factors critical for building the mitotic spindle (Schweizer et al., 
2015). Disruption of the spindle matrix causes disorganized spindle formation 
that leads to chromosome missegregation (Schweizer et al., 2015). The ER-
resident protein STIM1 is phosphorylated in mitosis to abolish its association with 
the microtubule plus end-interacting protein EB1 (Smyth et al., 2012). REEP3/4 
on ER membranes also facilitate removal of ER membranes from chromatin; 
though REEP3/4 interact with microtubules and ER membranes exhibit minus-
ward movement, REEP3/4 do not interact with the minus-ward motor dynein 
(Schlaitz et al., 2013). It is not known how REEP3/4 drive membrane dissociation 
from mitotic chromosomes along microtubules. What remains to be described for 
mitotic ER localization is how lateral contacts between ER membranes and 
spindle microtubules are avoided, as ER membranes interact with microtubules 
(MTs) along their lengths by ER-resident MT-binding proteins and interactions 
with cargo motors (Bola and Allan, 2009). Other membranous organelles also 
localize to the cell cortex during mitosis to facilitate coordinated division and 
organelle inheritance (Carlton et al., 2020). Persistence of membranes on 
chromosomes during mitosis leads to chromosome segregation errors, 
highlighting the importance of the cortical localization of ER membranes in 
mitosis (Champion et al., 2019; Schlaitz et al., 2013). It is not known how 
membrane biogenesis by the ER is coordinated with membrane dynamics during 
cell division, although clearance of membranes to the cell periphery in mitosis 
may ensure proper mitotic progression. 
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In addition to abolition of ER-MT contacts, ER membranes restructure 
during mitosis. Some have observed transition of ER structure to mainly sheet-
like cisternae (Lu et al., 2009; Wang et al., 2013), while others have observed a 
transition to tubule-like structures, dependent on cell type (Puhka et al., 2007, 
2012). REEP3/4 have shown to be important for maintaining ER structure in 
mitosis independently from their function to clear ER membranes from 
metaphase chromatin. Cells upregulate REEP4 expression by 50% in mitosis 
compared to interphase, and mitotic cells lacking REEP3/4 have large extended 
ER sheets instead of a network of tubules and sheets (Kumar et al., 2019). 
Abundance of ER-shaping proteins (specifically reticulons) has shown to 
influence the rate of reestablishment of the nuclear permeability barrier during 
mitotic exit, showing how ER structure in mitosis may regulate the progression of 
mitotic events (Anderson and Hetzer, 2008).  
Nuclear envelope reassembly 
During mitotic exit, the nuclear envelope reassembles from ER 
membranes (Figure 1.4). After anaphase onset and cyclin B degradation, protein 
phosphatases reverse phosphorylation of nuclear envelope proteins to facilitate 
nuclear envelope reformation (Asencio et al., 2012; Schmitz et al., 2010). 
Transmembrane INM proteins in ER membranes interact with DNA directly or 
through DNA-binding proteins like barrier to autointegration factor (BAF) or 
heterochromatin protein 1 to initiate nuclear envelope reassembly (Anderson and 
Hetzer, 2007; Schellhaus et al., 2015; Ulbert et al., 2006). ER membranes are 
recruited to chromatin in distinct regions based on spindle microtubule 
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localization (Haraguchi et al., 2008; Liu et al., 2018) (Figure 1.4). In the “non-
core” region that is distal from spindle microtubules, almost all nuclear envelope 
proteins are present on the reforming nuclear envelope, including the nuclear 
pore complexes that assemble during mitotic exit (Clever et al., 2012; Haraguchi 
et al., 2000, 2008; Lee et al., 2001; Liu et al., 2018). In contrast, the “core” region 
where spindle microtubules are located possesses inner nuclear membrane 
proteins and most of the proteins involved in nuclear sealing but is bereft of 
NPCs (Haraguchi et al., 2000, 2008; Lee et al., 2001; Liu et al., 2018).  Lamin A 
is associated with the “core” region, whereas lamin B is associated with the 
“noncore” region (Haraguchi et al., 2008). BAF, a traditionally “core” protein, 
localizes to the entire reforming nuclear envelope but is enriched close to the 
spindle later on in the reassembly process, indicating that “core” regions could 
correspond to all surfaces of chromatin, with only “non-core” proteins being 
spatially restricted by the spindle (Samwer et al., 2017). In agreement with this 
idea, missegregating chromosomes located close to the spindle inherit only 
“core” proteins when they form micronuclei, while micronuclei forming from 
chromosomes in the cell periphery have the full complement of nuclear proteins 
(Liu et al., 2018).  
During and after recruitment of ER membranes, the membranes spread 
and nuclear pore complexes assemble (Anderson and Hetzer, 2007; Schooley et 
al., 2012). ER membranes progressively cover the surface of chromatin; in the 
presence of an intact ER network, membrane fusion by GTPases is not 
necessary for reforming the nuclear envelope (Anderson and Hetzer, 2007). 
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Local lipid synthesis at the nuclear envelope could also provide the substrate for 
nuclear envelope reassembly, as newly synthesized phosphatidylcholine is 
selectively incorporated into the nascent nuclear envelope (Henry and Hodge, 
1983; Rodriguez Sawicki et al., 2019). It is not fully understood how lipid 
synthesis before and during mitosis are coordinated to allow proper nuclear 
assembly. A combination of preexisting membranes spreading and local 
synthesis of new lipids could contribute to the rapid formation of a nuclear 
envelope, which is performed on the order of 10 minutes in mammalian cells 
(Anderson and Hetzer, 2008; Lu et al., 2011).  
Nuclear pore complexes also assemble in a mechanism distinct from 
interphase NPC insertion (Schooley et al., 2012). First, soluble MEL28/ELYS 
interacts with chromatin and recruits NUP107-160 (Franz et al., 2007). Then, 
POM121 on ER membranes interacts with NUP160 (Mitchell et al., 2010). 
Additional soluble nucleoporins are incorporated to form the functional NPC 
(Schooley et al., 2012). The membrane topology of this process is such that 
NPCs are built into holes in the nuclear envelope membrane that shrink and then 
dilate to accommodate the nucleoporins (Otsuka et al., 2018). Nuclear pore 
complexes are transport-competent before they are fully built and begin importing 
from the “non-core” regions before the nuclear envelope is completely assembled 
(Lu et al., 2011; Otsuka et al., 2018). The nuclear envelope is not sealed at this 




Toward the end of nuclear envelope reassembly, the nuclear envelope is 
sealed, and DNA-bound microtubules are severed. Nuclear sealing is performed 
by ESCRT-III complexes (Olmos et al., 2015; Vietri et al., 2015). LEM2 on ER 
membranes interacts with BAF on chromatin and recruits the ESCRT component 
CHMP7 (Gu et al., 2017), which also binds membrane PA (Thaller et al., 2021). 
LEM2 has shown to condense to a separated liquid phase around spindle 
microtubules that will be severed, creating a ring-like seal (von Appen et al., 
2020). This seal facilitates assembly of ESCRT-III spiral filaments that constrict 
and lead to membrane fusion by VPS4 and hole resolution (von Appen et al., 
2020; Olmos et al., 2015; Vietri et al., 2015). The spindle microtubule is severed 
by spastin (Vietri et al., 2015). Coordination of membrane lipid synthesis by 
CNEP-1/CTDNEP1 facilitates proper nuclear sealing (Penfield et al., 2020). After 
completion of nuclear sealing, the daughter nuclei are transport-competent and 
fully sealed, and the nuclei expand to their interphase size as additional pores 
are incorporated (Carlton et al., 2020; Ungricht and Kutay, 2017). The 
coordination of membrane dynamics from nuclear envelope breakdown to 
nuclear sealing are crucial for limiting abnormal nuclear formation. 
Micronuclei 
Micronuclei are small nuclei that form from missegregated chromosomes 
or chromosome fragments that form their own nuclear envelope separate from 
the primary nucleus (Fenech et al., 2011) (Figure 1.5). Micronuclei are commonly 
found in cancer and serve as prognostic markers for cancer progression 
(Adhikari, 2019). Micronuclei are also used as a biomarker for exposure to 
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genotoxic agents suspected to cause DNA damage or chromosomal instability 
(Adhikari, 2019; Nikolouzakis et al., 2019). Therefore, understanding the 
mechanisms by which micronuclei form is important for understanding cancer 
progression and underlying chromosomal instability. 
Mechanisms of formation of micronuclei 
Chromosome fragments can form micronuclei (Figure 1.5). Chromosome 
fragments form when non-homologous end joining repairs DNA double strand 
breaks in such a way that two breaks that do not belong together are joined; 
these fragments can subsequently have zero or two centromeres (Fenech et al., 
2011). Erroneous repair leads to chromosome fragmentation in other situations 
as well. Chromosome fragmentation resulting in micronuclei can also occur in 
chromosome bridges, wherein a chromatid or chromosome attached to two sides 
of the spindle spans and links the segregating chromosome masses (Fenech et 
al., 2011; Gisselsson, 2008; Janssen et al., 2011). However, chromosome 
bridges do not form micronuclei if the missegregated chromosome is 
incorporated into one or both primary nuclei (Pampalona et al., 2016). 
Chromosome fragments can also arise from chromothripsis, a catastrophic 
genetic event in which 3 or more double strand breaks rearrange at once to lead 
to randomly strung together fragments (Leibowitz et al., 2015). These are not 
mutually exclusive, as chromosome bridges from dicentric chromosomes can 
also undergo chromothripsis (Maciejowski et al., 2015). 
Micronuclei can also occur from missegregation of whole chromosomes 
and chromatids (Figure 1.5). Micronuclei caused by chromosome missegregation 
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occur when the lagging chromosomes are excluded from primary nuclei before 
the nuclear envelope reassembles.  Lagging chromosomes can be caused by 
defective spindle assembly checkpoint activity, merotelic (unbalanced) 
kinetochore-microtubule attachments, or faulty chromosome alignment. Spindle 
assembly checkpoint proteins limit chromosome missegregation by surveying 
attachments of spindle microtubules to kinetochores. Chromosomes attached to 
one spindle pole (or neither spindle pole) are sensed by the spindle assembly 
checkpoint. Deficiency in the surveillance parts of the spindle assembly 
checkpoint permits the cell to progress from metaphase to anaphase before all 
chromosomes are attached (Fenech et al., 2011). Defects in centromere or 
kinetochore architecture can also contribute to chromosome missegregation by 
causing misattachments to not be surveilled properly by the spindle assembly 
checkpoint (Fenech et al., 2011). Merotely is another major mechanism that 
generates lagging chromosomes (Cimini et al., 2001). Merotelic attachments 
occur when a kinetochore of a chromosome is attached to microtubules from 
both spindle poles, leading to a tug-of-war instead of poleward movement for that 
chromatid at anaphase onset (Gregan et al., 2011). It is important to note that 
although the spindle assembly checkpoint surveils for unattached kinetochores, 
merotelic attachments satisfy the checkpoint. Because the attachment is 
imbalanced, merotelically attached chromosomes lag in anaphase and form 
micronuclei (Figure 1.5, “Merotely”). Merotely can be recovered during 
prometaphase and metaphase, indicating that lack of recovery is part of the 
mechanism for lagging chromosome formation (Cimini, 2003; Wang et al., 2017). 
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The extent to which the number of microtubules attached to a merotelically 
attached kinetochore from each side is unbalanced also influences whether or 
not the chromosome will missegregate during anaphase (Cimini et al., 2004; 
Thompson and Compton, 2011). 
Chromosome misalignment is another mechanism by which micronuclei 
can form through chromosome missegregation. Alignment occurs during 
chromosome congression in prometaphase, when chromosomes attached to the 
mitotic spindle move toward the metaphase plate. Congression is performed by 
chromokinesins, kinesin motor proteins that interact with chromosomes and 
spindle microtubules and generate chromosome movement (Almeida and 
Maiato, 2018). Loss of kinesin KIF18A, which suppresses kinetochore dynamics 
to promote congression, leads to increased formation of micronuclei (Fonseca et 
al., 2019). The micronuclei form from missegregated but normally attached 
chromosomes that arise from having to travel longer distances during anaphase 
(Fonseca et al., 2019). These data suggest that having chromosomes lined up at 
the metaphase plate allows all chromosomes to travel together upon anaphase 
onset so that all chromosomes can be incorporated into primary nuclei before the 
nuclear envelope reassembles. Consistent with this idea, it has been proposed 
that late-aligning chromosomes are more likely to become lagging chromosomes 
after anaphase onset (Kuniyasu et al., 2019).  
It is important to note that p53, a tumor suppressor very frequently lost in 
cancer, is thought to arrest the cell cycle of cells with aneuploidy resulting from 
chromosome fragments (Soto et al., 2017). In contrast, aneuploidy from 
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missegregation of whole chromosomes is tolerated by p53 with regards to cell 
cycle progression (Soto et al., 2017). p53 is mutated in 42% of cancers overall, 
though the frequency ranges from 2.2% to 95% depending on the tissue of origin 
(Bykov et al., 2018). Therefore, in cases where cells have intact p53, whole 
chromosome missegregation may contribute further to chromosomal instability. 
Consequences of formation of micronuclei 
Nuclear envelope reassembly in micronuclei differs from in the main 
nucleus, and this has consequences for nuclear envelope integrity. It has been 
proposed that nuclear envelope reassembly occurs more slowly (by NUP107 
fluorescence tracking) on lagging chromosomes due to a limiting Aurora B 
gradient in the spindle midzone (Afonso et al., 2014). Live and fixed cell imaging 
with more nuclear envelope markers has since revealed that the nuclear 
envelope reforms on micronuclei at the same time as the main nucleus, (Liu et 
al., 2018). However, in lagging chromosomes in the spindle midzone, only “core” 
nuclear envelope proteins are recruited, in contrast to recruitment of the full 
complement of nuclear envelope proteins, including NPCs, in lagging 
chromosomes located in the cell periphery (Liu et al., 2018). The mechanism for 
two modes of nuclear assembly is due to presence of tightly-bundled spindle 
microtubules in the midzone restricting membrane access, as opposed to an 
Aurora B gradient restricting protein localization (Liu et al., 2018). 
 This finding might shed light on a discrepancy in findings regarding the 
fate of micronuclei depending on how the lagging chromosome formed. 
Chromatids in micronuclei generated by merotely do not replicate DNA and have 
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shown to missegregate often in future divisions (Crasta et al., 2012; Soto et al., 
2018), whereas chromatids in micronuclei generated by misalignment may 
missegregate less often (Fonseca et al., 2019). Merotelic chromosomes can be 
seen as lagging chromosomes within the spindle midzone (Cimini, 2003; Cimini 
et al., 2004), whereas this is not always the case with misaligned chromosomes 
(Fonseca et al., 2019). Micronuclei generated by misaligned chromosomes away 
from the spindle midzone may be more likely to have functioning NPCs and may 
thereby be able to import factors that allow DNA replication and functional 
kinetochore assembly. Further studies will illuminate whether different 
mechanisms of chromosome missegregation lead to micronuclei that contribute 
to aneuploidy more or less due to different levels of completeness in nuclear 
envelope reassembly. This is especially important to understand because 
micronuclei are additionally subject to adverse events that may lead to mutations. 
DNA within micronuclei is subject to damage, innate immune detection, 
deficient replication, and missegregation. It has been shown that micronuclei can 
undergo a loss in compartmentalization characterized by infiltration of the 
chromosome by ER membranes and increased DNA damage; this collapse is 
influenced by lamin B levels in micronuclei (Crasta et al., 2012; Hatch et al., 
2013; Vietri et al., 2020). Chromothripsis has also shown to occur in micronuclei, 
leading to complex rearrangements and indels in the chromosome contained in 
the micronucleus (Zhang et al., 2015). Collapse of the nuclear envelope in 
micronuclei leads to recognition of micronuclear cytosolic DNA by cGAS, which 
leads to downstream upregulation of type I interferon response genes 
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(MacKenzie et al., 2017). Nuclear rupture in micronuclei also cannot be repaired 
in a coordinated manner as in primary nuclei (Vietri et al., 2020). Finally, as 
mentioned previously, DNA in micronuclei may not replicate properly and often 
missegregates during mitosis (Crasta et al., 2012; Soto et al., 2018). Even if the 
DNA is incorporated into a primary daughter nucleus in the subsequent division, 
the cell runs the risk of damaged DNA from the micronucleus being propagated 
in future divisions (Giam and Rancati, 2015). The high prevalence of micronuclei 
in aggressive cancers likely reflects their role in increasing genome instability. 
Role of membrane dynamics in formation of micronuclei 
 Membrane dynamics have been implicated in chromosome missegregation 
that can lead to formation of micronuclei. Preventing clearance of ER 
membranes from chromatin by knocking down REEP3 and REEP4 leads to 
chromosome missegregation, including lagging chromosomes and chromosome 
bridges (Schlaitz et al., 2013). Artificially tethering ER membranes to chromatin 
prior to anaphase onset likewise prevents proper chromosome segregation 
(Champion et al., 2019). These data support the idea that membranes can 
impede proper chromosome segregation and raise the question of how 
membrane abundance and dynamics in mitosis regulate mitotic progression. 
 Despite the importance of membrane dynamics in mitosis influencing 
chromosome segregation, the role of lipid synthesis regulation of membrane 
abundance in regulation chromosome segregation has not been studied. 
Mammalian cells accumulate lipids prior to entry into mitosis (Jackowski, 1994), 
but it is not known if limiting membrane lipid synthesis impacts mitotic fidelity. 
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Here, I identify a link between regulation of ER membrane biogenesis and 
formation of micronuclei through the lipin phosphatase CTDNEP1. In Chapter 2, I 
characterize ER and nuclear envelope protein localization and functions using 
CRISPR-Cas9 gene editing in human cell lines, and I use a CRISPR-edited cell 
line to show that CTDNEP1 limits ER membrane abundance through its catalytic 
activity on lipin 1 and limits formation of micronuclei. In Chapter 3, I use live cell 
imaging time lapses to characterize the membrane dynamics of CTDNEP1-
depleted cells during cell division. I show that membranes are more abundant 
and less cleared in mitotic cells depleted of CTDNEP1. In Chapter 4, I investigate 
specific mechanisms of chromosome missegregation in CTDNEP1-depleted cells 
using small molecule inhibitors to show that specific errors that are not sensed by 
the spindle assembly checkpoint are less corrected in CTDNEP1-depleted cells. 
In Chapter 5, I elucidate the mechanism by which CTDNEP1 limits membrane 
biogenesis using lipidomic analysis, small molecule inhibition of fatty acid 
synthesis, and RNAi modulation of fatty acid synthesis gene expression. I show 
that CTDNEP1 limits flux into fatty acid and ER membrane lipid synthesis to limit 
membrane biogenesis. I additionally show that inhibition of fatty acid synthesis 
suppresses formation of micronuclei in CTDNEP1-depleted cells, which links the 
excess membranes in mitosis to error correction defects seen with loss of 
CTDNEP1. In Chapter 6, I discuss remaining questions and possibilities for 
future experiments. 
Together, these show that the protein phosphatase CTDNEP1 restricts ER 
membrane biogenesis through lipin 1 to facilitate mitotic error correction that 
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limits the formation of micronuclei in human cell lines. These data link regulation 
of lipid synthesis to chromosome segregation errors resulting in micronuclei, 
which can inform as to how chromosomal instability can occur in cancer cells 





Figure 1.1 Types of cellular lipids and their properties 
Schematic of types of membrane lipids. Organization of glycerolipids, 
sphingolipids and cholesterol into membrane microdomains shown. Head groups 
of lipids are shown in blue, backbones are shown in red, and fatty acid chains are 








Figure 1.2 The nuclear envelope and endoplasmic reticulum 
Organization of nuclear envelope and ER (focusing on peripheral ER) is shown. 
The nuclear lamina and chromatin are anchored to the inner nuclear membrane 
through inner nuclear membrane proteins. Nuclear pore complexes span the inner 
and outer nuclear membrane, and the LINC complex spans the nuclear 
membranes and connects the nuclear envelope to the cytoskeleton. In the ER, 
curvature-stabilizing proteins stabilize curvature at tubules, tubule junctions, sheet 
edges, and on ER nanohole edges. Sheet-stabilizing proteins localize to the center 
of sheets and stabilize the luminal width. ER structure is also dependent on 
contacts with the cytoskeleton and contact sites with other organelles (tethered 






Figure 1.3 Lipid synthesis pathways in the ER 
Schematic of lipid synthesis pathways in the ER (steps occurring in the ER are 
outlined in green). Citrate is converted to acetyl-CoA by ATP citrate lyase (ACLY). 
Acetyl-CoA is converted to acetoacetyl-CoA, and subsequent steps result in 
synthesis of cholesterol. Acetyl-CoA is also formed into fatty acids starting with 
conversion to malonyl Co-A by acetyl-CoA carboxylase (ACAC). Fatty acid 
synthase (FASN) elongates malonyl-CoA to palmitate, which is then converted to 
palmitoyl-CoA. Fatty acids are desaturated at the Δ9 position by stearoyl-CoA 
desaturase (SCD) and/or additionally desaturated by fatty acid desaturases 
(FADs) or elongated by ELOVs (Elongation of very long chain fatty acids proteins). 
These acyl-CoAs can be incorporated into sphingolipids or glycerolipids. Acyl-CoA 
is combined with glycerol-3-phosphate by glycerol-3-phosphate acyltransferase 
(GPAT) to form LPA. LPA can be additionally acylated by 1-acylglycerol-3-
phosphate-O-acyltransferase (AGPAT) to form PA. PA can be converted to CDP-
DAG by CDP-DAG synthase (CDS) and then PI by PI synthase (PIS). PI can be 
phosphorylated to form phosphatidylinositol phosphate derivatives (PIPs). PA can 
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be dephosphorylated by PAPs (including lipins) to DAG. DAG can be formed to 
TAG by diacylglycerol acyltransferase (DGAT) or PC or PE by choline or 
choline/ethanolamine phosphotransferase (CPT, CEPT); PC and PE can be 







Figure 1.4 Nuclear envelope and ER dynamics in mitosis 
Schematic of ER and nuclear envelope dynamics from nuclear envelope 
breakdown through mitotic exit. The nuclear envelope is intact in interphase, and 
centrosomes are unduplicated. During prometaphase, the nuclear envelope 
breaks down, and the nuclear envelope membranes are absorbed into ER 
membranes. Membranes are cleared from chromosomes and cleared to the cell 
periphery, excluded from the spindle. After anaphase, nuclear membranes contact 
chromosomes and reform the nuclear envelope. The membranes are sealed by 







Figure 1.5 Mechanisms of formation of micronuclei 
Schematic of mechanisms for how micronuclei can form. Chromosome 
abnormalities and attachment abnormalities in metaphase are shown with insets 
showing kinetochore-microtubule attachments and tension/pulling forces (black 
 
 38 
arrows). The result for chromosome segregation in anaphase is shown, as well as 
the consequence for interphase primary and micro-nuclei. In “SAC failure,” insets 







Chapter 2: Nuclear envelope-localized human CTDNEP1 regulates ER 
membrane biogenesis, nuclear morphology and formation of micronuclei 
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The structure of organelle membranes is important for organelle function. 
Tissue-specific functions rely on unique and highly adapted organelle structures, 
such as long ER tubules in neurons (Yalçın et al., 2017) or multilobed, flexible 
nuclei in some immune cells (Skinner and Johnson, 2017). Maintenance of 
organelle structure is shown to be specifically disrupted in many human 
diseases, highlighting the importance of understanding how organelle structure is 
established and maintained. 
Organelle structure can be maintained by membrane-shaping proteins. In 
the ER, reticulons stabilize membrane curvature through insertion of two 
hydrophobic helices (Voeltz et al., 2006). Reticulons oligomerize and cooperate 
with other ER-shaping proteins to stabilize new and existing curvature, including 
sheet edges and nanoholes (Hu et al., 2008; Schroeder et al., 2018; Shibata et 
al., 2010; Wang et al., 2016b). Ectopic reticulon overexpression causes formation 
of long, unbranched peripheral ER tubules, whereas knockdown of reticulons 
leads to an increase in ER sheets and decrease in tubules (Anderson and 
Hetzer, 2008; Schroeder et al., 2018; Shibata et al., 2010; Voeltz et al., 2006). 
Both reticulon overexpression and downregulation can be observed in 
neurodegenerative diseases, reflecting how tuning ER structure is important for 
cell function (Chiurchiù et al., 2014).  
Organelle structure is also determined by ER lipid synthesis. 
Overabundance of membranes through increased fatty acid synthesis without 
increased reticulon expression leads to ER sheet formation (Shibata et al., 2010). 
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Increased synthesis of PI, PC, and PE in yeast and PA and PI in C. elegans by 
deletion of the lipin phosphatase CTDNEP1 leads to ER membrane expansion 
and sheet formation, respectively, while nuclear envelope structure is also 
affected (Bahmanyar et al., 2014; Kim et al., 2007; Siniossoglou et al., 1998). For 
this study, we primarily focused on the function of human CTDNEP1 for 
maintaining ER and nucleus morphology through lipin 1 dephosphorylation. 
In metazoans, lipin’s catalytic activity determines whether glycerolipid 
species derived from PA or DAG are made in the ER. Lipin has also shown to 
have transcriptional regulation activities, in some cases indirectly through 
regulation of PA levels. In mice, lipin 1 has shown to positively regulate PPARα 
and PPARγ-dependent transcription to activate lipid breakdown and adipocyte 
differentiation (through transcription factor or repressor binding) (Finck et al., 
2006; Phan et al., 2004; Zhang et al., 2012). Nuclear lipin 1 represses SREBP-
dependent fatty acid synthesis gene transcription through an unknown 
mechanism (Peterson et al., 2011). Lipin 1 is sensitive to metabolic status 
through insulin-dependent phosphorylation by the nutrient-sensing kinase mTOR 
(Huffman et al., 2002; Peterson et al., 2011). Lipin 1 isoforms α and β 
transcriptional regulation permits differentiation of adipocytes through modulating 
PA levels (Grimsey et al., 2008; Koh et al., 2008; Phan et al., 2004; Zhang et al., 
2012), and consistent with this role, lipin 1-deficient mice and flies exhibit 
lipodystrophy (Péterfy et al., 2001; Ugrankar et al., 2011). Lipin 1’s transcriptional 
regulation activity is dependent on its localization; dephosphorylated lipin 
 
 42 
localizes to the nucleus, while phosphorylated lipin is retained in the cytoplasm 
and degraded (Peterson et al., 2011; Shimizu et al., 2017). 
CTDNEP1 and lipin 1 are both HAD superfamily phosphatases with 
canonical DXDX(T/V) active sites (Seifried et al., 2013) (Figure 2.1B-2.1C). 
CTDNEP1 has an N-terminal transmembrane domain and localizes to nuclear 
envelope and ER membranes (Bahmanyar et al., 2014; Han et al., 2012; 
Siniossoglou et al., 1998), while Pah1/lipin 1 is a cytosolic/nuclear protein that 
binds to PA in membranes for its PAP activity (Eaton et al., 2013; Han et al., 
2006). Lipin’s polybasic domain is important for its PA binding and is thought to 
serve as its nuclear localization signal (Eaton et al., 2013; Ren et al., 2010) 
(Figure 2.1C). CTDNEP1 localization and activity is allowed through interaction 
with its obligate binding partner, NEP1R1 (ySpo7) (Han et al., 2012; Siniossoglou 
et al., 1998). While CTDNEP1 and lipin 1 are HAD superfamily phosphatases, 
the phosphatase domain of lipins was recently found to be split into the NLIP and 
CLIP domains, which fold together to form the functional phosphatase domain 
(Khayyo et al., 2020) (Figure 2.1B-2.1C). Lipin 1 linker phosphorylation is now 
thought to prevent functional assembly of the phosphatase domain (Khayyo et 
al., 2020). 
The functions of human CTDNEP1 and lipin 1 are not fully known. Unlike 
the mouse model of lipodystrophy, human patients with lipin 1-inactivating 
mutations do not have lipodystrophy but instead present with rhabdomyolysis, 
episodic breakdown of muscle tissue leading to myoglobinuria, during childhood 
(Michot et al., 2010; Zeharia et al., 2008). Truncating mutations in CTDNEP1 are 
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found in Group 3/4 and uncharacterized medulloblastomas, cancers of the 
cerebellum (Jones et al., 2012; Northcott et al., 2017). Patients in these 
subgroups of medulloblastoma frequently have loss of heterozygosity at Chr17p 
where CTDNEP1 (and prominent tumor suppressor TP53) are located, while 
TP53 is unaltered, making CTDNEP1 a tumor suppressor candidate in this 
region (Jones et al., 2012). The disease mechanisms for loss of function of 
CTDNEP1 and lipin 1 are not understood. Unlike in lipin-deficient mice, adipose 
tissue of patients lacking functional lipin 1 has normal composition, though lipid 
droplets are smaller, and adipogenic gene expression is upregulated (Pelosi et 
al., 2017). Human adipose tissue may have compensatory mechanisms in place 
that are not present in mice, or lipin’s functions in human adipose tissue may not 
be fully conserved. These differences warrant study of lipin 1 and CTDNEP1 to 
further understand their regulation of lipid synthesis in human cells. 
Here, I show that CTDNEP1 is required for limiting ER membrane 
biogenesis in a human cancer cell line. I establish methods for quantifying ER 
membrane abundance and qualitatively assessing changes in ER structure 
through modulating reticulon levels versus ER abundance through CTDNEP1 
and lipin. I also demonstrate that CTDNEP1 and lipin 1 catalytic activity are 
required for limiting ER membrane abundance. I also show that CTDNEP1 has a 
conserved role for maintaining nuclear shape. These data show that regulation of 
ER membrane biogenesis and nuclear morphology in human cells through 
CTDNEP1 and lipin 1 converges with limiting ER biogenesis in other model 
organisms, despite differences in lipid synthesis pathways and lipid synthesis 
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regulation between organisms. These data also uncover a previously unknown 
role for CTDNEP1 in regulating formation of micronuclei.  
Results 
CRISPR-Cas9 strategies for targeting nuclear envelope and ER proteins reveals 
role for reticulons in ER nanohole formation/stability 
 To determine the role of reticulons in the formation or stabilization of 
curvature within ER sheets in ER nanoholes, I generated a CRISPR knockout 
cell line of all isoforms of reticulon 4 (Figure 2.2A-B). The sgRNA targeted the 
sequence corresponding to a hydrophobic region within the reticulon homology 
domain, in order to disrupt the synthesis of stable reticulon 4 isoforms (Figure 
2.2A). Consistent with the depletion of reticulon isoforms, reticulon 4 B/D were 
unable to be detected by immunoblot in RTN4KO U2OS cells (Figure 2.2B). 
Immunostaining RTN4KO cells with an antibody targeting the reticulon 4 N 
terminus (targeting RTN4A/B/D) did not show any specific staining unlike in 
unmodified U2OS cells (data not shown). Triple knockdown of reticulons 1,3, and 
4 induces ER sheet formation (Anderson and Hetzer, 2008). With L. K. 
Schroeder, I imaged U2OS or RTN4KO U2OS cells treated with control or 
RTN1/3-targeting siRNA by confocal and stimulated emission depletion (STED) 
nanoscopy (Figure 2.2C). Nanoholes can be seen in ER sheets in control cells 
(Figure 2.2C, above inset and arrows), whereas sheets in reticulon-depleted cells 
are devoid of nanoholes (Figure 2.2C, below inset). On the population level, 
control U2OS cells have more small peripheral sheets that are non-uniform in 
appearance, whereas reticulon-depleted cells have extended ER sheets that are 
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uniform in appearance throughout (Schroeder et al., 2018). Thus, reticulons are 
involved in ER nanohole formation or maintenance. 
 To determine nanohole size relative to other membrane features by live 
STED nanoscopy, a homozygous endogenous marker of a well-defined feature 
was needed. Nuclear pore complexes have a defined size of ~100 nm and vary 
little in size, making them an ideal candidate. I targeted the Y complex 
nucleoporin NUP160 because NUP160 fusion proteins are functional in multiple 
model organisms, which is particularly important in the case where every copy of 
the gene is tagged. Using homology-directed repair with CRISPR-Cas9, I tagged 
all alleles of endogenous NUP160 with the coding sequence for the dye ligand 
covalent binding partner HaloTag7 (Figure 2.3A-2.3B). Endogenously-tagged 
NUP160 localized to the nuclear envelope in a punctate localization, as expected 
(Figure 2.3C). A coverslip-level section highlights the punctate localization of the 
protein (Figure 2.3C). STED nanoscopy of NUP160-Halo revealed a consistent 
~100 nm size of nuclear pore complex membrane holes, which contrasts with a 
large range of ER nanohole sizes (Schroeder et al., 2018). 
CRISPR-Cas9 strategies for targeting human CTDNEP1  
To understand the cellular functions of human lipin 1 and CTDNEP1 in this 
study, I targeted human CTDNEP1 for generation of tagging knock-in and 
knockout cell lines (Figure 2.4, Figure 2.6). Targeting CTDNEP1 is preferable to 
targeting lipin due to the presence of 3 lipins in human cells with some functional 
redundancy, and targeting lipin activation is less detrimental to cell health than 
lipin deletion to permit functional studies (Bahmanyar et al., 2014; Donkor et al., 
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2007; Gorjánácz and Mattaj, 2009). Depleting cells of CTDNEP1 also allows us 
to study the roles of lipin’s S/T phosphorylation state, as there are post-
translational modifications of lipin not regulated by CTDNEP1 that cannot be 
ruled out by targeting lipin alone (Liu and Gerace, 2009; Song et al., 2020). 
 I generated a CTDNEP1 knockout clonal U2OS human osteosarcoma cell 
line using CRISPR-Cas9 (Figure 2.4A). This knockout cell line has a 
homozygous truncating single-nucleotide insertion in exon 3 just past the DLDET 
active site (Figure 2.4B). Although the active site is intact, this truncating 
mutation makes CTDNEP1 transcripts in this cell line candidates for nonsense-
mediated decay, as CTDNEP1 mRNA levels in CTDNEP1KO U2OS cells are 
decreased by >80%, similar to knockdown of CTDNEP1 in U2OS and RPE-1 
cells (Figure 2.5A). This cell line is deficient in CTDNEP1 phosphatase activity, 
as J. W. Carrasquillo Rodríguez found that lipin 1 in CTDNEP1KO cells is 
hyperphosphorylated and less abundant (Merta et al., 2021).  
Localization of endogenous CTDNEP1 
The localization of CTDNEP1 in human cells is not known but has the 
potential to inform the mechanism for how lipin 1’s localization to the nucleus is 
regulated – Nem1 in yeast localizes to nuclear envelope/ER membranes, but 
CNEP-1 in C. elegans is enriched at the nuclear envelope (Bahmanyar et al., 
2014; Siniossoglou et al., 1998). Generation of a CTDNEP1-specific antibody 
has proven difficult (S. Bahmanyar, G. Celma, T. Vitale, Y. Kim, 
correspondence). A commercial CTDNEP1 peptide antibody, a commissioned 
commercial peptide antibody, and an antibody made using CTDNEP1 with 3 
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internal deletions to improve solubility all failed to show specific staining by 
immunoblot or immunofluorescence (data not shown; with Tevis Vitale and Gunta 
Celma). To determine the localization of endogenous human CTDNEP1, I 
generated a CRISPR knock-in U2OS cell line in which all copies of CTDNEP1 
are tagged with GFP (Figure 2.6). Live spinning disk confocal imaging of GFP 
signal in U2OS CTDNEP1EN-GFP cells reveals that CTDNEP1 localizes to the 
nuclear envelope with some cytoplasmic localization likely corresponding to ER 
membranes (Figure 2.7A, left). Knockdown of CTDNEP1 in U2OS CTDNEP1EN-
GFP cells abrogates GFP fluorescence at the nuclear envelope (data not 
shown). Fluorescent punctae are also seen in the perinuclear region of cells 
(Figure 2.7A, left). Imaging immunostained GFP in U2OS CTDNEP1EN-GFP cells 
shows nuclear envelope localization and perinuclear diffuse staining, perhaps 
localizing to ER membranes (Figure 2.7A, right). The perinuclear punctate 
fluorescence seen in live imaging of CTDNEP1-GFP is not seen in 
immunostained cells, indicating that this could be an artifact of high exposure 
needed to visualize low-expressing CTDNEP1. If not, this localization could 
correspond to lipid droplets, which CTDNEP1 has shown to localize to in yeast 
(Choudhary et al., 2020). Future colocalization studies will reveal if CTDNEP1 in 
human cells localizes to compartments other than the nuclear envelope, as well 
as what face of the nuclear envelope CTDNEP1 localizes to, to further enlighten 
its functions. 
CTDNEP1 controls ER membrane abundance in human cells 
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 Deletion of CTDNEP1 in yeast (yNem1) leads to a proliferation of ER and 
nuclear envelope membranes (Kim et al., 2007; Siniossoglou et al., 1998). I 
transiently expressed GFP-KDEL in U2OS CTDNEP1KO cells to visualize ER 
morphology. Control U2OS cells have an ER morphology consisting of dense ER 
sheets close to the nucleus and a peripheral network of mostly tubules arranged 
in 3-way junctions (Figure 2.8A, top and top inset). In contrast, CTDNEP1KO 
U2OS ER appears to be expanded and dense uniformly throughout the cell, 
extending to the periphery (Figure 2.8A, bottom). ER tubules and sheets can be 
seen in the cell periphery (Figure 2.8A, bottom inset). This phenotype is highly 
penetrant, occurring in 93.7 ± 3.9 % of cells (Figure 2.8B). To rule out the 
possibility that this “expanded ER” phenotype is exclusive to GFP-KDEL 
overexpression, I fixed U2OS cells with formaldehyde and glutaraldehyde to 
preserve membrane structure and stained them with a calnexin antibody to mark 
ER membranes. Staining of this endogenous ER marker also revealed that the 
ER is more packed and denser in CTDNEP1KO U2OS cells compared to control 
cells (Figure 2.8C).  
 Two subsequent attempts to generate of a second clonal CTDNEP1KO cell 
line using a different guide RNA sequence (targeting exon 1) were unsuccessful. 
To control for the possibility that the expansion of ER membranes in CTDNEP1KO 
cells could be due to non-CTDNEP1 mutations in the clonal cell line, I knocked 
down CTDNEP1 in unmodified U2OS cells (Figure 2.5A, right; Figure 2.9). Cells 
subject to CTDNEP1 RNAi showed expanded ER membranes (Figure 2.9A). 
With a knockdown to 9.3 ± 0.43% of CTDNEP1 mRNA transcript levels 
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determined by qRT-PCR, 77.5 ± 6.42% of cells treated with CTDNEP1 siRNA 
had expanded ER, closely resembling the phenotype penetrance in CTDNEP1KO 
U2OS cells (Figure 2.5A, right; Figure 2.9B). 
 To determine if the effect of depleting CTDNEP1 leading to expansion of ER 
membranes is cell line-specific, I chose RPE-1 cells to replicate this phenotype. 
Although U2OS cells are amenable to imaging organelles due to their size and 
spread-out shape, U2OS is a cancer cell line, and cancer cell lines can have 
upregulated expression of fatty acid synthesis genes (Cheng et al., 2018). This 
could possibly sensitize them to alterations in lipid synthesis pathways. RPE-1 
cells are non-transformed, non-cancer, and mostly karyotypically normal, and 
they are ideal for ruling out the possibility of cancer cell specificity for CTDNEP1 
depletion phenotypes. RPE-1 cells have a smaller ER tubular network per cell 
area compared to U2OS cells (Figure 2.10A, left), but expansion of ER 
membranes can still be seen when CTDNEP1 is knocked down (Figure 2.10A, 
right). This presents as a disappearance of the peripheral tubular network and 
bright ER filling the cell to the cell edge, obscuring individual ER features, like 
tubules (Figure 2.10A, right). This phenotype was also highly penetrant in RPE-1 
cells (Figure 2.10B). In addition to replicating expansion of ER membranes with 
CTDNEP1 depletion in RPE-1 cells, E. Guinn and S. Lee have found that 
depletion of CTDNEP1 leads to ER expansion in COS-7 (African green monkey 
kidney) and DLD-1 (human colorectal adenocarcinoma) cells (data not shown). 
These data support the conclusion that CTDNEP1 limits the abundance of ER 
membranes in human cells from multiple tissue types and origins. 
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Quantitative and qualitative assessment of ER membrane morphology and 
abundance 
 To assess penetrance of the expanded ER phenotype in cell lines, I used 
scoring and incidence of the phenotype to report our findings. However, 
quantification of ER membrane expansion is needed to confirm the findings and 
to assess if a continuum of phenotypes exists. Segmentation of fluorescent ER 
signal has been used to discern the percentage of ER-positive pixels belonging 
to ER tubules or sheets to show which how a membrane fusion-regulating protein 
is required for tubule fusion and reducing ER sheets (English and Voeltz, 2013). 
In this study, the authors made maximum projections of ER signal, reduced the 
bit depth from 16-bit to 8-bit, and segmented both total ER and sheet-like ER 
using the Renyi entropy thresholding algorithm before quantifying sheet-like ER 
versus total ER (English and Voeltz, 2013). The advantage of this approach is 
that reducing the bit depth and making the image a maximum projection of ER 
signal makes it easier to segment total ER, which takes on a variety of 
morphologies of different brightnesses due to different thicknesses and, in some 
cases, non-uniform distribution of fluorescent markers or ms-scale ER movement 
(Nixon-Abell et al., 2016; Schroeder et al., 2018). I sought to adapt this technique 
to quantify changes in ER membrane overall abundance rather than structure. 
To quantify changes in the amount of membranes in cells with altered lipid 
synthesis by depletion of CTDNEP1, I measured the area fractions of cells that 
are taken up by ER membranes. Starting with 16-bit spinning disk confocal 
image stacks of GFP-KDEL (live) or calnexin (fixed) signal that encompassed the 
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entire cell volume, I reduced the bit depth to 8-bit and made maximum intensity 
projections of the image stacks. To ensure that peripheral tubules would be 
segmented as well as brighter ER features, I applied an unsharp masking filter to 
the maximum projection images, which subtracts a Gaussian blurred image (here 
with a radius of 0.2 and mask of 0.6) from the unaltered image to sharpen it 
(Figure 2.11A). I then thresholded the image using the Huang algorithm, which 
relies on measures of image fuzziness (Huang and Wang, 1995) (Figure 2.11A). 
Fuzziness in images refers to the extent of lack of belonging to the object or the 
background (Huang and Wang, 1995). The Huang algorithm in ImageJ finds the 
threshold at which fuzziness is minimized. I rationalized using the Huang 
algorithm for segmenting total ER because there is a wide dynamic range of 
maximum projection ER brightness due to morphology differences throughout the 
cell, and maximizing object-belonging is desirable to segment dim tubules with 
bright perinuclear ER. In practice, this thresholding segments total ER well 
(Figure 2.11A, images). I then manually drew outlines of the cell border and 
nucleus and then measured the percent area of the cytoplasm occupied by ER 
membranes (Figure 2.11A). Using this method, I show that CTDNEP1KO U2OS 
cells have higher occupancy of the cytoplasm with ER membranes compared to 
control U2OS cells (Figure 2.11B). Cells depleted of CTDNEP1 by RNAi also 
have a higher percentage of ER-positive pixels taking up the cytoplasm area 
compared to cells treated with control siRNA (Figure 2.11B). The spread of 
individual values in control U2OS cells is large compared to the spread of values 
in CTDNEP1KO cells (~55-85% in control cells versus ~85-100% in CTDNEP1KO 
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cells) reflecting how CTDNEP1KO cells’ ER takes up a large proportion of the 
cytoplasm (Figure 2.11B). Cells treated with CTDNEP1 siRNA also have a larger 
spread of individual values and lower overall occupancy of ER in the cytoplasm 
compared to CTDNEP1KO cells, likely due to a lesser extent of CTDNEP1 
depletion with RNAi knockdown (Figure 2.11B). 
 To distinguish between expansion of ER membranes due to increased 
membrane abundance and alteration of ER morphology, I compared cells 
depleted of CTDNEP1 to cells depleted of reticulons 1, 3, and 4 (Figure 2.12). 
Depletion of reticulons 1, 3, and 4 causes the ER to form more membrane sheets 
that lack nanoholes, as well as thicker ER tubules (Anderson and Hetzer, 2008; 
Schroeder et al., 2018) (Figure 2.2C; Figure 2.12A, below, yellow arrow). In all 
cells, perinuclear ER is brightest and appears most dense (Figure 2.12A, blue 
arrows). In control U2OS and reticulon-depleted U2OS, peripheral ER tubules 
can be seen at the edge of cells, and ER sheets of roughly the same brightness 
as tubules can be seen in reticulon-depleted cells (Figure 2.12, left and below, 
yellow arrows). In contrast, the ER in CTDNEP1KO cells is more uniformly bright 
in all areas of the cell, reflecting increased membranes rather than a shift in 
structure of existing membranes (Figure 2.12, right, yellow arrow). Thus, the 
appearance of expanded ER membranes in CTDNEP1KO cells can be 
distinguished from a change in ER membrane structure by assessment of 
uniform ER brightness through the whole cell.  




 To determine if the expansion of ER membranes in CTDNEP1KO cells is due 
to loss of CTDNEP1 phosphatase activity, I transiently overexpressed 
CTDNEP1-HA wild type and mutant constructs with and without its obligate 
binding partner NEP1R1 (Figure 2.13A-B). Overexpressed CTDNEP1 and 
NEP1R1 localize to the nuclear envelope and ER membranes (Figure 2.13A). 
Expression of wild type CTDNEP1-HA alone (Figure 2.13A-B, “WT”) partially 
suppressed the incidence of expansion of ER membranes in CTDNEP1KO cells 
(Figure 2.13B). Consistent with its role in stabilizing CTDNEP1 localization and 
activity, NEP1R1 overexpression with expression of catalytically active 
CTDNEP1 rescued expansion of ER membranes to a greater extent (Santos-
Rosa et al., 2005) (Figure 2.13B). CTDNEP1 in which the DLDET active site is 
mutated to ELDET (D67E; “PD”) to render it phosphatase dead does not rescue 
ER expansion when co-expressed with NEP1R1, indicating that it is loss of active 
CTDNEP1 that is responsible for expansion of ER membranes in CTDNEP1KO 
cells (Figure 2.13A-B). 
 Transient overexpression of CTDNEP1 in U2OS cells leads to localization 
that is not consistent with localization of endogenous CTDNEP1 (Figure 2.7; 
Figure 2.13A). Therefore, I quantified the incidence of ER expansion and 
occupancy of ER membranes in CTDNEP1KO cells stably expressing wild type 
CTDNEP1 (Figures 2.13C-D, “WT (stable)”). Stable overexpression of 
CTDNEP1-HA substantially reduced the incidence of expanded ER in 
CTDNEP1KO cells (Figure 2.13C). Stable overexpression of CTDNEP1-HA also 
reduced the occupancy of ER membranes in the cytoplasm of CTDNEP1KO cells 
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(Figure 2.13D). Together, these data support the conclusion that expansion of 
ER membranes in CTDNEP1KO cells is due to loss of CTDNEP1 catalytic activity. 
 CTDNEP1’s primary known substrate for dephosphorylation is the 
phosphatidic acid phosphatase lipin (Santos-Rosa et al., 2005). Since lipin 
controls ER membrane lipid synthesis (Figure 2.1A), I sought to determine if the 
expansion of ER membranes in CTDNEP1KO cells is caused by loss of lipin 1 
control of lipid synthesis. I overexpressed lipin 1 in CTDNEP1KO cells (Figure 
2.14A). Mouse lipin 1β is the most well-studied mammalian lipin and has a 
variety of known mutants for studying its activity and localization (Harris et al., 
2007; Peterson et al., 2011). Further, unlike in humans, the S/T phospho-sites of 
lipin 1 in mouse are confirmed by multiple mass spectrometry studies and are 
well-characterized (Harris et al., 2007; Peterson et al., 2011). I overexpressed 
FLAG-lipin 1β constructs in CTDNEP1KO cells and visualized ER morphology 
with calnexin staining (Figure 2.14A).  Wild type lipin 1β overexpression partially 
suppressed the incidence of expanded ER in CTDNEP1KO U2OS cells (Figure 
2.14A-B). This rescue is likely partial because CTDNEP1 is not present to 
dephosphorylate the overexpressed lipin. Therefore, I overexpressed a mutant 
form of lipin 1β in which 19 of the S/T sites identified by mass spectrometry as 
being known or probable insulin-dependent phosphosites are mutated to alanine 
(“19S/T to A”, Figure 2.1A/B). This construct drives nuclear localization of lipin 1β 
in mouse cells (Peterson et al., 2011). Consistent with this finding, lipin 1β 19S/T 
to A localizes more to the nucleus than wild type lipin 1β in U2OS cells (Figure 
2.14A, 2.15C). In order to determine if the loss of membrane biogenesis 
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regulation in CTDNEP1KO cells is specifically due to loss of lipin 1 phosphatidic 
acid phosphatase activity, I overexpressed a mutant form of mouse lipin 1β that 
has 19 S/T residues mutated to A but also has two mutations in the DXDXT 
active site (DIDGT>EIEGT) that renders it phosphatase dead (Figure 2.14A-
2.14B, “19S/T to A PAP dead”). Overexpression of this construct does not 
suppress the incidence of ER expansion in CTDNEP1KO cells (Figure 2.14B). 
Based on these data, I conclude that the expansion of ER membranes is due to 
loss of CTDNEP1 dephosphorylation of lipin 1 to potentiate its catalytic activity. 
 Lipin 1 is known to regulate multiple transcription-based mechanisms of lipid 
homeostasis in a manner that is dependent on its localization to either the 
nucleus or cytoplasm (Finck et al., 2006; Peterson et al., 2011; Phan et al., 2004; 
Zhang et al., 2012). PPAR-mediated gene transcription is thought to be activated 
by lipin 1 binding a transcription factor or binding and sequestering a nuclear 
repressor (Finck et al., 2006; Phan et al., 2004; Zhang et al., 2012). Conversely, 
SREBP-mediated gene transcription is negatively regulated by nuclear lipin 1, 
although the mechanism for this is not clear (Peterson et al., 2011). To determine 
the impact of localization of lipin on the abundance of ER membranes in 
CTDNEP1KO U2OS cells, I transiently expressed constructs of mouse lipin 1β 
with either a nuclear localization signal or nuclear export signal appended to the 
C terminus (Figure 2.15A). These signals were introduced to the C termini of the 
lipin constructs to minimize interference with the endogenous NLS located near 
the N terminus (that is also important for PA binding and thus lipin activity) (Eaton 
et al., 2013) (Figure 2.1C). In contrast to wild-type lipin 1β, which localizes to 
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mostly the cytoplasm, lipin 1β-NES localized more to the cytoplasm, and lipin 1β-
NLS localized more to the nuclear compartment (Figure 2.15C).  
 Overexpression of wild type lipin 1β partially suppressed the incidence of 
expanded ER in CTDNEP1KO cells (54.6 ± 8.1% in transfected cells vs 93.2 ± 
4.4% in untransfected cells; Figure 2.14B). Appending either an NLS or NES to 
lipin 1β did not increase the extent of rescue of expanded ER in CTDNEP1KO 
cells (64.2 ± 0.1% in lipin 1β-NLS-transfected cells vs 83.3 ± 2.5% in 
untransfected cells; 58.9 ± 3.7% in lipin 1β-NES-transfected cells vs 83.5 ± 1.5% 
in untransfected cells; Figure 2.15B). This finding is surprising given that lipin’s 
localization has shown to be important for mediating transcription of fatty acid 
synthesis genes (Peterson et al., 2011). These data suggest that restoring lipin 
1β activity overall in the cell is what is important for regulating ER abundance 
rather than localization of lipin alone. Alternatively, minor pools of lipin in cellular 
compartments may be sufficient to limit the synthesis of ER membranes.  
An alternative mechanism for the etiology of ER membrane expansion in 
CTDNEP1-depleted cells is that PPARα activation by lipin is lowered, leading to 
decreased lipid breakdown (Finck et al., 2006). There is a known PPARα-binding 
motif, LXXIL, in lipin 1β, and mutation of this motif to LXXFF reduces the 
interaction with PPARα (Finck et al., 2006). This mutation also greatly reduces 
lipin 1β PAP activity, likely because the LXXIL motif is 6 residues away from the 
active site (Finck et al., 2006). We reasoned that if ER expansion is mediated 
through PPARα activation, overexpression of the binding mutant lipin would not 
rescue ER expansion to any extent, despite the PAP activity being reduced. 
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Unexpectedly, overexpression of lipin 1β with 19 S/T residues mutated to A and 
the LXXIL motif mutated to LXXFF partially suppressed ER membrane expansion 
in CTDNEP1KO cells (Figure 2.15B), indicating that lack of PPARα transcriptional 
regulation is not the major mechanism of ER expansion in CTDNEP1KO cells. 
Since phosphatase-deficient lipin 1β does not rescue ER membrane expansion 
at all, we conclude that lipin 1β 19xA LXXFF is at least partially functional. 
Mutation of S/T residues to alanine greatly increases PAP activity because 
dephosphorylation increases PAP activity (Eaton et al., 2013); the 19xA 
mutations may have a larger positive effect on the PAP activity of lipin 1β than 
the negative effect of the LXXFF mutation. These data together support the 
conclusion that ER membrane expansion in CTDNEP1KO U2OS cells is due to 
loss of lipin 1β catalytic activity that is not dependent on lipin 1β localization and 
may not involve PPARα-dependent transcription. Thus, when CTDNEP1 is 
present, dephosphorylated, active lipin 1β limits ER membrane biogenesis. 
Expression of endogenous ER proteins in CTDNEP1KO cells 
The expansion of ER membranes in CTDNEP1KO cells raises the question of 
whether CTDNEP1-depleted cells contain more ER-resident proteins. Further, a 
mouse model of lipin 1 depletion in only muscle tissue exhibits accumulation of 
neutral lipids and ER stress of the sarcoplasmic reticulum (muscle cell ER), with 
consistently increased expression of the ER protein folding chaperone Binding 
immunoglobulin Protein (BiP) (Rashid et al., 2019). To establish whether ER-
resident protein levels are increased in CTDNEP1KO cells, I determined the 
expression of ER-resident proteins calnexin, calreticulin, and BiP by immunoblot 
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(Figure 2.16). Calnexin and calreticulin are protein folding chaperones that bind 
and stabilize glycosylated proteins to facilitate folding and oligosaccharide 
processing (Williams, 2006). Levels of calnexin and calreticulin in CTDNEP1KO 
U2OS cells are not increased relative to control levels (Figure 2.16A). BiP levels 
are also not increased in CTDNEP1KO cells (Figure 2.16B). Thus, ER-resident 
protein levels appear to not be increased with loss of CTDNEP1. Future studies 
will clarify if other ER stress pathways are upregulated with loss of CTDNEP1. 
 As stated previously, it has been hypothesized that the morphology of the ER 
depends on membrane abundance and concentration of curvature/morphology-
stabilizing proteins (Shibata et al., 2010). To determine reticulon expression in 
CTDNEP1KO cells, I immunoblotted for reticulon 4B/D (Figure 2.16C). In 
immunoblotted control cell lysates, two bands can be seen (Figure 2.16C). 
Surprisingly, a third, higher molecular-weight species was present in 
CTDNEP1KO lysates, and the RTN4B/D species that were also in control cells 
were less abundant (Figure 2.16C). This higher molecular weight species is 
unlikely to be a reticulon oligomer due to its size (~55 kDa vs 50 kDa). RTN4B 
can be phosphorylated on S16 by cyclin-dependent kinases and on S107 with 
oxidative stress induction (Rodríguez-Feo et al., 2015; Schweigreiter et al., 
2007), so these species might represent phosphorylated RTN4B or RTN4B/D 
with other post-translational modifications. Future studies will clarify if reticulon 
levels or post-translational modifications are altered with loss of CTDNEP1 and 




CTDNEP1 has a conserved function for maintaining nuclear shape 
Loss of CTDNEP1 leads to altered nuclear morphology in multiple model 
systems. Expansion of ER and nuclear envelope membranes in budding and 
fission yeast with loss of Nem1 leads to lobulated nuclear structures 
(Siniossoglou et al., 1998; Tange et al., 2002). I sought to determine if regulation 
of nuclear structure by CTDNEP1 is conserved in human cells. Nuclear shape 
was measured by assessing solidity of DAPI-stained nuclei (Figure 2.17A). 
Solidity is defined as the area fraction of a convex hull for an object; more circular 
nuclei have solidity values closer to 1.0, whereas highly lobulated nuclei have 
solidity values less than 1 and decreasing with lobulation (Figure 2.17A). Nuclei 
of CTDNEP1KO cells have lower solidity compared to nuclei from control U2OS 
cells (Figure 2.17B). An established measure for the percentage of nuclei in a 
population that have low solidity is the percentage of nuclei that have solidity 
values less than one standard deviation from the mean control solidity value 
(Fonseca et al., 2019). By this standard, a higher percentage of CTDNEP1KO 
cells have low nuclear solidity values compared to control cells (31.7 ± 14.3 % of 
CTDNEP1KO cells compared to 12.9 ± 5.3 % of control cells; Figure 2.17C). To 
determine if this change in nuclear shape is due to loss of CTDNEP1, I measured 
nuclear solidity in CTDNEP1KO cells stably overexpressing CTDNEP1-HA (Figure 
2.18). Overexpression of CTDNEP1 suppresses the low solidity of CTDNEP1KO 
cells, both by measuring the population averages and percentage of nuclei with 
low solidity (12.8 ± 1.3 % of CTDNEP1-overexpressing CTDNEP1KO cells 
compared to 39.3 ± 5.5 % of CTDNEP1KO cells; Figure 2.18A-2.18B). These data 
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support the conclusion that CTDNEP1 has a conserved function for maintaining 
nuclear morphology. 
CTDNEP1 limits formation of micronuclei  
 While observing nuclear morphology, I noticed that nuclei of CTDNEP1KO 
cells frequently had micronuclei (Figure 2.19A, arrow in inset). I quantified the 
percentage of nuclei with micronuclei and found that more CTDNEP1KO cells had 
micronuclei than control cells (10.2 ± 2.9 % of CTDNEP1KO cells compared to 4.3 
± 0.8% of control cells; Figure 2.19B, above). To determine if the increase in 
micronuclei in CTDNEP1KO cells is due to loss of CTDNEP1 function, I quantified 
the incidence of micronuclei in CTDNEP1KO cells stably overexpressing 
CTDNEP1-HA. Overexpression of CTDNEP1 suppressed formation of 
micronuclei in CTDNEP1KO cells (2.6 ± 1.3 % of CTDNEP1-expressing 
CTDNEP1KO cells compared to 13.2 ± 5.1 % of CTDNEP1KO cells; Figure 2.19B). 
Thus, CTDNEP1 limits formation of micronuclei. 
Discussion 
This work defines the roles of CTDNEP1 and lipin 1 in regulating ER 
membrane biogenesis (Figure 2.20) and nuclear structure (Figure 2.21) in human 
cells. Using human cell lines edited using CRISPR-Cas9 to tag endogenous 
CTDNEP1 loci with GFP, we show that CTDNEP1 is enriched at the nuclear 
envelope as CNEP-1 is in C. elegans early embryos (Bahmanyar et al., 2014). 
Using RNAi depletion of CTDNEP1 and a U2OS cell line in which CTDNEP1 was 
knocked out using CRISPR-Cas9, we show that CTDNEP1 limits the abundance 
of ER membranes. Quantitation of ER membrane segmentation confirms this 
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finding and provides a tool for future assessment of genetic modifications that 
alter lipid synthesis to determine if ER membrane abundance is affected. 
Qualitative comparison of CTDNEP1-depleted cells to ER shaping protein-
depleted cells reveals that densely packed ER in CTDNEP1-depleted cells 
appears different from ER with more sheets. Overexpression of CTDNEP1 
constructs in CTDNEP1KO cells confirms a role for NEP1R1 in human cells for 
stabilizing CTDNEP1 as in yeast (Han et al., 2012; Santos-Rosa et al., 2005) and 
confirms that expansion of ER membranes in CTDNEP1KO cells is due to loss of 
CTDNEP1 catalytic activity. Overexpression of mouse lipin 1β constructs in 
CTDNEP1KO cells reveals that ER membrane expansion is due to loss of lipin 1 
catalytic activity. Together, these data show that CTDNEP1 and lipin 1 control 
ER membrane biogenesis in human cells. 
The finding that lipin 1 localizing to either the nucleus or cytoplasm 
partially rescue ER expansion in CTDNEP1KO cells to a similar extent as non-
specifically localized lipin is surprising given the nuclear envelope localization of 
endogenous CTDNEP1, which suggests local regulation of lipin. One 
consequence of CTDNEP1 depletion is that lipin levels are reduced (Merta et al., 
2021) (finding by J.W. Carrasquillo Rodríguez). It is possible that overexpressed 
catalytically active lipin satisfies a requirement of raising levels of lipin in the cell 
to raise overall cellular PA, which then re-balances ER lipid synthesis (Figure 
2.20A-B). In yeast, lipin localizes to the nuclear envelope (to the nuclear-vacuolar 
junction) under starvation conditions and produces DAG for TAG synthesis 
(Barbosa et al., 2015), so a similar mechanism may be in place for lipin and 
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CTDNEP1 localization to control lipid synthesis. We additionally found that a 
PPARα binding site mutant of dephospho-mimic 19xA lipin 1β appears to be 
catalytically active in that it partially suppresses ER expansion with loss of 
CTDNEP1, in contrast to previous findings. As previously mentioned, the 
dephosphorylation-mimic mutations may counteract the effects of reducing PAP 
activity that is caused by mutating the PPARα binding site. Future studies will 
illuminate the specific effects of lipin localization and post-translational 
modification in regulating its catalytic activity and ER lipid synthesis in human 
cells. 
 An open question that remains is whether the catalytic activity of lipin 1 limits 
ER membrane biogenesis by limiting synthesis of certain lipids, or shifting flux of 
lipid synthesis toward triglycerides and away from membrane biogenesis, or by 
influencing a combination of these (Bahmanyar et al., 2014; Grillet et al., 2016). 
In transcriptionally quiescent C. elegans early embryos, loss of CNEP-1 leads to 
an increase in PA and PI and increased ER sheets (Bahmanyar et al., 2014). In 
yeast, depletion of Nem1p leads to increased nuclear envelope and ER 
membrane biogenesis (Barbosa et al., 2015; Santos-Rosa et al., 2005; 
Siniossoglou et al., 1998). Loss of lipin 1 (yPah1) catalytic activity alone can 
explain the expansion of ER membranes in yeast, because yeast can utilize the 
CDP-DAG pathway to make PC and PE in addition to PI (the major membrane 
glycerophospholipid in yeast) (Barbosa et al., 2015). It has been hypothesized 
that lipin activity balances energy storage (as triglycerides) and membrane 
biogenesis (as PC and PE synthesis) in mammalian cells (Grillet et al., 2016). In 
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this model, increased lipin activity leads to greater DAG stores and higher TAG 
synthesis. Loss of lipin activity leads to increased synthesis of CDP-choline to in 
turn form PC because increased PA leads to increased CCTα activation (Grillet 
et al., 2016). In Arabidopsis, lipin (PAH1) depletion leads to increased ER sheets, 
and this occurs through increased PA activating CCTα to upregulate PC 
synthesis (Craddock et al., 2015). Evidence of PA activating CCTα in mammalian 
cells is lacking. It is known in multiple organisms, however, that CCTα senses 
membrane packing to increase CDP-choline synthesis (Cornell and Ridgway, 
2015). DAG is also required for PC synthesis through the Kennedy pathway; in 
Arabidopsis, DAG levels in lipin mutants are not limiting for PC synthesis 
(Craddock et al., 2015), though it is not known if this is the case in mammals. 
Thus, the contribution of CCTα to increasing PC synthesis in human cells lacking 
lipin 1 catalytic activity is unclear. In all organisms, however, CTDNEP1 and lipin 
1 orthologues limit ER membrane biogenesis through limiting synthesis of certain 
glycerolipids, though the mechanism appears to differ between yeast, worms, 
and plants. In human cells, CTDNEP1 (with its obligate binding partner NEP1R1) 
dephosphorylates lipin 1 (Figure 2.20A). CTDNEP1 regulates lipin 1 activation to 
control ER lipid synthesis, and multiple levels of lipin 1 regulation of lipid 
synthesis could contribute to limiting ER membrane biogenesis (Figure 2.20B-C). 
Whether lipin 1 limits ER membrane biogenesis through enzymatic, 
transcriptional, or indirect enzymatic regulation remains to be seen.  
 CTDNEP1 has a conserved function of maintaining nuclear structure (Figure 
2.21). In yeast, loss of Pah1 catalytic activity leads to increased PA that feeds 
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into upregulation of fatty acid synthesis through Ino2/Ino4 derepression, and PA 
can form membrane glycerophospholipids that feed into membrane synthesis as 
opposed to TAG production (Figure 2.21A-B). This leads to an expansion of ER 
membranes but also a proliferation of nuclear envelope membranes 
(Siniossoglou et al., 1998). In human cells, despite differences in lipid synthesis 
pathways, CTDNEP1’s function of controlling nuclear structure is conserved 
(Figure 2.21C-D).  
CTDNEP1 also limits formation of micronuclei in human cells (Figure 
2.19). CTDNEP1 has not been implicated in regulating formation of micronuclei 
in other organisms. CTDNEP1’s role in limiting formation of micronuclei may be 
part of why it is commonly mutated in medulloblastoma subgroups associated 
with chromosomal instability, as micronuclei are a common consequence of 
chromosomal instability in cancer (Giam and Rancati, 2015; Jones et al., 2012). 
The remainder of this work will investigate the mechanism for formation of 
micronuclei with loss of CTDNEP1. The next chapter will describe investigation of 
the dynamics of expanded ER membranes during cell division to uncover how 







Figure 2.1 CTDNEP1 and lipin 1 control of lipid synthesis 
A) Overview of CTDNEP1/lipin 1-controlled ER lipid synthesis. Direct activities of 
CTDNEP1 and lipin 1 are outlined with a dashed box. Membrane 
glycerophospholipids are circled in green, and lipid droplet glycerolipids are circled 
in orange. P, phosphate; Pi, inorganic phosphate. B) Domain architecture of 
human CTDNEP1. HAD, haloacid dehalogenase. C) Domain architecture of 







Figure 2.2 depletion of reticulons 1,3, and 4 reveals role for 
formation/stabilization of ER nanoholes 
A) Domain architecture of reticulon 4 isoforms, with the region targeted by the 
RTN4 sgRNA to generate a RTN4KO cell line shown. B) Immunoblot of endogenous 
RTN4B/D from whole cell lysates derived from control and RTN4KO U2OS cells. C) 
Scanning confocal (left) and stimulated emission depletion (STED) (inset, right) 
images of SNAP-KDEL signal in cell lines treated as indicated. Scale bars, 10 μm 








Figure 2.3 Localization of endogenous NUP160 in human cells 
A) Domain architecture of endogenous NUP160-Halo. B) Immunoblot of HaloTag 
in whole cell lysates derived from indicated cell lines. “Bulk pop.” refers to a bulk 
population of Cas9/guide/homology repair template-transfected cells. C) Spinning 
disk confocal images of HaloTag-TMR signal in NUP160EN-Halo U2OS cells. Scale 







Figure 2.4 Generation of CTDNEP1KO U2OS cells 
A) Domain architecture of CTDNEP1 mapped to the gene architecture of 
CTDNEP1. sgRNA, single guide RNA. 5’ and 3’ untranslated regions marked in 
yellow, exons as white or marked boxes, and introns as lines. Colors indicate 
exons coding for parts of domains. B) Schematic of single nucleotide insertion and 
subsequent consequence for the CTDNEP1 protein sequence induced by 
CRISPR-Cas9 in CTDNEP1KO U2OS cells. Untranslated regions and exons 






Figure 2.5 CTDNEP1KO U2OS cells and CTDNEP1 siRNA-treated cells have 
reduced levels of CTDNEP1 mRNA 
A) qRT-PCR of CTDNEP1 transcript levels in human cell lines with indicated 
treatments. U2OS siRNA-treated cells are overexpressing GFP-KDEL and are 
from the same experiment as Figures 2.9 and 2.11. RPE-1 siRNA-treated cells are 
overexpressing GFP-KDEL and are from the same experiment as Figure 2.10. 
Values are normalized to GAPDH expression. Results are expressed as the fold 
change in expression and relative to mean of control U2OS or siCtrl-treated U2OS 
or RPE-1 values. Expression data from control U2OS and CTDNEP1KO U2OS 
collected by J. W. Carrasquillo Rodríguez. P values, paired t tests of ΔCt values. 







Figure 2.6 Generation of endogenously-tagged CTDNEP1EN-GFP cells 
A) Schematic of strategy for homology-directed repair by CRISPR-Cas9 to tag 
endogenous CTDNEP1 with a C-terminal GFP tag. 5’ and 3’ untranslated regions 
marked in yellow, exons as white or marked boxes, and introns as lines. Colors 
indicate exons coding for parts of domains. B) Domain architecture of 









Figure 2.7 Endogenous localization of human CTDNEP1 
A) Left, live spinning disk confocal microscopy image of GFP in live U2OS 
CTDNEP1EN-GFP cells. Right, confocal microscopy image of GFP staining in fixed 







Figure 2.8 Expansion of ER membranes in CTDNEP1KO U2OS cells 
A) Spinning disk confocal microscopy images of GFP-KDEL transiently expressed 
in U2OS cells. Scale bars, 10 µm. B) Quantification of incidence of expanded ER 
phenotype in cells from (A). n = number of cells, N = 3 experimental repeats. Mean 
± SD shown. P value, Fisher’s exact test of total incidences. C) Spinning disk 
confocal microscopy image of calnexin signal in immunostained U2OS cells. Inset 
brightness adjusted relative to uncropped image to highlight fine ER morphology. 







Figure 2.9 Expansion of ER membranes in U2OS cells treated with 
CTDNEP1 siRNA 
A) Spinning disk confocal microscopy images of GFP-KDEL transiently expressed 
in U2OS cells. Scale bars, 10 µm. Inset brightness adjusted relative to uncropped 
image to highlight fine ER morphology. Scale bars, 10 μm. B) Quantification of 
incidence of expanded ER phenotype in cells from (A). n = number of cells, N = 3 







Figure 2.10 Expansion of ER membranes in RPE-1 cells treated with 
CTDNEP1 siRNA 
A) Spinning disk confocal microscopy images of GFP-KDEL in transiently-
expressing RPE-1 cells treated with indicated siRNAs. Inset brightness adjusted 
relative to uncropped image to highlight fine ER morphology. Scale bars, 10 μm. 
B) Quantification of incidence of expanded ER phenotype in cells from (A). n = 
number of cells, N = 3 experimental repeats. Mean ± SD shown. P value, Fisher’s 





Figure 2.11 Quantification of ER membrane abundance using ER 
fluorescent signal segmentation 
A) Spinning disk confocal mages of GFP-KDEL in transiently-expressing cells were 
processed as described and quantified for percent of pixels in cytoplasm area 
positive for segmented ER signal pixels. Scale bar, 10 μm. B) Plot of percentage 
of ER-positive pixels in cytoplasm area in cells (n) under the indicated conditions. 
N = 3 experimental replicates. Means ± SDs shown. P values, paired t tests of 





Figure 2.12 Qualitative comparison of ER morphology between CTDNEP1-
depleted and reticulon 1,3,4-depleted U2OS cells 
A) Spinning disk confocal microscopy images of transiently-expressed GFP-KDEL 
in cells in the indicated conditions. Blue arrows point to morphologies in the 
perinuclear ER, and yellow arrows point to morphologies in the peripheral ER. 
Lower image is from a separate experiment from the left 2 images. In all images, 






Figure 2.13 Stable or transient overexpression of catalytically active 
CTDNEP1 suppresses ER membrane expansion in CTDNEP1KO cells 
A) Spinning disk confocal microscopy images of GFP (KDEL), HA (CTDNEP1), 
and FLAG (NEP1R1) staining in U2OS cells overexpressing the indicated 
constructs, including empty vector (-), wild-type CTDNEP1-HA (WT), or 
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phosphatase dead D67E CTDNEP1 (PD). Scale bar, 10 μm. B) Quantification of 
incidence of expanded ER phenotype in cells from (A). n = number of cells, N = 3 
experimental repeats. Mean ± SD shown. P values, Fisher’s exact tests of total 
incidences. C) Quantification of incidence of expanded ER phenotype in cells with 
indicated conditions. WT (stable) refers to stable cell line overexpressing 
CTDNEP1-HA. N = number of cells, N = 3 experimental repeats. Mean ± SD 
shown. P value, Fisher’s exact test of total incidences. D) Plot of percentage of 
ER-positive pixels in cytoplasm area in cells (n) under the indicated conditions. N 








Figure 2.14 Transient overexpression of catalytically active lipin 1 
suppresses ER membrane expansion in CTDNEP1KO cells 
A) Spinning disk confocal microscopy images of calnexin and FLAG staining in 
U2OS cells overexpressing the indicated constructs and GFP-KDEL as a co-
transfection marker (not shown). 19 S/T to A refers to 19 serine/threonine sites 
mutated to dephospho-mimic alanine residues. PAP dead refers to phosphatase 
dead lipin 1. Scale bar 10 μm. B) Quantification of incidence of expanded ER 
phenotype in cells from (A). “-“ and “+” refer to cells not expressing and expressing 
lipin 1 and the co-transfection marker in the same experiment, respectively. n= 
number of cells, N = 3 experimental repeats. Mean ± SD shown. P values, Fisher’s 




Figure 2.15 Localization of lipin 1 and suppression of ER membrane 
expansion in CTDNEP1KO cells 
A) Spinning disk confocal microscopy images of calnexin and FLAG staining in 
U2OS cells overexpressing the indicated constructs and GFP-KDEL as a co-
transfection marker (not shown). 19 S/T to A refers to 19 serine/threonine sites 
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mutated to dephospho-mimic alanine residues. NLS = nuclear localization signal 
and NES = nuclear export signal. PPAR binding mutant has LXXIL PPARα binding 
motif mutated to LXXFF (Finck et al., 2005). Scale bar 10 μm. B) Quantification of 
incidence of expanded ER phenotype in cells from (A). “-“ and “+” refer to cells not 
expressing and expressing lipin 1 and the co-transfection marker in the same 
experiment, respectively. n = cells, N = 3 experimental repeats. Mean ± SD shown. 
P values, Fisher’s exact tests of total incidences. C) Incidence of nuclear 
localization phenotypes for indicated FLAG constructs. n = number of cells from N 








Figure 2.16 Expression of ER-resident proteins in CTDNEP1KO cells 
A, B, C) Immunoblot (using indicated antibodies) from whole cell lysates derived 






Figure 2.17 CTDNEP1KO cells have decreased nuclear solidity 
A) Epifluorescence images of DAPI/Hoechst staining in control and CTDNEP1KO 
cells showing nuclear morphologies and their corresponding solidity values. Scale 
bar 10 μm. B) Plot of solidity of nuclei (n) from cells as in (A). N = 3 experimental 
repeats. Individual values and means ± SDs shown. P value, paired t test of 
replicate means. C) Quantification of incidence of solidity less than 1 SD from the 
mean of control nuclei solidity (0.944). n = number of nuclei, N = 3 experimental 






Figure 2.18 Stable overexpression of CTDNEP1 rescues nuclear solidity of 
CTDNEP1KO cells 
A) Plot of solidity of nuclei (n) of cells from indicated conditions. “WT (stable)” refers 
to cells stably overexpressing CTDNEP1-HA. N = 3 experimental repeats. Means 
± SDs shown. P value, paired t test of replicate means. B) Quantification of 
incidence of solidity less than 1 SD from the mean of control nuclei solidity n = 
number of nuclei, N = 3 experimental repeats. Mean ± SD shown. P value, Fisher’s 






Figure 2.19 CTDNEP1 limits formation of micronuclei, and stable 
overexpression of CTDNEP1 in CTDNEP1KO cells suppresses 
formation of micronuclei 
A) Epifluorescence images of DAPI/Hoechst in cells from indicated conditions. 
Scale bars, 10 μm. B) Quantification of incidence of micronuclei in cells in indicated 
conditions. WT refers to stable overexpression of CTDNEP1-HA. n = number of 
cells from N = 3 experimental repeats. Means ± SDs shown. P values, Fisher’s 





Figure 2.20 Role of CTDNEP1 in limiting expansion of ER membranes 
A) Schematic of proposed lipin 1 dephosphorylation and activation at the nuclear 
envelope by CTDNEP1/NEP1R1 (dark gray). B) Schematic of potential 
mechanisms for how CTDNEP1 control of lipid synthesis could lead to increased 
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membrane abundance. C) Schematic showing how membrane abundance is 






Figure 2.21 Roles of CTDNEP1 in maintaining nuclear shape 
A,C) Lipid synthesis pathways in yeast and human cells and nuclear shape during 
lipid homeostasis. B,D) Lipid synthesis alterations with loss of Nem1p and 
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 Membrane biogenesis and dynamics are tightly controlled throughout the cell 
cycle (Storck et al., 2018). Coordination of phosphatidylcholine synthesis with 
ramping down glycerophospholipid breakdown leads to an accumulation of 
glycerophospholipids during S phase (Jackowski, 1994). ER membranes are 
cleared to the cell periphery during mitosis; limiting clearance from mitotic 
chromosomes throughout mitosis leads to chromosome segregation defects 
(Champion et al., 2019; Schlaitz et al., 2013). 
 In C. elegans early embryos, CNEP-1 is known to regulate membrane 
dynamics in mitosis and mitotic progression. Loss of lipin or CNEP-1 activity 
leads to deficient nuclear envelope breakdown that leads to lack of mixing of 
parental genomes and the persistence of two ‘twinned’ nuclei or oblong single 
nuclei (Bahmanyar et al., 2014; Golden et al., 2009; Gorjánácz and Mattaj, 
2009). In cnep-1Δ embryos, this is accompanied with an increase in ER sheets, 
and the nuclear envelope at nuclear envelope breakdown has an additional 
membrane layer enwrapping the nuclear envelope (Bahmanyar et al., 2014). 
During nuclear reformation in meiosis II, membrane extensions can be seen in 
nuclei of cnep-1Δ embryos, and the nuclei are more permeable than those of 
control embryos (Penfield et al., 2020). The nuclear envelope and ER 
phenotypes in cnep-1Δ embryos can be rescued by suppression of PI synthesis 
(Bahmanyar et al., 2014; Penfield et al., 2020). Thus, flux of ER lipid synthesis 
controlled by lipin limits membrane clearance and limits abnormal localization of 
membranes in and around nuclei in mitosis.  
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In human cells, depletion of lipin or CTDNEP1 by RNAi leads to delayed 
lamin B1 disassembly and delayed mitotic progression (including delayed 
chromosome congression) (Mall et al., 2012). The delay in nuclear envelope 
breakdown can be rescued by exogenous supplementation with lipin’s product, 
DAG, and the delay in mitotic progression is partially rescued with DAG 
supplementation (Mall et al., 2012). The authors conclude that lack of DAG limits 
protein kinase C activation to phosphorylate lamin and facilitate nuclear envelope 
breakdown. It is unclear if any other consequences of lipin inactivation, such as 
flux toward PI synthesis, affect mitotic progression. The role of human CTDNEP1 
and lipin 1 in regulating mitotic progression after nuclear envelope breakdown, 
especially during chromosome congression in prometaphase, is unclear. 
 Here, we show that CTDNEP1 regulates membrane abundance and 
clearance during mitosis to facilitate mitotic progression during prometaphase. 
We show that CTDNEP1KO cells have a higher percentage of prometaphase cells 
within the mitotic cell population, and membranes are more abundant and less 
cleared in prometaphase and metaphase CTDNEP1KO cells. ER membranes can 
be seen enwrapping aligning chromosomes in prometaphase to metaphase, and 
ER membranes are not restricted from the nuclear interior upon mitotic exit. We 
show that CTDNEP1-depleted cells additionally show increased nuclear size and 
faster reestablishment of nuclear import upon mitotic exit. These data show that 
CTDNEP1-controlled membrane biogenesis limits abnormal membrane 




Higher incidence of prometaphase cells in mitotic CTDNEP1-deleted cells 
Previous work showed that depletion of CTDNEP1 or lipins in human cells leads 
to delayed mitotic progression, including delayed nuclear breakdown and 
delayed chromosome congression (Mall et al., 2012). To determine if mitotic 
progression is altered in CTDNEP1KO cells, I imaged a fixed asynchronous 
population of control or CTDNEP1KO U2OS cells and quantified the incidence of 
cells in each mitotic stage from prometaphase to telophase within the mitotic cell 
population (Figure 3.1A). Consistent with the previous findings, CTDNEP1KO cells 
had a higher proportion of mitotic cells in prometaphase and lower proportion in 
other stages, which suggests that prometaphase could be lengthened (Figure 
3.1B). Live imaging of CTDNEP1KO cells can determine the timing by which loss 
of CTDNEP1 delays mitotic progression, which is not able to be determined with 
imaging an asynchronous cell population. These results are consistent with the 
previous finding that depletion of loss of CTDNEP1 delays mitotic progression.  
Prometaphase ER membrane localization and relation to chromosomes 
I next sought to determine if ER membrane clearance in CTDNEP1-
depleted human cells is delayed and to investigate the dynamics of ER 
membranes during prometaphase. I imaged a population of control and 
CTDNEP1KO cells expressing the ER marker GFP-KDEL, enriched for 
prometaphase and metaphase cells by drugless mitotic shakeoff and using DIC 
to determine mitotic staging and chromosome localization (Figure 3.2A). I blindly 
scored these images with categories based on the prevalence of intracellular ER 
membranes (“cleared”, “partially cleared”, and “not cleared”, Figure 3.2) and 
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found that a higher proportion of CTDNEP1KO cells lacked GFP-KDEL clearance 
from the region occupied by chromosomes compared to control cells (47.4 ± 6.8 
% of CTDNEP1KO cells compared to 25.4 ± 11.4 % of cells categorized as “not 
cleared”, Figure 3.2B). To assess whether chromosomes interact with ER 
membranes during chromosome congression, I imaged control and CTDNEP1KO 
cells transiently expressing GFP-KDEL/H2B-mCherry after washout from a Cdk1 
inhibitor-mediated G2/M arrest (Figure 3.3A). We observed that, over the course 
of chromosome congression, unaligned chromosomes could be seen within 
peripheral ER of control and CTDNEP1KO cells before aligning to the metaphase 
plate (Figure 3.3A, yellow arrows). In CTDNEP1KO prometaphase cells, ER 
tubules could also be seen within the spindle region leading up to chromosomes 
at the metaphase plate (Figure 3.3A, cyan arrows). These data show that 
CTDNEP1 activity facilitates clearance of membranes after nuclear envelope 
breakdown. 
Excess ER membranes fill mitotic cytoplasm in CTDNEP1KO cells and 
CTDNEP1-depleted cells 
 I previously showed that CTDNEP1 limits ER membrane abundance in 
human cells. To determine if expansion of ER membranes persists in CTDNEP1-
depleted cells in mitosis, I imaged U2OS cells stably expressing the ER 
transmembrane marker GFP-Sec61β and chromatin marker H2B-mCherry 
treated with control or CTDNEP1 siRNA from anaphase onset through telophase 
(Figure 3.4A). Membranes are largely cleared to the cell periphery by anaphase 
onset (“0 min”, Figure 3.4A), so measurement of relative ER membrane 
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abundance in mitotic cells can be performed by measuring the thickness of the 
cortical ER membranes at a consistent location in the cells. I measured the 
percent of the cell diameter at the metaphase plate that is occupied by Sec61β 
signal by measuring the full width at half max of Sec61β signal (Figure 3.4B). 
Consistent with our findings in interphase cells, a greater percentage of the cell 
diameter was taken up by ER membranes in mitotic CTDNEP1-depleted cells 
compared to cells treated with control siRNA (Figure 3.4B-C). Individual traces of 
ER and chromatin marker signal additionally revealed that greater occupancy by 
ER membranes at the metaphase plate leaves less space for chromosomes to 
localize (Figure 3.4B). 
 To confirm these findings in cells in which every cell is depleted of 
CTDNEP1, I imaged control and CTDNEP1KO cells transiently expressing GFP-
KDEL and stained with the live Hoechst dye SiR-DNA to mark chromosomes 
from anaphase onset (Figure 3.5A; SiR not shown). I measured the percentage 
of cell diameter occupied by GFP-KDEL and found that CTDNEP1KO cells had a 
greater occupancy of the cell diameter by ER membranes (Figure 3.5B-3.5C).  
M. I. Anjur-Dietrich (under the supervision of D. Needleman) introduced 
magnetic beads about the size of a mitotic chromosome (~2-3 μm) into 
CTDNEP1KO cells and measured bead displacement upon pulling with defined 
force using magnetic tweezers and found that the cytoplasm is more viscous in 
CTDNEP1KO cells than in control cells (Merta et al., 2021). Further, 
chromosomes in prometaphase have a lower average velocity in CTDNEP1KO 
cells compared to control cells (Merta et al., 2021) (finding by M. I. Anjur-
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Dietrich). Because uncleared membranes occur more frequently in 
prometaphase CTDNEP1KO cells, these data suggest that expanded ER 
membranes can limit chromosome movements. The decreased space taken up 
by chromosomes at the metaphase plate because of increased space taken up 
by ER membranes in CTDNEP1KO cells supports this idea (Figure 3.4B). 
Together, these data support the conclusion that more abundant and 
uncleared ER membranes in mitosis in CTDNEP1KO cells contribute to viscous 
forces exerted on mitotic chromosomes to limit chromosome motions. With 
CTDNEP1, membrane biogenesis is limited to maintain mitotic membrane 
clearance, contain cytoplasmic viscosity, and facilitate chromosome movement. 
Conserved function for CTDNEP1 in limiting membrane extensions into post-
mitotic nuclei 
 In meiosis II of C. elegans early embryos deleted of CNEP-1, membrane 
extensions can be seen inside of newly reformed nuclei; these extensions are 
exacerbated by additional depletion of the ESCRT-III sealing factor CHMP7 and 
can be rescued by suppressing PI synthesis (Penfield et al., 2020). I thus sought 
to determine if human CTDNEP1 restricts membrane localization from the 
nuclear interior following mitotic exit. I imaged control and CTDNEP1KO cells 
transiently expressing GFP-KDEL and enriched for mitotic cells by drugless 
mitotic shakeoff from anaphase onset through telophase (Figure 3.6A). After 
nuclear envelope reformation, at 25 min after anaphase onset, CTDNEP1KO cell 
nuclei had more membrane extensions as determined by GFP-KDEL 
fluorescence (Figure 3.6A, inset and arrows; Figure 3.6B). These membrane 
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extensions were fainter than nuclear envelope signal, which is consistent with 
findings in C. elegans embryo post-meiotic nuclei (Penfield et al., 2020).  
 I next sought to determine if nuclear membrane extensions formed in mitosis 
persist in interphase cells. I imaged CTDNEP1KO and control U2OS cells 
transiently expressing GFP-KDEL in long-term (8-12 hr) time-lapse format 
(Figure 3.7A). A greater proportion of CTDNEP1KO cells in early G1 had nuclear 
membrane extensions compared to control cells (Figure 3.7A, pink arrows; 
Figure 3.7B). Unlike invaginations of the outer and inner nuclear membranes, 
which are as bright as the rest of the nuclear envelope and are common in 
control U2OS cells (Figure 3.7A, green arrows), nuclear membrane extensions 
are fainter than the rest of the nuclear envelope (Figure 3.7A, pink arrows). 
Future studies will determine if the nuclear membrane extensions in CTDNEP1-
depleted human cells are derived from the inner nuclear membrane. Together, 
these data support the conclusion that human CTDNEP1 has a conserved role 
for limiting membrane extensions from forming inside of newly reassembled 
nuclei. 
CTDNEP1 limits reestablishment of nuclear import and nuclear size during 
mitotic exit 
 To determine if altered membrane dynamics during nuclear envelope 
reassembly impacts nuclear import or growth, I imaged U2OS cells stably 
expressing a single importin β binding domain of importin α fused to GFP (IBB-
GFP) and H2B-mCherry, treated with control or CTDNEP1 siRNA. IBB localizes 
to the nucleus during interphase, then to the cytoplasm after nuclear envelope 
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breakdown, then to the nucleus again as nuclear pores are rebuilt and import is 
re-established (Figure 3.8A). Cells treated with CTDNEP1 siRNA appeared to 
have faster colocalization of IBB with chromatin after anaphase onset, and nuclei 
appeared slightly larger (Figure 3.8B). I measured the integrated intensity of IBB 
signal in the nucleus and expressed it as fold increase over integrated intensity 3 
min after anaphase onset (a time point >5 min prior to initiation of nuclear import) 
(Lu et al., 2011) ( Figure 3.8C). The integrated intensity of IBB signal in nuclei 
was higher in CTDNEP1-depleted cells compared to control cells starting at 
around 15 min after anaphase onset, which corresponds to when membranes 
are finished wrapping around chromosomes by visualization of Sec61β 
fluorescence (Lu et al., 2011) (Figure 3.8C). Measurements of H2B signal 
surface area revealed a similar timing for CTDNEP1-depleted cell nuclei 
expanding faster than control cell nuclei (Figure 3.8D). One caveat of these 
results is that the images were taken at low resolution and with low signal to 
noise. IBB is not imported uniformly in the reforming nucleus but is imported at 
“non-core” regions before “core” regions (Lu et al., 2011), so higher magnification 
imaging with better signal to noise is needed to confirm these findings. Another 
notable caveat of these results is that the a single IBB domain fused to GFP (~33 
kDa) is small enough to freely diffuse through the nuclear pore and likely through 
unsealed nuclear envelope holes, so the reestablishment of nuclear import being 
measured in this study is of net nuclear import. Additionally, postmeiotic nuclei of 
C. elegans early embryos lacking CNEP-1 are leaky most likely due to unsealed 
nuclear envelope holes (Penfield et al., 2020); leakiness of nuclei in this cell line 
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would not be detected due to the size of the IBB reporter. To address these 
caveats, a triple-GFP IBB reporter can be used, as it is large enough to be 
retained in the nucleus without diffusing back through pores (Hatch et al., 2013). 
Together, these results suggest that CTDNEP1 limits reestablishment of nuclear 
import and nuclear growth during mitotic exit. 
Discussion 
 These data reveal multiple roles for CTDNEP1-controlled membrane 
biogenesis in regulating mitotic events. We confirmed that CTDNEP1 limits 
mitotic progression during prometaphase and found that CTDNEP1 limits excess 
membranes in mitosis and regulates membrane clearance during prometaphase 
and metaphase. Excess membranes can contribute to viscous forces exerted on 
chromosomes, and chromosome movements are dampened in CTDNEP1KO 
cells. We additionally show that CTDNEP1 limits reestablishment of nuclear 
import and nuclear growth and restricts membrane localization from the nuclear 
interior during mitotic exit. 
 The finding that depletion of CTDNEP1 limits reestablishment of nuclear 
import and nuclear growth suggests that ER membrane access might be limiting 
for postmitotic nuclear pore complex assembly. Overexpression of CTDNEP1 or 
its obligate binding partner NEP1R1 in fly fat body cells leads to less 
fluorescence labeling of FG-Nups by the nucleoporin antibody mAb414, although 
pore density appears to be unaffected; the authors conclude that CTDNEP1 
limits pore maturation (Jacquemyn et al., 2020). Future studies will determine the 
mechanisms by which CTDNEP1 limits nuclear pore complex assembly or 
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maturation to regulate nuclear import following mitosis. In sea urchin embryos, 
availability of perinuclear ER membranes allows nuclear expansion (Mukherjee 
et al., 2020). Nuclear growth also scales with nuclear import (Levy and Heald, 
2010). Because CTDNEP1 limits ER membranes and also appears to limit 
nuclear pore complex assembly/maturation, it is unclear what is the mechanism 
for how CTDNEP1 regulates nuclear growth. Future studies uncoupling import 
from membrane availability will illuminate how these factors regulate nuclear size 
with loss of CTDNEP1. 
CTDNEP1 has a conserved role for restricting ER membranes to the 
surface of the nuclear envelope during and after mitotic exit. Membrane 
extensions are likely not seen earlier in nuclear envelope reformation because 
chromosomes are crosslinked together by barrier to autointegration factor (BAF) 
which does not crosslink chromosomes during mitotic exit (Samwer et al., 2017). 
The mechanism for how nuclear membrane extensions are made or persist in the 
nucleus is not fully understood. CTDNEP1 interacts genetically with the ESCRT-
III sealing factor CHMP7, revealing that coordination of lipid synthesis acts with 
nuclear envelope sealing to keep membranes from the nuclear interior (Penfield 
et al., 2020). These data support the idea that nuclear extensions could be 
produced during nuclear sealing by uncoordinated lipid synthesis with ESCRT-III 
activity. Other cases exist in which uncoordinated ESCRT-III activity leads to 
nuclear membrane abnormalities. Micronuclei lack the ability to spatially restrict 
ESCRT-III sealing and often have several membrane intrusions upon nuclear 
rupture (Vietri et al., 2020). CHMP7 has shown to bind PA in the inner nuclear 
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membrane in yeast (Thaller et al., 2021). Future studies will illuminate if lipid flux 
by lipin controlled by CTDNEP1 serves to regulate targeting of CHMP7 to the 
inner nuclear membrane to coordinate sealing and limit the formation of nuclear 
envelope extensions.  
 CTDNEP1 regulation of membrane biogenesis facilitates prometaphase and 
metaphase ER membrane clearance from the region around chromosomes in 
human cells (Figure 3.2; Figure 3.9). Expansion of ER membranes of CTDNEP1-
depleted cells persists into mitosis, leading to an excess of membranes that are 
not cleared as fast as membranes in control cells. It is not clear if the membranes 
are less cleared because of the sheer amount of membranes overwhelming 
clearing mechanisms like REEP3/4, but future studies can determine if this is the 
case. Together, these data support the idea that uncleared membranes can 
impede proper mitotic progression. 
ER membranes appear to contribute to the viscosity of the mitotic 
cytoplasm. These results show that ER lipid synthesis is limited to contain 
cytoplasmic viscosity in mitosis. Prometaphase chromosome velocity is also 
dampened in CTDNEP1KO U2OS cells. High cytoplasmic viscosity due to 
increased ER membranes may limit the movements of chromosomes being 
pushed and pulled by the mitotic spindle in prometaphase. 
 Micronuclei are not observed in S. cerevisiae or C. elegans depleted of 
CTDNEP1, despite alterations in ER membrane biogenesis present in these cells 
(Bahmanyar et al., 2014; Siniossoglou et al., 1998). We hypothesize that 
differences in mitoses may account for the differences in chromosome 
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segregation (Figure 3.10). S. cerevisiae have closed mitosis, in which the spindle 
assembles and chromosome segregation occurs inside of the nucleus (Figure 
3.10, above). C. elegans have semi-open mitosis, in which nuclear envelope 
membranes become permeable and are detached from chromosomes, but the 
spindle assembles inside of nuclear envelope (Figure 3.10, middle). In human 
cells, membranes are totally cleared from chromosomes and the mitotic spindle 
(Figure 3.10, below). In the absence of membrane clearance, interference by 
membranes may inhibit proper chromosome segregation, leading to formation of 
micronuclei (Figure 3.10, below). This suggests that nuclear envelope breakdown 
and membrane clearance may be coordinated to occur before the spindle 
assembles in human cells to allow unimpeded spindle assembly to promote 
proper chromosome segregation. 
 It is unclear exactly how excess membranes in mitosis in CTDNEP1KO cells 
could lead to formation of micronuclei, given that error correction mechanisms 
are in place to limit chromosome missegregation in human cells. The next 
chapter will discuss data that assess chromosome segregation in CTDNEP1KO 
with respect to multiple aspects of mitotic error correction to determine how 






Figure 3.1 CTDNEP1KO cells have a higher incidence of prometaphase cells 
A) Confocal images of DAPI/Hoechst and tubulin staining in U2OS cells used for 
mitotic staging. Scale bar = 10 μm. B) Plot of quantification of percent of mitotic 
cells in each stage of mitosis in control and CTDNEP1KO U2OS cells. Means ± SDs 
of proportions shown. n = number of cells, N = 3 experimental repeats. P value, 
Fisher’s exact test of incidences of prometaphase cells vs incidences of cells in 







Figure 3.2 Prometaphase and metaphase CTDNEP1KO cells have more 
uncleared membranes in proximity to chromosomes 
A) Confocal image of GFP-KDEL or DIC in transiently-expressing U2OS 
CTDNEP1KO cells subject to mitotic shakeoff, with phenotypic categorization. 
Scale bar 10 μm. B) Plot of incidence of indicated phenotypes in cells imaged as 
in (A). Means ± SDs shown. n = number of cells, N = 3 experimental repeats. P 





Figure 3.3 Chromosomes in prometaphase cells can be embedded in ER 
membranes during mitotic progression in control and CTDNEP1KO 
cells 
A) Select images from confocal time lapse of GFP-KDEL and H2B-mCherry in 
transiently-expressing U2OS CTDNEP1KO cells subject to Cdk1 inhibitor washout. 
Yellow arrows point to unaligned chromosomes; cyan arrows point to ER tubules 





Figure 3.4 Excess ER membranes fill mitotic cytoplasm in CTDNEP1-
depleted U2OS cells, and chromosomes take up less space 
A) Selected spinning disk confocal images of GFP-Sec61β and H2B-mCherry from 
a time lapse movie of U2OS cells treated with indicated siRNAs. Scale bar 10 μm. 
B) Graphs plotting fluorescent intensities of GFP-Sec61β (gray) and mCherry-H2B 
(magenta) along a 10-pixel line profile drawn along the equatorial region at 
anaphase onset for indicated conditions. Values are normalized to minimum and 
maximum values for each channel and to the percentage of the cell diameter. Blue 
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lines indicate percentage of the cell diameter at the half maximum value for GFP-
Sec61β. C) Plot of percent of cell diameter occupied by Sec61β-positive pixels in 
cells treated with indicated siRNA as in (A) and (B). Means ± SDs shown. n = 
number of cells, N = 7 experimental repeats. P value, Mann-Whitney 2-tailed 




Figure 3.5 Excess ER membranes fill mitotic cytoplasm in CTDNEP1KO 
U2OS cells 
A) Confocal images of GFP-KDEL signal from a time lapse movie of U2OS cells 
at anaphase onset as determined by SiR-DNA staining (not shown). Scale bar 10 
μm. B) Graphs plotting fluorescent intensities of GFP-KDEL along a 10-pixel line 
profile drawn along the equatorial region at anaphase onset for indicated 
conditions. Values are normalized to minimum and maximum values for each 
channel and to the percentage of the cell diameter. Blue lines indicate percentage 
of the cell diameter at the half maximum value for GFP-Sec61β. C) Plot of percent 
of cell diameter occupied by KDEL-positive pixels in cells treated with indicated 
siRNA as in (A). Means ± SDs shown. n = number of cells, N = 3 experimental 







Figure 3.6 Membrane extensions in CTDNEP1KO U2OS cells during mitotic 
exit 
A) Selected spinning disk confocal images of GFP-KDEL signal (inverted) from a 
time lapse movie of U2OS cells after mitotic shakeoff. Mitotic staging determined 
by SiR-DNA staining (not shown). Arrows point to intranuclear membrane 
extensions. Scale bar 10 μm. B) Plot of incidence of membrane extensions in 
postmitotic nuclei. Means ± SDs shown. n = number of daughter cell pairs, N = 3 








Figure 3.7 Persistence of membrane extensions in early G1 CTDNEP1KO 
U2OS cells 
A) Selected spinning disk confocal images of GFP-KDEL (inverted) from a time 
lapse movie of U2OS cells in early G1. Mitotic staging determined by SiR-DNA 
staining (not shown). Arrows point to intranuclear membrane extensions. Scale bar 
10 μm. B) Plot of incidence of membrane extensions in post-mitotic G1 nuclei. 
Means ± SDs shown. n = number of daughter cell pairs from N = 5 experimental 






Figure 3.8 siCTDNEP1-treated cells show faster reestablishment of net 
nuclear import and faster nuclear growth during mitotic exit 
A) Schematic of importin β-binding domain of importin α (IBB) localization with 
chromatin (H2B) during the cell cycle. B) Images from spinning disk confocal time 
lapse movie of IBB and H2B signal during mitotic exit. Scale bar, 10 μm. C) Plot of 
fold increase of integrated IBB intensity in the chromatin-containing region over 
time in cells treated with the indicated siRNA. Fold increase is compared to value 
at t = 3 min. Means ± SD shown. D) Plot of fold increase in nuclear surface area 
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over time in cells treated with the indicated siRNA. Fold increase is compared to 







Figure 3.9 Coordination of membrane clearing is obfuscated by increased 
lipid synthesis controlled by CTDNEP1 
A) Schematic for how membranes are cleared to the cell periphery after nuclear 
envelope breakdown and cell rounding. This process is disrupted with excess ER 
membranes in CTDNEP1KO cells, leading to persistence of uncleared membranes 
in prometaphase to metaphase cells. Light green = ER, dark green = nuclear 








Figure 3.10 Comparison of closed vs semi-open vs open mitosis and 
implications for improper membrane clearance for chromosome 
segregation 
A) Schematic showing differences between nuclear envelope membrane 
dynamics during mitosis in yeast, worm, and human cells. Dark green = nuclear 
envelope; pink = DNA, and blue = mitotic spindle. ER (light green) also shown in 
human cell to demonstrate membrane clearing to cell periphery. Bottom, deficient 
membrane clearance leads to formation of micronuclei in open mitosis. 
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 We have shown that CTDNEP1 limits ER membrane biogenesis to limit 
membrane abundance and clearance in mitosis. We have also shown that mitotic 
cells without CTDNEP1 have higher cytoplasmic viscosity and lower 
prometaphase average chromosome velocity. What remains to be shown is how 
micronuclei can form in CTDNEP1-depleted cells. In this chapter, I investigate 
known mechanisms of chromosome missegregation in CTDNEP1-depleted cells 
to determine how CTDNEP1 limits formation of micronuclei. 
Micronuclei can form from either missegregation of non-centromere-
containing chromosome fragments induced by DNA damage/breaks or 
missegregation of whole chromosomes (Fenech et al., 2011). We have found 
that CTDNEP1KO U2OS cells exhibit excess ER membranes and less ER 
membrane clearance in mitosis. Previous studies implicating membrane 
clearance in chromosome segregation have found that poor clearance of 
membranes from chromatin resulted in anaphase bridges and chromosome 
missegregation (Schlaitz et al., 2013), both of which involve chromosomes with 
intact centromeres (Pampalona et al., 2016). Therefore, we hypothesize that 
missegregation of whole chromosomes is more likely to be the culprit than 
missegregation of chromosome fragments. 
 Missegregation of whole chromosome fragments can occur by failed 
congression, merotely, or premature spindle assembly checkpoint (SAC) 
inactivation, or a combination of these (Fenech et al., 2011). Failed chromosome 
congression can occur by chromosomes not aligning on the metaphase plate, 
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then being unable to reach the main chromosome mass to reform into the main 
nucleus after anaphase onset (Fonseca et al., 2019). Merotely occurs when one 
or both kinetochores of a chromosome are attached to microtubules emanating 
from both spindle poles, instead of only one (Cimini et al., 2001). If the abnormal 
attachment is strong enough to sufficiently counter the tension from the correct 
attachments, the chromosome lags and does not incorporate with the main 
chromosome mass during anaphase (Cimini et al., 2004). Merotely can occur 
when spindle geometry is altered; for example, multipolar spindles that cluster 
centrosomes to become bipolar later (transient multipolarity) frequently have 
merotelic attachments biased toward the spindle pole with two centrosomes 
(Silkworth and Cimini, 2012). Cells with delayed spindle pole separation also 
have more merotelically attached chromosomes (Cimini, 2003; Silkworth and 
Cimini, 2012). Altered kinetochore architecture has also been shown to 
contribute to merotely (Gregan et al., 2011). Merotely is a common occurrence in 
prometaphase cells, and merotelic attachments are typically repaired before 
anaphase onset (Cimini et al., 2004). Prolonging metaphase reduces the 
proportion of wrongly attached microtubules to correctly attached microtubules 
and decreases the overall incidence of merotelic attachments (Cimini et al., 
2004). Aurora B has been implicated in mediating merotelic attachment 
correction; an Aurora B-generated phosphorylation gradient around centrosomes 
allows spatially controlled motor protein and attachment-regulating protein 
activities to promote correct attachments and destabilize incorrect ones (Cimini et 
al., 2006; DeLuca et al., 2006; Gregan et al., 2011). Merotelic attachments are 
 
 112 
not sensed by the spindle assembly checkpoint (Gregan et al., 2011), making 
these distinct mechanisms contributing to formation of micronuclei. 
 Premature inactivation of the spindle assembly checkpoint also leads to 
formation of micronuclei (Liu et al., 2018). The spindle assembly checkpoint 
monitors for unattached and improperly attached kinetochores and prevents 
sister chromatids from separating and cell cycle progression into anaphase 
(Musacchio, 2015). Broadly, the spindle assembly checkpoint prevents cyclin B 
(part of the cyclin dependent-kinase 1/cyclin B kinase complex) and securin (a 
protein that inhibits separase, which mediates chromatid dissociation through 
cohesin dissociation) from being degraded (Musacchio, 2015). At unattached 
kinetochores, the mitotic checkpoint complex (MCC) inhibits the anaphase 
promoting complex/cyclosome (APC/C), which would otherwise ubiquitinate 
cyclin B and securin (Hayward et al., 2019; Musacchio, 2015). MCC assembly 
and recruitment to unattached kinetochores appears to be a tunable response 
based on the frequency of unattached kinetochores (Collin et al., 2013), yet one 
unattached kinetochore is sufficient to activate the spindle assembly checkpoint 
(Dick and Gerlich, 2013). Aurora B recruits the checkpoint kinase MPS1 to 
kinetochores, and MPS1 phosphorylates kinetochore proteins to create a docking 
site for spindle assembly checkpoint players that make up or support the MCC 
(Hayward et al., 2019; Musacchio, 2015). When all kinetochores are properly 
attached, these steps are reversed; and passive and active SAC silencing 
mechanisms facilitate MCC dissociation from the kinetochore and from APC/C 
(Hayward et al., 2019; Musacchio, 2015). APC/C then ubiquitinates cyclin B and 
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securin to allow chromatids to separate and anaphase to proceed (Musacchio, 
2015). Premature inactivation of the spindle assembly checkpoint occurs in some 
cancer cells and contributes to aneuploidy and formation of micronuclei 
(Bharadwaj and Yu, 2004; Fenech et al., 2011). 
 Here we show that CTDNEP1 is required for mitotic error correction. We 
show that CTDNEP1-depleted cells have more lagging chromosomes and have 
longer spindles. Prematurely inactivating the spindle assembly checkpoint 
modestly increases the number of micronuclei in CTDNEP1KO cells compared to 
control cells. On the other hand, increasing merotelic attachments by subjecting 
cells to transient spindle disassembly causes severe micronucleation in 
CTDNEP1KO cells and CTDNEP1-depleted cells. This severe micronucleation is 
suppressed by CTDNEP1/NEP1R1 or catalytically active lipin 1 overexpression. 
These data show that CTDNEP1 limits correction of merotelic errors, illuminating 
the mechanism for how chromosome segregation changes can lead to formation 
of micronuclei in cells lacking CTDNEP1 and informing how CTDNEP1 mutations 
might contribute to chromosomal instability in cancer. 
Results 
Lagging chromosomes in CTDNEP1-depleted cells 
 To confirm that CTDNEP1-depleted cells have increased rates of 
chromosome missegregation that can contribute to formation of micronuclei, I 
sought to quantify kinetochore or centromere localization during anaphase 
relative to chromosome and spindle markers. I used a U2OS cell line stably 
expressing GFP-Centrin 2 (centrosome marker), GFP-CENPA (centromere 
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marker), and mCherry-α tubulin (Yu et al., 2019) and RNAi-depleted of 
CTDNEP1 (Figure 4.1). To enrich for mitotic cells for live imaging, I performed a 
drugless mitotic shakeoff and plated and imaged cells immediately. In mid-late 
anaphase and early telophase cells, lagging chromosomes could be visualized 
as GFP punctae localized away from the segregating chromosomes, either in the 
spindle midzone or in the cell periphery, (Figure 4.1A, yellow arrow). One caveat 
of this experiment is that the cells had CENPA and Centrin 2 fluorescing at the 
same wavelength. However, Centrin 2 punctae were brighter than CENPA 
punctae and had associated bright tubulin signal that occurs at centrosomes 
(Figure 4.1A, cyan arrow), making them easily distinguishable for this analysis. 
By blind categorization, I quantified the percentage of anaphase/telophase cells 
with GFP-CENPA punctae apart from chromosome masses and found that cells 
treated with CTDNEP1 siRNA had significantly more lagging chromosome 
punctae than control cells (32.6 ± 5.2 % in CTDNEP1 RNAi-depleted cells vs 9.6 
± 6.5 % of cells treated with control siRNA; Figure 4.1B). These results show that 
depletion of CTDNEP1 results in an increase in lagging chromosomes, which can 
contribute to formation of micronuclei. 
Bypassing the spindle assembly checkpoint in CTDNEP1-depleted cells 
increases formation of micronuclei 
 An increase in lagging chromosomes can indicate that errors that are sensed 
by the spindle assembly checkpoint are increased in CTDNEP1-depleted cells. 
To determine the rate of attachment errors, one can use an inhibitor of the 
spindle assembly checkpoint on a synchronized cell population; cells will enter 
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anaphase with improperly attached kinetochores, and the cells will form 
micronuclei in the subsequent interphase (Liu et al., 2018) (Figure 4.2A). To test 
if CTDNEP1 depletion leads to increased erroneous kinetochore attachments, I 
synchronized control and CTDNEP1KO cells at the G2/M transition using a Cdk1 
inhibitor, RO-3306 (Ki = 35 nM for Cdk1/cyclin B1 and Ki = 110 nM for 
Cdk1/cyclin A (Calbiochem)), and released the cells from the G2 block in the 
presence of an inhibitor of the checkpoint kinase MPS1 (NMS-P715, Ki = 0.99 
nM (Calbiochem)) (Liu et al., 2018) (Figure 4.2A-4.2B). CTDNEP1KO cells had a 
higher incidence of micronuclei compared to control cells with MPS1 inhibition 
(43.3 ± 4.9 % of CTDNEP1KO cells compared to 39.9 ± 1.9 % of control cells; 
Figure 4.2C). Although significant, the small magnitude of this difference led us to 
conclude that increased kinetochore attachment errors sensed by the SAC is 
likely not the major mechanism that contributed to lagging chromosomes and 
formation of micronuclei in cells lacking CTDNEP1, and so we assessed other 
mechanisms that cause lagging chromosomes. 
Recovery from transient spindle disassembly leads to abnormal hyper-
micronucleation in CTDNEP1-depleted cells that is suppressed with 
CTDNEP1/lipin expression 
 Increased formation or decreased correction of merotelic attachments is 
another mechanism by which lagging chromosomes and micronuclei can form. 
Transient disassembly of the mitotic spindle is known to increase merotelic 
attachments and is used to enrich for micronuclei (Cimini, 2003; Cimini et al., 
2001; Liu et al., 2018) (Figure 4.3). During recovery from spindle 
 
 116 
depolymerization, a delay in establishing spindle bipolarity and stretching of 
kinetochores leads to increased merotelic attachments that persist into anaphase 
(Cimini, 2003). To determine if correction of merotelic errors is deficient in 
CTDNEP1-deleted cells, I treated cells with a low dose of nocodazole and 
performed mitotic shakeoff, then allowed cells to recover from nocodazole 
treatment (“nocodazole washout”) (Liu et al., 2018); I then performed 
immunofluorescence processing on the cells in interphase to score cells for the 
presence of micronuclei (Figure 4.3A; Figure 4.4A). In control cells, recovery 
from spindle depolymerization by nocodazole washout led to an increase in 
micronuclei (Figures 4.4A-4.4B; compare 10.6 ± 2.0 % in Figure 2.19B to 4.3 ± 
0.8 % in Figure 4.4B). In CTDNEP1KO cells, a significant proportion of nuclei 
appeared severely multilobed/micronucleated, a phenotype we refer to as “hyper-
micronucleated” nuclei (40.0 ± 8.5 % in CTDNEP1KO cells compared to 4.3 ± 1.2 
% of control cells; Figure 4.4A-4.4B). To confirm that this phenotype is not 
exclusive to U2OS cells, I also performed nocodazole washout on RPE-1 cells 
RNAi-depleted of CTDNEP1 (Figure 4.5A). Consistent with the previous results, 
RPE-1 cells depleted of CTDNEP1 exhibited more hyper-micronucleated nuclei 
(21.5 ± 2.6 % in CTDNEP1-depleted cells compared to 9.2 ± 2.4 % of control 
cells; Figure 4.5B). To determine if loss of CTDNEP1 is responsible for 
controlling formation of hyper-micronucleated nuclei in CTDNEP1KO cells, I 
transiently overexpressed CTDNEP1-HA and FLAG-NEP1R1 and subjected cells 
to nocodazole washout and found that CTDNEP1/NEP1R1 expression reduces 
the number of hyper-micronucleated nuclei compared to overexpression of a 
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control vector (Figure 4.6A-4.6B). Together, these data show that CTDNEP1 is 
required for the correction of merotelic attachment errors.  
 I next sought to determine if CTDNEP1 control of lipin 1 plays a role in 
regulating correction of merotelic attachments, because CTDNEP1 
dephosphorylation of other unknown substrates could also control this regulation. 
I transiently expressed the mouse lipin 1β construct with 19 S/T sites mutated to 
alanine, which rescues ER expansion in CTDNEP1KO cells (Figure 2.14A-2.14B), 
as well as the PAP dead version of this construct, and performed nocodazole 
washout. Overexpression of lipin 1β 19xA suppressed formation of hyper-
micronucleated nuclei, whereas overexpression of the PAP dead construct did 
not (8.7 ± 1.0 % with FLAG-lipin 1β 19xA compared to 30.7 ± 1.4 % in control; 
26.2 ± 2.8 % with phosphatase-dead FLAG-lipin 1β 19xA compared to 25.3 ± 3.4 
% in control, Figure 4.7A-4.7B). Thus, loss of lipin 1 catalytic activity upon 
CTDNEP1 depletion allows hyper-micronucleated nuclei formation with 
nocodazole washout. These data show that CTDNEP1 control of lipin 1 
phosphorylation allows correction of merotelic attachments in mitosis. 
Mitotic exit in CTDNEP1KO cells recovering from transient spindle disassembly  
The appearance of multiple large micronuclei in hyper-micronucleated 
cells is suggestive of multiple chromosomes segregating into micronuclei during 
recovery from spindle depolymerization in CTDNEP1KO cells. I performed 
nocodazole washout on control and CTDNEP1KO U2OS cells and fixed cells 45-
60 min after mitotic shakeoff and release from nocodazole to capture cells in 
mitotic exit (Liu et al., 2018) (Figure 4.8A). Consistent with previous results that 
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CTDNEP1 depletion leads to a prometaphase delay, a larger proportion of 
CTDNEP1KO cells were still in prometaphase after 1 hour of nocodazole washout 
compared to control cells (Figure 4.8B). Among anaphase and telophase cells, 
CTDNEP1KO cells recovering from nocodazole treatment frequently had masses 
of chromosomes and concomitant tubulin staining in the periphery of cells (55.2 ± 
5.0 % of CTDNEP1KO cells compared to 7.8 ± 7.9 % of control cells, Figure 
4.9A). These data support the conclusion that lack of CTDNEP1 control of lipin 1 
allows merotelic attachments to persist and lead to chromosome missegregation 
that results in severe micronucleation.  
Longer spindle lengths in CTDNEP1-depleted U2OS mitotic cells 
  I previously showed that CTDNEP1-depleted cells exhibit sensitivity to 
spindle depolymerization and dampened prometaphase chromosome 
movements. These findings prompted us to observe chromosome dynamics and 
mitotic spindles in CTDNEP1-depleted cells stably expressing Centrin-2, CENPA, 
and mCherry-α tubulin in metaphase (Figure 4.10A, left). Chromosome alignment 
was not significantly decreased in CTDNEP1-depleted metaphase cells 
compared to control cells (data not shown). I found that the pole-pole distance of 
mitotic spindles in CTDNEP1-depleted metaphase cells was increased compared 
to the spindle lengths in control cells (Figure 4.10A, right). 
Discussion 
These data show that CTDNEP1 is required for mitotic error correction and 
proper chromosome segregation. We show that kinetochore attachment errors 
that are sensed by the spindle assembly checkpoint are not greatly increased in 
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CTDNEP1KO cells. CTDNEP1-deleted cells are greatly sensitized to merotelic 
kinetochore attachment errors that are brought about by transient spindle 
disassembly, and this sensitization is due to loss of lipin 1 catalytic activity.  
 I previously described data showing that CTDNEP1 controls membrane 
abundance and clearing during mitosis. In CTDNEP1KO cells, the cytoplasmic 
viscosity is increased, and prometaphase chromosome movements are 
decreased. Merotelic errors are resolved by detaching microtubules from the 
incorrect spindle pole, which involves rotation of the chromosome to keep 
microtubules from the same incorrect spindle pole from reattaching (Cimini, 
2003). Thus, dampened chromosome movements in CTDNEP1KO cells could 
contribute to reduced mitotic error correction. 
 It is not clear why metaphase spindles appear longer in CTDNEP1-depleted 
cells. A previous computational modeling study has shown that an elastic, 
deformable membrane around the spindle can assist with focusing minus ends of 
microtubules by forming pockets for filaments to gather, promoting longer spindle 
length (Poirier et al., 2010). Future studies can determine if expanded 
membranes are more elastic (more able to retain their shape) in CTDNEP1KO 
cells and whether this might contribute to spindle microtubule focusing. 
Alternatively, a membranous spindle matrix has been proposed to surround the 
mitotic spindle and concentrate components of the spindle (Schweizer et al., 
2014, 2015). I previously showed that CTDNEP1-depleted mitotic cells have a 
greater occupancy by ER membranes, with less room for chromosomes to 
occupy (Figure 3.4B). The expanded membranes and increased cytoplasmic 
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viscosity in the region where membranes are present in mitotic CTDNEP1KO cells 
could lead to higher concentration of spindle components that allows spindles to 
grow longer. Future studies can confirm these results and test these hypotheses 
to determine how lipid synthesis regulation by CTDNEP1 might control mitotic 
spindle length. 
 Another remaining question is to what extent mitotic errors that are not 
related to merotelic attachments could be impacted by CTDNEP1 depletion. For 
example, the possibility of missegregation of chromosome fragments in 
CTDNEP1-depleted cells still needs to be ruled out. In nocodazole washout, 
transient spindle multipolarity is more common, and this leads to more merotelic 
attachments. Longer spindles in CTDNEP1-depleted cells, slower chromosome 
movement, and the peripheral localization of lagging chromosomes and tubulin in 
CTDNEP1KO cells during telophase after nocodazole washout hint that spindle 
dynamics are altered with loss of CTDNEP1, while persistence of merotelic 
attachments could result from this. Future studies can determine if spindle 
architecture is challenged by the presence of excess membranes in mitosis and 
what additional mechanisms can contribute to formation of micronuclei. 
 These data show that CTDNEP1 promotes proper chromosome segregation 
by permitting merotelic attachment correction. What remains to be seen is how 







Figure 4.1 CTDNEP1-depleted cells have a higher incidence of lagging 
chromosomes 
A) Spinning disk confocal images of Centrin2/CENPA/α tubulin fluorescence signal 
in stably-expressing live cells treated with indicated siRNAs. Scale bar, 10 μm. B) 
Quantification of incidence of lagging CENPA punctae in cells in indicated 
conditions. Means ± SDs shown. n = number of cells, N = number of experimental 







Figure 4.2 Bypassing the spindle assembly checkpoint in CTDNEP1KO cells 
does not highly increase formation of micronuclei compared to 
control cells 
A) Schematic of generating micronuclei using synchronization with RO-3306 
(Cdki) and spindle assembly checkpoint bypass with NMS-P719 (MPS1i). DNA is 
pink, mitotic spindle is in blue, and nuclear envelope is in green. B) Confocal 
images of emerin and DAPI/Hoechst staining in fixed cells treated as in (A). Scale 
bars, 10 μm. C) Quantification of incidence of indicated phenotypes in cells treated 
as shown. n = number of cells, N = 3 experimental repeats. Means + SDs shown. 







Figure 4.3 Using recovery from nocodazole treatment to assess sensitivity 
to acute spindle depolymerization for formation of micronuclei 
A) Schematic of generating micronuclei using transient spindle disassembly with 








Figure 4.4 Recovery from transient spindle disassembly leads to abnormal 
hyper-micronucleation in CTDNEP1KO U2OS cells 
A) Epifluorescence (DAPI/Hoechst) and confocal (emerin) images of 
immunostained cells treated as in Figure 4.3A. Scale bar 10 μm. B) Quantification 
of incidence of indicated phenotypes in cells treated as shown. n = number of cells, 







Figure 4.5 Recovery from transient spindle disassembly leads to abnormal 
hyper-micronucleation in CTDNEP1-depleted RPE-1 cells 
A) Schematic of combined nocodazole washout and RNAi; epifluorescence 
(DAPI/Hoechst) and confocal (emerin) images of immunostained cells treated as 
shown in the schematic. Scale bar 10 μm. B) Quantification of incidence of 
indicated phenotypes in cells treated as shown. n = number of cells, N = 3 








Figure 4.6 Overexpression of CTDNEP1/NEP1R1 suppresses hyper-
micronucleation in CTDNEP1KO cells upon recovery from transient 
spindle disassembly 
A) Epifluorescence (DAPI/Hoechst) and confocal (FLAG, HA) images of 
immunostained cells transfected with indicated vectors and subject to nocodazole 
washout for 18 hrs as in Figure 4.3A. Scale bar 10 μm. B) Quantification of 
incidence of indicated phenotypes in cells treated as shown. n = number of cells, 








Figure 4.7 Overexpression of catalytically active lipin 1 suppresses hyper-
micronucleation in CTDNEP1KO cells upon recovery from transient 
spindle disassembly 
A) Epifluorescence (DAPI/Hoechst) and confocal (FLAG, emerin) images of 
immunostained cells transfected with indicated vectors and subject to nocodazole 
washout for 18 hrs as in Figure 4.3. Scale bar 10 μm. 19 S/T to A refers to 19 
serine/threonine sites mutated to dephospho-mimic alanine residues. PAP dead 
refers to phosphatase dead lipin 1. B) Quantification of incidence of indicated 
phenotypes in cells treated as shown. “-“ refers to non-construct-expressing, and 
“+” refers to construct-expressing cells in the same experiment. n = number of 
cells, N = 3 experimental repeats. Means + SDs shown. P values, Chi squared 







Figure 4.8 CTDNEP1KO cells have a higher incidence of prometaphase cells 
upon recovery from transient spindle disassembly 
A) Schematic for transient spindle disassembly with washout from acute 
nocodazole treatment. B) Plot of quantification of percent of mitotic cells in each 
stage of mitosis in control and CTDNEP1KO U2OS cells treated as shown. Means 
± SDs shown. n = number of cells, N = 3 experimental repeats. P value, Fisher’s 








Figure 4.9 Anaphase and telophase CTDNEP1KO cells recovering from 
transient spindle disassembly have more frequent chromosome 
masses and tubulin apart from the main nuclei and spindle 
A) Spinning disk confocal images of DAPI/Hoechst and tubulin-stained telophase 
cells subject to nocodazole washout for 45-60 min as in Figure 4.3. Cells were 
treated with Ca2+-buffer to depolymerize non-kinetochore microtubules just before 
fixation. Quantification of indicated phenotype shown. n = number of cells from N 







Figure 4.10 Longer spindle lengths in CTDNEP1-depleted U2OS 
prometaphase-metaphase cells 
A) Confocal images of Centrin2, CENPA, and α tubulin signal in metaphase U2OS 
cells treated with the indicated siRNAs and subject to mitotic shakeoff. Scale bar, 
5 μm. B) Plot of spindle pole-pole distance in cells as in (A). n = number of cells. 
N = 4 experimental repeats. Individual data points and means ± SDs shown. P 





Chapter 5: A CTDNEP1-lipin 1 regulatory network controls fatty acid 
synthesis to limit ER membrane biogenesis, nuclear morphology defects, 
and formation of micronuclei 
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We have shown that CTDNEP1 limits ER membrane biogenesis and 
controls membrane dynamics in mitosis. CTDNEP1 additionally limits 
cytoplasmic viscosity, allows prometaphase chromosome movements, and 
promotes mitotic error correction to limit formation of micronuclei. Major 
questions that remain are the mechanism by which CTDNEP1 limits ER 
membrane synthesis, as well as the connection between CTDNEP1’s control of 
lipid synthesis and regulation of chromosome segregation. 
One possibility for how CTDNEP1 can control ER membrane biogenesis is 
through regulation of sterol regulatory element binding protein (SREBP)-
dependent transcription, mediated through lipin. The primary mechanism of 
controlling fatty acid synthesis in human cells is through SREBP-dependent 
transcription (Figure 5.1). SREBPs change cellular localization from ER 
membrane-bound to soluble and nuclear in response to changes in ER 
membrane cholesterol levels (Inoue and Sato, 2013) (Figure 5.1A). At normal ER 
membrane cholesterol levels, SREBP cleavage-activating protein (SCAP) 
remains bound to cholesterol and Insulin-sensitive gene (Insig) (Inoue and Sato, 
2013). When cholesterol levels in the ER are reduced, SCAP binds to SREBP via 
its basic helix-loop-helix (bHLH) domain and causes it to be taken up for 
anterograde trafficking to the Golgi through COPII proteins Sec23/24 and Sar1 
(Inoue and Sato, 2013). In the Golgi, SREBP is cleaved by proteases S1P and 
S2P to free the bHLH domain to enter the nucleus and activate SREBP-
dependent transcription (Inoue and Sato, 2013). SREBP1 target genes control 
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fatty acid synthesis (Figure 5.1B, above), while SREBP2 target genes control 
steps in cholesterol synthesis (Figure 5.1B, below). 
 Lipin has shown to control fatty acid pools on multiple fronts, including 
synthesis (regulated by mTOR and mediated through SREBP transcriptional 
regulation) and breakdown (mediated through PPARα transcriptional regulation) 
(Finck et al., 2006; Peterson et al., 2011). Lipin has repeatedly been shown to be 
phosphoregulated with insulin and nutrient stimulation, demonstrating that it 
responds to metabolic inputs (Harris et al., 2007; Huffman et al., 2002; Peterson 
et al., 2011). mTOR (specifically, mTORC1) has been identified as the insulin 
and nutrient-sensitive kinase complex that phosphorylates lipin 1 (Harris et al., 
2007; Peterson et al., 2011). In response to serum and glucose/amino acid 
stimulation, lipin 1 is phosphorylated by mTOR on phosphosites known to be 
regulated upon insulin stimulation (Peterson et al., 2011).  
Lipin has shown to control SREBP-dependent gene expression. Inhibition 
of mTOR reduces SREBP target gene expression, including SREBP1c target 
genes fatty acid synthase (FASN), acetyl-CoA carboxylase alpha (ACACA), and 
stearoyl-CoA decarboxylase (SCD), as well as SREBP2 targets 3-hydroxy-3-
methylglutaryl-coenzyme A reductase (HMGCR) and farnesyl diphosphate 
synthase (FDPS) (Peterson et al., 2011). Lipin 1-deficient mice do not have 
elevated SREBP target gene expression in a basal state, but SREBP target gene 
expression is unresponsive to mTOR inhibition (Peterson et al., 2011). On the 
other hand, expression of dephospho-mimic lipin 1 is sufficient to restore SREBP 
response to mTOR inhibition in lipin 1-deficient mouse cells (Peterson et al., 
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2011). These data indicate that lipin 1 represses SREBP-dependent gene 
transcription when dephosphorylated. While the mechanism of this repression is 
not understood, it is known that phosphorylated lipin is retained in the cytoplasm 
and is degraded (Shimizu et al., 2017). It remains to be seen if hyper-
phosphorylated lipin increases SREBP-dependent gene transcription through 
derepression to positively regulate fatty acid synthesis. In CTDNEP1-depleted 
cells, derepression of SREBPs by hyperphosphorylated, low-abundance lipin 
could lead to increased fatty acid synthesis to feed into membrane biogenesis. 
Here, I show that increased fatty acid synthesis and flux of lipid synthesis 
into membrane biogenesis increase ER membrane abundance in CTDNEP1-
depleted cells. I report that CTDNEP1-depleted cells have elevated levels of 
membrane glycerophospholipids. I show that inhibition of a SREBP1 target gene 
to shut off fatty acid synthesis partially suppresses ER membrane expansion in 
CTDNEP1KO cells. I additionally show that supplementation with free fatty acids 
restores ER membrane expansion in CTDNEP1KO cells in the absence of fatty 
acid synthesis, showing that flux into ER lipid synthesis is also increased. I 
explore the contributions of SREBPs 1 and 2 and SREBP1 target gene SCD to 
ER membrane expansion in CTDNEP1KO cells to reveal a partial role for 
SREBPs in mediating fatty acid synthesis to control ER membrane abundance 
through lipin and CTDNEP1. I show that inhibition of fatty acid synthesis 
suppresses formation of micronuclei in CTDNEP1KO cells. These findings reveal 
multiple mechanisms for CTDNEP1 control of ER membrane abundance via lipid 
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synthesis and flux and connect control of fatty acid synthesis to regulation of 
mitotic error correction to limit formation of micronuclei. 
Results 
Lipidomic analysis of total cellular lipids in CTDNEP1KO cells 
 Depletion of CNEP-1 in C. elegans and PAH1 (lipin) in A. thaliana cells leads 
to increased cellular PA/PI and PC, respectively (Bahmanyar et al., 2014; 
Craddock et al., 2015). CTDNEP1 has known roles in limiting glycerolipid 
synthesis in all organisms tested (Bahmanyar et al., 2014; Craddock et al., 2015; 
Siniossoglou et al., 1998; Tange et al., 2002). We sought to determine the lipid 
profiles in CTDNEP1-depleted human cells by mass spectrometry lipidomic 
analysis. We submitted samples of U2OS cells to Lipotype GmbH, who 
performed lipid extraction, sample infusion, mass spectrometry and/or tandem 
mass spectrometry analysis, and lipid identification using Lipotype Xplorer. Data 
were reported to us as pmols of lipid species per sample (with sample volume 
utilized), with species reported in species class-combined chain length-combined 
desaturation format (e.g. PC with 18:1 and 16:0 side chains reported as PC 
(34:1). Using this information, we were able to extrapolate molar percentage of 
lipid classes and, with sample protein concentration, pmols lipid class per mg 
protein (Figure 5.2, Figure 5.3). 
 We first examined molar percentage of lipid classes in control and 
CTDNEP1KO U2OS cells to determine if lipid flux favored formation of certain 
species over others (Figure 5.2A). From this analysis, in CTDNEP1KO cells, PC 
appeared to be increased in its contribution to the lipid profile, and TAG was also 
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increased, while cholesterol esters (CE) and sphingomyelin (SM) were 
decreased (Figure 5.2A). These results indicated to us that overall the lipidome 
was not shifted toward PI/PA accumulation in CTDNEP1-depleted cells as in C. 
elegans and brought up the possibility that TAG may be increased in addition to 
membrane glycerolipids. To confirm these results, I resubmitted a new set of 
samples of control and CTDNEP1KO cells (Figure 5.2B, “-“), this time also with a 
sample of CTDNEP1KO cells stably overexpressing wild-type CTDNEP1-HA 
(Figure 5.2B, “WT”) to determine what lipidome changes are rescued by 
overexpressing CTDNEP1. PC was modestly increased in representation in 
CTDNEP1KO cells compared to control cells and the rescue cell line, while other 
glycerophospholipid species appeared unchanged in representation (Figure 
5.2B). Triglycerides were no longer lower in control cells compared to 
CTDNEP1KO cells with analysis of the second submission (Figure 5.2B). CE and 
SM molar percentages remained lower in CTDNEP1KO cells relative to control 
cells, and these were partially rescued in CTDNEP1KO cells stably expressing 
CTDNEP1-HA (Figure 5.2B). These data indicate that representation of lipid 
classes is overall similar in CTDNEP1KO cells relative to control except for PC 
and lipids that are not synthesized in the ER. 
 To determine if absolute levels of lipid classes are elevated in CTDNEP1-
depleted cells, I normalized pmol of lipid classes to mg of protein in samples 
(Figure 5.3). This analysis revealed that PC levels (and, to a lesser extent, PE 
levels) are higher in CTDNEP1KO cells, and this is rescued by stable expression 
of CTDNEP1 (Figure 5.3A). Cholesterol ester and SM levels were lower in 
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CTDNEP1KO cells compared to control cells, and CE levels were rescued by 
CTDNEP1 expression, whereas lower sphingomyelin levels were not rescued 
(Figure 5.3A). These data show that loss of CTDNEP1 leads to increased cellular 
PC/PE and decreased cholesterol esters. These data point to a conserved 
mechanism for increased PC synthesis in human cells with loss of CTDNEP1 
activation of lipin. The similar molar percentage profiles of CTDNEP1KO and 
control cells and elevated pmol of lipid classes point to control of fatty acid 
synthesis as a possible mechanism for CTDNEP1 regulation of ER membrane 
biogenesis. 
Inhibition of fatty acid synthesis reduces ER membranes in control cell and 
suppresses ER expansion in CTDNEP1KO cells 
 Acetate incorporation into lipids is increased in CTDNEP1KO cells, indicating 
that fatty acid synthesis may be increased with loss of CTDNEP1 (Merta et al., 
2021) (finding by M.E. Granade, supervised by T. Harris). I targeted fatty acid 
synthesis to determine if increased fatty acid synthesis feeds into ER membrane 
biogenesis in CTDNEP1-depleted cells (Figure 5.4). I used a small molecule 
inhibitor of acetyl coenzyme-A carboxylase (ACAC) forms α and β, 5-
(tetradecyloxy)-2-furancarboxylic acid (TOFA) (IC50 4.5-5.0 μg/ml, (Wang et al., 
2009)) (Figure 5.4). ACAC catalyzes the conversion of acetyl-CoA into malonyl-
CoA in the rate-limiting and committing step for fixation of cellular acetate into 
fatty acids in mammalian cells (Tong, 2005). M. E. Granade found that TOFA 
reduced acetate incorporation into lipids in control U2OS and CTDNEP1KO U2OS 
cells, reflecting reduced acetyl-CoA fixation into lipids (Merta et al., 2021). 
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Inhibiting ACAC limits malonyl-CoA formation, which limits fatty acid synthesis 
and incorporation into PA, which should decrease ER membrane lipid synthesis 
(Figure 5.4). Supplementation with exogenous fatty acids would bypass ACAC, 
serving as a control to help determine if changes in ER membranes are due to 
altered flux of fatty acid synthesis into ER membrane biogenesis (Figure 5.4). 
 Treatment of U2OS cells with 10 μM TOFA for 24 hours severely reduces ER 
membranes (Figure 5.5A, above). In contrast to DMSO-treated cells, which have 
sheet-like perinuclear ER membranes and peripheral reticular ER, TOFA-treated 
U2OS cells have thin ER tubules with wide spaces in between or completely lack 
a peripheral ER network (Figure 5.5A, red arrows). The remaining ER in these 
cells is concentrated around the nucleus and appears thinner than perinuclear 
ER in control cells (Figure 5.5A, above). TOFA also suppresses ER membrane 
expansion in CTDNEP1KO cells (Figure 5.5A, below). The appearance of the ER 
in TOFA-treated CTDNEP1KO cells more closely resembles control U2OS cells’ 
ER than DMSO-treated CTDNEP1KO cells or TOFA-treated U2OS cells (Figure 
5.5A). A peripheral ER network is apparent in the majority of TOFA-treated 
CTDNEP1KO cells (Figure 5.5A, blue arrows). These data show that fatty acid 
synthesis feeds into ER membrane synthesis to control ER membrane 
abundance, and that fatty acid synthesis may be increased in CTDNEP1KO cells. 
 To quantify the extent to which ER membranes were reduced in control and 
CTDNEP1KO cells, I measured the percent area of cytoplasm taken up by ER 
membranes as in Figure 2.11 and compared it to previously determined 
phenotypic categorization of TOFA-treated control U2OS and CTDNEP1KO cells 
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(Figure 5.6A). I found that the percent area of ER of cells categorized as having 
“normal ER” is similar in U2OS cells and CTDNEP1KO cells treated with TOFA 
(Figure 5.6A). CTDNEP1KO cells categorized as having “reduced” ER have 
percent area of ER that falls within the range of areas of cells categorized as 
having “reduced” ER, but in line with qualitative findings, the extent of reduced 
ER could be much more severe in control U2OS cells (Figure 5.6A). These 
findings reflect that the phenotypic categorization is accurate to the abundance of 
ER membranes in TOFA-treated cells. 
 I next sought to determine the time scales at which ACAC inhibition could 
cause ER membranes to be reduced in both control and CTDNEP1KO cells 
(Figure 5.7). I treated cells with TOFA for 5 hours, 24 hours, and 48 hours 
(Figure 5.7A). Treatment with TOFA for 72 hours showed no effect, reflecting that 
the drug may be metabolized or degraded around that time (data not shown). 
After 5 hours of TOFA treatment, 16.0 ± 10.3 % of U2OS cells have reduced ER 
(Figures 5.7A-5.7B). In contrast, after 5 hours, 8.9 ± 1.9 % of DMSO-treated and 
77.4 ± 4.5 % of TOFA-treated CTDNEP1KO cells show suppression of ER 
membrane expansion to a “normal”-looking ER (Figures 5.7A, 5.7C). This finding 
suggests that the ER membranes of CTDNEP1KO cells respond faster to TOFA 
treatment than unmodified U2OS cells – either fatty acid synthesis is upregulated 
to the extent that ACAC inhibition causes a more pronounced effect faster, or 
fatty acid breakdown could be faster in CTDNEP1-depleted cells. In both 
unmodified U2OS cells and CTDNEP1KO U2OS cells, the maximum effect of 
TOFA treatment is observed after 24 hours (Figures 5.7A-5.7C). 
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Fatty acid supplementation restores ER appearance in cells with fatty acid 
synthesis inhibition 
 To determine if reduction of ER membranes in TOFA-treated cells was 
indeed caused by lack of fatty acid incorporation into membrane lipids, I treated 
cells with TOFA with or without exogenous fatty acid supplementation (Figure 
5.8A). To treat cells with exogenous fatty acids, I used a total concentration of 
100 μM and a makeup of 1:2:1 palmitic:oleic:linoleic acid, which were conjugated 
to 0.5% fatty acid-free bovine serum albumin (BSA) to facilitate solubilization of 
fatty acids into the media. The concentration and makeup of fatty acids more 
closely resembles physiological extracellular conditions as opposed to mixes 
containing only palmitate or oleate (Watt et al., 2012).   
 Treatment of control U2OS cells with TOFA and exogenous fatty acids 
restores the appearance of the peripheral ER compared to cells treated with 
TOFA and fatty acid-free BSA (Figures 5.8A-B). Similarly, supplementation with 
exogenous fatty acids restores the expanded appearance of the ER in 
CTDNEP1KO cells treated with TOFA (Figures 5.8A-B).  Treating control or 
CTDNEP1KO cells with exogenous fatty acids in the absence of TOFA does not 
change ER appearance (Figure 5.9A), so there appears to be a mechanism in 
place to keep exogenous fatty acids from being incorporated into excess 
membranes that appears to not be as active in CTDNEP1KO cells. Together, 
these data support the conclusion that CTDNEP1KO cells have increased fatty 
acid synthesis and flux of fatty acids into ER lipid synthesis, and this feeds into 
ER membrane biogenesis. Thus, CTDNEP1 limits fatty acid synthesis and 
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incorporation of fatty acids into membranes to limit the abundance of ER 
membranes. 
Depletion of SREBPs and SREBP target genes to assess contribution to 
SREBP-controlled fatty acid synthesis to ER membrane expansion 
 Since it is known that SREBP-mediated transcription is regulated by lipin 
depending on its phosphorylation state, we next sought to determine the 
contribution of SREBP-dependent transcription on ER membrane biogenesis in 
CTDNEP1KO cells. Jake W. Carrasquillo Rodríguez found that mRNAs of 
SREBP1 target genes ACACA and SCD are upregulated ~1.3-fold and ~1.5-fold, 
respectively, in CTDNEP1KO cells compared to control cells (Merta et al., 2021). 
The SREBP1 targets FASN and SREBP2 targets FDPS and HMGCR are not 
upregulated (Merta et al., 2021). Although modest, the upregulation of these 
SREBP targets could explain the apparent increase in fatty acid synthesis in 
CTDNEP1KO cells. 
 Since ACACA and SCD are SREBP1 target genes, I first sought to deplete 
SREBP1 by RNAi in control U2OS and CTDNEP1KO cells to determine if 
SREBP1 depletion impacts ER morphology in unmodified U2OS cells or 
suppresses ER membrane expansion in CTDNEP1KO cells (Figures 5.10A-B). 
U2OS cells did not appear to have altered ER morphology with SREBP1 
depletion (Figure 5.10B). Some CTDNEP1KO cells appeared to have suppression 
of ER membrane expansion such that the peripheral ER network was visible in 
SREBP1 siRNA-treated cells (Figure 5.10B). SREBP1 depletion reduces the 
incidence of ER membrane expansion in CTDNEP1KO cells from 98.2 ± 1.6 % of 
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cells to 93.4 ± 1.6 % (Figure 5.10C). SREBP1-dependent transcription appears 
to at least partially contribute to fatty acid synthesis that feeds into ER membrane 
expansion in CTDNEP1-depleted cells. Future experiments to determine if 
knockdown of SREBP1 decreases levels of nuclear SREBP1 and decreases 
SREBP1-dependent gene transcription will confirm these findings. 
 Studies in transgenic mice with deletion of either Srebp1 or Srebp2 show that 
Srebp1 and Srebp2 can compensate for each other to some extent (Horton et al., 
2002; Vergnes et al., 2016). To determine if SREBP2 upregulation in SREBP1-
depleted cells could be masking an effect of SREBP1 depletion on ER expansion 
in CTDNEP1KO cells, I co-depleted SREBP1 and SREBP2 with RNAi (Figures 
5.11A-B). Like with RNAi depletion of SREBP1 alone, some CTDNEP1KO cells 
depleted of SREBP1/2 show suppression of ER membrane expansion and 
restoration of the reticular peripheral ER (Figure 5.11B). The incidence of the 
expanded ER phenotype in CTDNEP1KO cells decreased from 99.7 ± 0.5 % to 
96.2 ± 1.2 % with SREBP1/2 knockdown (Figure 5.11C). This reduction is of 
similar magnitude as the suppression of ER membrane expansion with depletion 
of SREBP1 alone, suggesting that cross-talk between SREBP1/2 does not limit 
suppression of ER membrane expansion in CTDNEP1KO cells depleted of 
SREBP1. Together, these data support the conclusion that SREBP-mediated 
fatty acid synthesis gene transcription is at least partially responsible for 




 CTDNEP1KO U2OS cells exhibit increased SCD expression relative to control 
U2OS cells and is the most upregulated SREBP target gene (Merta et al., 2021) 
(finding by Jake W. Carrasquillo Rodríguez). SCD catalyzes the desaturation of 
saturated fatty acyl-CoAs like palmitoyl- and stearoyl-CoA at the carbon 9 
position to produce Δ9 destaurated fatty acyl-CoAs like palmitoleoyl-CoA and 
oleoyl-CoA. While this step is not rate-limiting or committing for fatty acid 
synthesis as a whole, it is the rate limiting step for synthesis of monounsaturated 
fatty acids that make up a large portion of side chains in cellular glycerolipids 
(ALJohani et al., 2017). Thus, upregulation of SCD specifically in CTDNEP1-
depleted cells could lead to expansion of ER membranes through increased 
availability of monounsaturated fatty acids to feed into membrane lipid synthesis. 
I depleted SCD in control U2OS and CTDNEP1KO U2OS cells with RNAi (Figure 
5.12A-B). Knockdown of SCD reduced the incidence of the expanded ER 
phenotype from 88.9 ± 1.7 % of cells to 72.3 ± 4.1 % (Figures 5.12B-C). Thus, 
we conclude that expansion of ER membranes in CTDNEP1KO is at least partially 
due to specific upregulation of SCD increasing synthesis of fatty acids for 
membrane biogenesis. I also observed bright punctae ~1 μm in diameter in the 
perinuclear ER of control and CTDNEP1KO U2OS cells depleted of SCD (Figure 
5.12B, 5.12D). In cells treated with high concentrations of palmitate, the rough 
ER appears distended, and this is thought to be caused by a combination of 
changes in membrane properties (membrane stiffening) as palmitate is 
incorporated into ER neutral lipids and increased ER stress in response to the 
membrane packing defects (Borradaile et al., 2006). Perhaps decreased SCD in 
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U2OS cells leads to punctae formation in rough ER because of decreased overall 
desaturation of fatty acids in membranes leading to packing defects. These data 
show that CTDNEP1 limits fatty acid synthesis and membrane biogenesis partly 
through limiting SCD activity to produce monounsaturated fatty acids for 
membranes. 
Inhibition of fatty acid synthesis restores nuclear shape in CTDNEP1-depleted 
cells 
 It is not known if the role CTDNEP1 plays in limiting fatty acid synthesis 
mediates its conserved function for maintaining nuclear morphology. I 
suppressed fatty acid synthesis in CTDNEP1KO cells with ACAC inhibition and 
found that nuclei appear more round and that nuclear solidity is increased (Figure 
5.13A). The proportion of nuclei characterized as having low solidity is reduced 
from 20.9 ± 2.3 % in DMSO-treated CTDNEP1KO cells to 2.5 ± 2.6 % in TOFA-
treated cells (Figure 5.13B). In control U2OS cells, however, TOFA treatment 
does not significantly increase nuclear solidity (Figure 5.14A, 5.14B). This data 
supports the conclusion that nuclear shape is at its maximum solidity when 
CTDNEP1 is intact, such that limiting membrane lipid synthesis does not take 
away from the nucleus’ ability to maintain its shape. 
 In CTDNEP1KO cells, increased fatty acid synthesis and flux of existing 
fatty acids into membranes could result in more membranes feeding into the 
nuclear envelope, causing its morphology to take on a more lobed shape. Upon 
treatment with the ACAC inhibitor TOFA, decreased fatty acid synthesis could 
limit the fatty acid pool that is available to incorporate into the nuclear 
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membranes. To confirm that this is the case, I treated CTDNEP1KO cells with 
TOFA or DMSO with or without 100 μM exogenous fatty acids (1:2:1 
palmitic:oleic:linoleic acid) for 24 hours (Figure 5.14A). As before, TOFA 
treatment increases nuclear solidity in CTDNEP1KO cells compared to untreated 
cells; in TOFA- and fatty acid-treated cells, however, nuclear solidity is not 
significantly changed, though the population values trend toward the solidity of 
untreated CTDNEP1KO cells (Figure 5.14B). The incidence of nuclei with solidity 
< 1 SD from the control mean is significantly lower in cells treated with TOFA with 
exogenous fatty acids compared to cells treated with TOFA alone (Figure 5.14C). 
We interpret that this result could be a partial rescue by fatty acid treatment of 
the suppression of decreased nuclear solidity that occurs with ACAC inhibition in 
CTDNEP1KO cells. This result is somewhat surprising given that fatty acid 
supplementation appears to restore ER membrane expansion in TOFA-treated 
CTDNEP1KO cells (Figure 5.8). Together, these data show that CTDNEP1 limits 
fatty acid synthesis and ER membrane lipid synthesis to control nuclear shape. 
Inhibition of fatty acid synthesis decreases formation of micronuclei in CTDNEP1-
depleted cells 
 To determine if the role CTDNEP1 plays in limiting fatty acid synthesis 
controls formation of micronuclei, I quantified the incidence of micronuclei in 
CTDNEP1KO cells treated with DMSO or TOFA (5.15A). I measured the doubling 
time of U2OS cells to be 20-22 hours (data not shown). To account for the time 
needed for a cell cycle to pass after limiting membrane synthesis, I treated 
CTDNEP1KO cells with TOFA for 48 hours, a timeframe during which cells 
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continue to show suppression of ER membrane synthesis (Figure 5.7). After 48 
hours of ACAC inhibition, the incidence of micronuclei was decreased (3.3 ± 1.4 
% of CTDNEP1KO cells treated with TOFA compared to 10.3 ± 2.3 % of cells 
treated with DMSO; Figure 5.15). Additionally, I sought to determine if 
CTDNEP1’s role in limiting fatty acid synthesis and ER membrane biogenesis 
mediates its role in permitting mitotic error correction. I subjected TOFA-treated 
CTDNEP1KO cells to nocodazole washout as shown (Figure 5.16A-5.16B). TOFA 
treatment reduced the incidence of hyper-micronucleated nuclei (20.1 ± 4.2 % of 
TOFA-treated CTDNEP1KO cells compared to 38.8 ± 3.3% of DMSO-treated 
cells; Figure 5.16C). Together, these data support the conclusion that 
CTDNEP1’s role in permitting mitotic error correct to limit formation of 
micronuclei occurs through its roles in limiting fatty acid synthesis and ER 
membrane biogenesis. 
Discussion 
Here, we have identified that CTDNEP1 and lipin 1 limit ER membrane 
biogenesis by limiting PC/PE formation and restricting fatty acid synthesis and 
flux of fatty acids into ER membrane lipids. We show that this control of 
membrane biogenesis by CTDNEP1 permits mitotic error correction to limit 
formation of micronuclei. 
In C. elegans early embryos, ER sheet formation was found to be due to 
loss of LPIN-1 conversion of PA to DAG, resulting in a buildup of PA that then is 
synthesized into PI through the CDP-DAG pathway (Bahmanyar et al., 2014). 
Knockdown of CDP-DAG synthase, which catalyzes the conversion of PA to 
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CDP-DAG, or PI synthase, which catalyzes the conversion of CDP-DAG to PI, 
rescues abnormal nuclear shapes caused by depletion of CNEP-1 or LPIN-1 
(Bahmanyar et al., 2014). Depletion of CDP-DAG synthase also restores PI and 
PA abundance and ER sheet formation in CNEP-1-depleted embryos 
(Bahmanyar et al., 2014). Using mass spectrometry lipidomic analysis, we have 
found that PI and PA levels are not increased in U2OS CTDNEP1KO cells and 
that PE and PC levels are increased. This suggests that loss of lipin’s PA to DAG 
conversion alone is not sufficient to explain ER membrane expansion with loss of 
CTDNEP1 in human cells. We have found that transcriptional control of fatty acid 
synthesis is altered in CTDNEP1KO U2OS cells. Since C. elegans early embryos 
are transcriptionally quiescent, CNEP-1 deletion does not lead to upregulated 
fatty acid synthesis as in human cells. 
Our data support a mechanism of CTDNEP1 limiting ER membrane 
biogenesis through multiple modes of regulation (Figure 5.17A-B). First, 
expression of SREBP1 target genes ACACA and SCD, which catalyze rate-
limiting steps of total fatty acid and monounsaturated fatty acid synthesis, is 
limited by CTDNEP1 to limit fatty acid synthesis (Figure 5.17B, “1.”). Addition of 
exogenous fatty acids with inhibition of fatty acid synthesis revealed that flux of 
fatty acids into membrane lipids is also limited by CTDNEP1 (Figure 5.17B, “2.”). 
Different rates of response to fatty acid inhibition raise the question of whether 
the rate of fatty acid breakdown is also modulated by CTDNEP1 (Figure 5.17B, 
“3.”). The combined effects limit synthesis of ER membrane lipids, especially PC 
and PE, to limit membrane biogenesis (Figure 5.17B, “4.” and “5.”).  
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It is not clear why fatty acid supplementation does not fully reverse the 
suppression of nuclear solidity changes that occurs when CTDNEP1KO cells are 
treated with an ACAC inhibitor to shut off fatty acid synthesis, despite fatty acid 
supplementation reversing suppression of ER membrane expansion with ACAC 
inhibitor treatment. Perhaps the ER’s morphology is responsive to changes in 
fatty acid synthesis on a faster time scale than the nuclear envelope. Another 
possibility is that exogenously supplied fatty acids are not incorporated into 
nuclear envelope lipids as easily as into ER membrane lipids to influence nuclear 
shape. The nuclear envelope has shown to be a metabolic territory of lipid 
synthesis (Drozdz et al., 2017; Goulbourne et al., 2011; Romanauska and 
Köhler, 2018); perhaps its lipid metabolic capacity relies more on fatty acids 
synthesized de novo in the interconnected ER. Live imaging studies with acute 
ACAC inhibition will help establish whether nuclear envelope shape with regards 
to lipid availability is established during mitosis or can be changed during 
interphase, the latter of which would lend some support for the hypothesis that 
nuclear envelope lipid synthesis plays a role in determining its own shape. 
This work has established a role for CTDNEP1 and lipin 1 for limiting ER 
membrane biogenesis in human cells through limiting fatty acid synthesis at least 
partly through SREBP-mediated gene transcription. This work has additionally 
connected control of fatty acid synthesis by CTDNEP1 to controlling formation of 
micronuclei (Figure 5.18). CTDNEP1 counteracts the nutrient-sensing kinase 
mTOR’s phosphorylation of lipin to stabilize a nuclear pool of active lipin 1 (Merta 
et al., 2021) (findings by J. W. Carrasquillo Rodríguez and T. Vitale). This activity 
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limits ER membrane biogenesis in interphase and mitosis. Less abundant 
membranes are more able to be cleared in mitosis, and cytoplasmic viscosity is 
maintained. We hypothesize that limiting cytoplasmic viscosity and limiting the 
presence of uncleared membranes permits chromosome movements that are 
necessary for mitotic error correction, especially correction of merotelic errors, 
which involve rotation of the chromosome (Cimini, 2003) (Figure 5.18). We 
propose that membrane clearance and containing cytoplasmic viscosity allows 
these error-correcting chromosome movements to occur (Figure 5.18). Finally, 
CTDNEP1 limiting mitotic error correction leads to restriction of formation of 
micronuclei during mitotic exit (Figure 5.18). 
One important future direction for this work will be to determine how 
reduction of fatty acid synthesis leads to a reduction in formation of micronuclei in 
CTDNEP1KO cells. According to our model, restricting fatty acid synthesis in 
CTDNEP1-depleted cells will reduce excess uncleared membranes in mitosis 
and maintain cytoplasmic viscosity to allow chromosome movements. An 
alternative possibility that remains to be excluded is that reducing fatty acid 
synthesis in any context reduces cellular division and thereby limits the 
opportunity for cells in a population to form micronuclei. The finding that TOFA 
treatment with nocodazole washout in cells subject to mitotic shakeoff reduces 
formation of hyper-micronucleated cells suggests that this is not the case. Still, 
imaging of membranes in mitosis in TOFA-treated cells can confirm that control 





Figure 5.1 SREBP transcriptional control of lipid synthesis 
A) Schematic of processing of SREBP from ER membranes to the nucleus in 
response to cholesterol and membrane packing sensing to upregulate lipid 
synthesis gene expression. SREBP, serum response element binding protein; 
Insig, Insulin induced gene; SCAP, SREBP cleavage-activating protein; bHLH, 
basic helix loop helix; S1P, signal peptidase 1; S2P, signal peptidase 2; SRE, 
sterol regulatory element. B) Schematic of how SREBP target genes control lipid 
synthesis. SREBP1 target genes (purple) control fatty acid synthesis, while 






Figure 5.2 Lipidome mole percent composition in CTDNEP1KO cells 
compared to control and CTDNEP1-overexpressed cells 
A, B) Plots of molar percentage of lipid classes as determined by mass 
spectrometry lipid profiling in indicated cell lines. n = 3 technical repeats per 
condition. WT refers to stable overexpression of CTDNEP1-HA. Plots in (A) and 






Figure 5.3 Lipidome pmol/mg protein lipid makeup in CTDNEP1KO cells 
compared to control and CTDNEP1-overexpressed cells 
A) Plots of pmol lipid per mg of protein as determined by mass spectrometry lipid 






Figure 5.4 Control of fatty acid synthesis with small molecule inhibition of 
acetyl-CoA carboxylase 
A) Schematic of how fatty acid synthesis feeds into ER membrane biogenesis and 
how it can be modulated using small molecule inhibitors and fatty acid 
supplementation. ACAC, acetyl-CoA carboxylase; TOFA, 5-(Tetradecyloxy)-2-
Furoic Acid; LPA, lyso-phosphatidic acid. Acetyl-CoA is converted to fatty acyl-
CoA by sequential carbon additions and can be additionally desaturated and 
elongated. 2 fatty acyl-CoAs can be formed into PA with glycerol, and PA/DAG can 








Figure 5.5 Inhibition of acetyl-CoA carboxylase suppresses ER expansion 
in CTDNEP1KO cells and reduces ER membranes in control U2OS 
cells 
A) Spinning disk confocal microscopy images of calnexin in immunostained U2OS 
cells treated as indicated. Yellow outlines show cell outlines as determined by 
manual outline of high-brightness ER signal. Blue arrows point to peripheral ER 
tubular networks, and red arrows point to thin or absent tubular networks. Scale 






Figure 5.6 Validation of ER phenotype categorization using ER fluorescent 
signal segmentation 
A) Plot, percent area quantification of ER signal segmentation from images of fatty 
acid-free BSA and DMSO or TOFA (24 hrs)-treated cells with phenotypic 
characterization for comparison. Values per cell (n) and phenotypic categorization 







Figure 5.7 Reduction of ER membranes by acetyl-CoA carboxylase 
inhibition over time 
A) Spinning disk confocal microscopy image of calnexin in immunostained U2OS 
cells treated as indicated. B,C) Quantification of incidence of indicated ER 
phenotypes in cells treated as indicated. n = number of cells, N = 3 experimental 





Figure 5.8 Supplementation with exogenous fatty acids restores ER 
appearance in cells with acetyl-CoA carboxylase inhibition 
A) Spinning disk confocal microscopy images of calnexin in immunostained U2OS 
cells treated as indicated. Yellow outlines show cell outlines as determined by 
manual outline of high-brightness ER signal. B,C) Quantification of incidence of 
indicated ER phenotypes in cells treated as indicated. n = number of cells, N = 3 
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Figure 5.9 Supplementation with exogenous fatty acids does not change 
ER appearance in untreated cells 
A) Quantification of incidence of indicated ER phenotypes in cells treated as 
indicated. n = number of cells, N = 3 experimental repeats. Mean + SD shown. P 
values, Chi squared tests of total incidences. Data are taken from the same dataset 





Figure 5.10 Depletion of SREBP1 partially suppresses expansion of ER 
membranes 
A) Representative immunoblot of whole cell lysates from cells treated as indicated 
with indicated antibodies. Unprocessed SREBP1 is shown. B) Spinning disk 
confocal microscopy images of GFP-KDEL transiently expressed in U2OS cells 
treated with the indicated siRNAs. Scale bars, 10 µm. C) Quantification of 
incidence of expanded ER phenotype in cells from (B). n = number of cells, N = 3 







Figure 5.11 Depletion of SREBP1/2 partially suppresses expansion of ER 
membranes 
A) Representative immunoblots of whole cell lysates from cells treated as indicated 
with indicated antibodies. Unprocessed SREBP1 and SREPB2 are shown. B) 
Spinning disk confocal microscopy images of GFP-KDEL transiently expressed in 
U2OS cells treated with the indicated siRNAs. Scale bars, 10 µm. C) Quantification 
of incidence of expanded ER phenotype in cells from (B). n = number of cells, N = 




Figure 5.12 Depletion of SCD partially suppresses expansion of ER 
membranes and leads to perinuclear ER puncta formation 
A) Immunoblot of whole cell lysates from cells treated as indicated with indicated 
antibodies. B) Spinning disk confocal microscopy images of GFP-KDEL transiently 
expressed in U2OS cells treated with the indicated siRNAs. Scale bars, 10 µm. 
Perinuclear ER punctae are shown with red arrows. C) Quantification of incidence 
of expanded ER phenotype in cells from (B). n = number of cells, N = 3 
experimental repeats. Mean ± SD shown. P value, Fisher’s exact test of total 
incidences. D) Quantification of incidence of perinuclear ER punctae phenotype in 
cells from (B). n = number of cells, N = 3 experimental repeats. Mean ± SD shown. 







Figure 5.13 Inhibition of acetyl-CoA carboxylase rescues nuclear solidity of 
CTDNEP1KO cells 
A) Plot of solidity of nuclei (n) of cells treated with DMSO or 10 μM TOFA for 24 
hrs. N = 3 experimental repeats. Individual values and means ± SD shown. P 
value, paired t test of replicate means. B) Quantification of incidence of solidity less 
than 1 SD from the mean of control nuclei solidity. n = number of nuclei, N = 3 





Figure 5.14 Partial suppression of nuclear solidity rescue with acetyl-CoA 
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carboxylase inhibition in CTDNEP1KO cells with fatty acid supplementation 
A) Epifluorescence images of DAPI/Hoechst staining in cells treated as indicated 
with fatty acid-free BSA or fatty acid-free BSA conjugated to 100 μM 1:2:1 
palmitic:oleic:linoleic acid and DMSO or 10 μM TOFA for 24 hrs. Scale bar 10 μm. 
B) Plots of solidity of nuclei (n) of cells treated as indicated. N = 3 experimental 
repeats. Individual values and means ± SD shown. P values, repeated measures 
ANOVA with post-hoc Šidák’s multiple comparisons test. C) Quantification of 
incidence of solidity less than 1 SD from the mean of control U2OS nuclei solidity. 
n = number of cells from N = 3 experimental repeats. Means ± SDs shown. P 
values, Fisher’s exact tests of total incidences. 
 
 
Figure 5.15 Inhibition of acetyl-CoA carboxylase suppresses formation of 
micronuclei in CTDNEP1KO cells 
A) Quantification of incidence of micronuclei in cells treated with DMSO or 10 μM 
TOFA for 48 hrs. n = number of cells from N = 3 experimental repeats. Means ± 





Figure 5.16 Inhibition of acetyl-CoA carboxylase suppresses hyper-
micronucleation in CTDNEP1KO cells upon recovery from transient spindle 
disassembly 
A) Schematic detailing nocodazole washout with TOFA treatment. B) 
Epifluorescence (DAPI/Hoechst) and confocal (emerin) images of immunostained 
cells treated with 10 μM TOFA or DMSO for 24 hrs (total) and subjected to 
nocodazole washout as shown. Scale bar 10 μm. C) Quantification of incidence of 
indicated phenotypes in cells treated as shown. n = number of cells from N = 3 






Figure 5.17 Mechanisms for expansion of ER membranes in CTDNEP1KO 
cells 
A) Schematic of showing how control of fatty acid synthesis by CTDNEP1/lipin 1 
mediated by SREBP1 target gene expression can feed into ER membrane 
synthesis. B) Schematic showing how increased expression of SREBP1 target 
genes (“1.”), increased flux into fatty acid and ER membrane lipid synthesis (“2.”, 
“4.”), and impacts on lipid breakdown (“3.”) can lead to increased ER membrane 





Figure 5.18 Excess membranes in CTDNEP1-depleted cells impact mitotic 
error correction to lead to formation of micronuclei 
A) Schematic showing how excess ER membranes in CTDNEP1KO cells caused 
by insufficient dephosphorylation of mTOR phosphorylation sites on lipin 1 disrupts 
mitotic error correction to lead to formation of micronuclei. Dark green = nuclear 
envelope; light green = ER; pink = DNA, and blue = mitotic spindle. In insets, 









Human CTDNEP1’s role in regulating lipid synthesis, ER membrane 
biogenesis, and nuclear morphology 
 Lipid synthesis is important for organelle maintenance, cell growth, and 
division, yet regulation of lipid synthesis in human cells is not fully understood. 
This work has elucidated some of the functions of CTDNEP1 in controlling ER 
lipid synthesis in human cells. We have established that human CTDNEP1 
restricts synthesis of PC and PE to limit ER membrane biogenesis through 
dephosphorylation of lipin 1 (Figure 6.1). Without CTDNEP1, lipin 1 is less able 
to repress SREBP-dependent fatty acid synthesis gene transcription, and flux 
into fatty acid and membrane lipid synthesis is increased (Figure 6.1). These 
mechanisms lead to the expansion of ER membranes in CTDNEP1-depleted 
cells. 
An important future direction for determining how CTDNEP1 limits ER 
membrane biogenesis will be determining the mechanism for how flux into 
PC/PE is increased with CTDNEP1 deletion in human cells (Figure 6.1). One 
aspect of this regulation that is known is that Mg2+-independent PAP activity is 
increased in CTDNEP1KO U2OS cells, likely to compensate for decreased Mg2+-
dependent PAP activity that also occurs (Merta et al., 2021) (finding by Mitchell 
E. Granade). Mammalians have 3 lipin genes, and these lipins are known to 
compensate for each other in mice by increased expression of the other lipins 
when one is depleted, although this can depend on tissue specific-lipin 
expression (Grimsey et al., 2008; Gropler et al., 2009). While loss of CTDNEP1 
can potentially limit activation all lipins, negating the effect of lipin-lipin 
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compensation, it is known that the PAP activities of lipin 2 and lipin 3 are 
unaffected by phosphoregulation (Boroda et al., 2017; Eaton et al., 2013). Thus, 
PAP activity of lipins 2 and 3 may continue conversion of PA to DAG in the 
absence of lipin 1 activation by CTDNEP1 to help shunt fatty acids into ER 
membrane lipids. As a whole, PAP activity not dependent on lipin 1 could 
contribute to increased membrane biogenesis in CTDNEP1-depleted cells 
(Figure 6.1). 
Another possibility for how CTDNEP1 limits flux of fatty acids into ER 
membrane biogenesis might be regulation of CCTα activity (Figure 6.1). The 
increase in PC and PE in CTDNEP1KO cells points to the possibility that CCTα 
activity may be increased with loss of lipin activity as in A. thaliana cells 
(Craddock et al., 2015). It is unclear if such activation would occur through PA 
activating CCTα or a more general sensing of membrane packing with increased 
fatty acid synthesis. Measuring CDP-choline output in CTDNEP1KO cells would 
help determine if CCTα activity is increased to raise PC synthesis. Other 
possibilities for how CTDNEP1 limits the flux of fatty acids into PC and PE could 
be regulation of fatty acid uptake by the cell or negative regulation of other 
processes that lead to breakdown of lipids, like lipophagy and autophagy in 
general. Determining the extent of these activities and measuring expression of 
related genes will elucidate their involvement in control of ER membrane 
biogenesis by CTDNEP1 and lipin 1.  
One remaining question is whether lipid breakdown is regulated by 
CTDNEP1/lipin 1 in human cells (Figure 6.1). It is known that lipin 1 can 
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positively regulate PPARα-mediated transcription to upregulate fatty acid 
oxidation genes in mouse liver cells (Finck et al., 2006). Lipin deficiency in 
humans causes symptoms that closely resemble those of fatty acid oxidation 
disorders (Knottnerus et al., 2018; Zeharia et al., 2008). I previously showed that 
PPARα binding-deficient lipin 1 can still rescue ER membrane expansion in 
CTDNEP1KO cells (Figure 2.15). In order to determine whether CTDNEP1 limits 
lipin 1 activation of lipid oxidation gene transcription, future studies should test for 
the expression of these genes, which include fatty acid transporters and fatty 
acid-metabolizing enzymes, in CTDNEP1KO cells and determine if 
overexpression can suppress ER membrane expansion.  
CTDNEP1’s control of nuclear morphology is also dependent on control of 
fatty acid synthesis— multilobed nuclear morphology in CTDNEP1KO cells is 
suppressed by inhibiting fatty acid synthesis. Future experiments should 
determine to what extent nuclear envelope morphology is established during 
nuclear envelope reassembly as opposed to remodeling during interphase. 
Future experiments can also determine if there is an interaction between 
CTDNEP1 control of lipid synthesis and other players in establishing nuclear 
envelope structure, such as the nuclear lamina, nuclear sealing, and connections 
to the cytoskeleton. 
How the study of CTDNEP1 has informed our knowledge of how membrane 
dynamics in mitosis are important for chromosome segregation 
 This work uncovers a previously unknown role for CTDNEP1 in regulating 
mitotic error correction to limit formation of micronuclei. We show that CTDNEP1 
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limits ER membrane biogenesis to restrict ER membrane abundance in mitosis 
(Figure 6.2). With intact CTDNEP1, ER membrane abundance is limited in 
interphase and mitosis, and ER membranes can properly clear from the mitotic 
spindle and chromosomes (Figure 6.2, “Control”). Mitotic error correction can 
proceed as normal, and nuclear envelope assembly ensures formation of single 
nuclei of the correct size and shape (Figure 6.2, “Control”). Without CTDNEP1, 
ER membranes are expanded due to increased membrane lipid synthesis, and 
ER membrane expansion persists through mitosis, when cytoplasmic viscosity is 
also increased (Figure 6.2, “Loss of CTDNEP1”). Consistent with findings in other 
organisms, expanded membranes in CTDNEP1-depleted human cells are less 
cleared during prometaphase. Prometaphase chromosome average velocity is 
also decreased, consistent with a prometaphase delay seen in other studies and 
corroborated in this study. Merotelic kinetochore attachment errors are less able 
to be corrected in CTDNEP1-depleted cells, contributing to formation of 
micronuclei (Figure 6.2, “Loss of CTDNEP1”). We propose that cytoplasmic 
viscosity and less cleared membranes limit chromosome movements, which in 
turn limits merotelically attached chromosomes from rotating to promote error 
correction, which then leads to the formation of micronuclei. Additionally, 
CTDNEP1-depleted cells are less able to limit membrane extensions from 
forming inside of nuclei during mitotic exit and to limit nuclear expansion (Figure 
6.2, “Loss of CTDNEP1”). Thus, CTDNEP1 controls ER membrane biogenesis 




Connecting lipid synthesis to chromosomal instability in cancer through 
CTDNEP1 
 Cancer cells frequently exhibit increased lipid synthesis and are prone to 
forming micronuclei, and these are conventionally thought to be separately 
occurring events. This work establishes a case in which formation of micronuclei 
depends on the extent of membrane lipid synthesis, with the deletion of a gene 
that is commonly mutated in medulloblastoma, CTDNEP1. 
 Our work shows that cells deleted of CTDNEP1 have upregulation of 
SREBP1-target fatty acid synthesis genes that are frequently upregulated in 
cancer. We show that increased fatty acid synthesis feeds into membrane lipid 
synthesis, which interferes with mitotic progression and error correction. We 
propose a mechanism for formation of micronuclei via improperly cleared and 
more abundant membranes contributing to higher cytoplasmic viscosity, all of 
which reduces chromosome motions to impede kinetochore attachment error 
correction.  
 CTDNEP1 truncating mutations occur frequently in Group 3 
medulloblastoma, a subgroup associated with young age at presentation and 
poor prognosis (CTDNEP1 frameshift, premature stop single-nucleotide 
variations, or splice site-altering mutations in 5% of cases) (Jones et al., 2012; 
Northcott et al., 2012, 2017). CTDNEP1 mutations primarily occur in the absence 
of known driver mutations in Group 3 medulloblastomas, including amplification 
of the pro-growth transcription factor MYC (Northcott et al., 2017) and 
homozygous tumor suppressor p53 deletion (Jones et al., 2012). At the same 
 
 172 
time, CTDNEP1 mutations occur with loss of heterozygosity at 17p, where 
CTDNEP1 and TP53 reside (Jones et al., 2012). It is possible that loss-of-
function mutations in a cell with one copy of CTDNEP1 would lead to increased 
lipid synthesis that supports cancer cell proliferation, along with decreased 
mitotic error correction leading to formation of micronuclei. These characteristics 
could contribute to cancer progression that leads to poor prognoses in the Group 
3 medulloblastoma subgroup. 
 An alternative hypothesis is that CTDNEP1 could control phosphorylation of 
substrates besides lipin 1. CTDNEP1 was identified in Xenopus embryos as a 
gene required for neural development through negative regulation of bone 
morphogenic protein (BMP) signaling (Satow et al., 2002). BMP signaling in this 
case occurs when BMP binds to its plasma membrane receptor, which then 
phosphorylates Smads, which then bind other Smads and enter the nucleus to 
act as transcription factors for genes important for tissue development (Derynck 
and Zhang, 2003).  Later studies implicated CTDNEP1 in limiting phospho-Smad 
abundance in kidney, bone, and heart tissues in Xenopus and mice (Darrigrand 
et al., 2020; Hayata et al., 2015; Sakaguchi et al., 2013). Evidence suggests that 
CTDNEP1 dephosphorylates Smad in Drosophila, but direct evidence of 
phosphorylation of Smads by CTDNEP1 is lacking in other organisms (Urrutia et 
al., 2016). The well-characterized role of CTDNEP1 in regulating lipid synthesis 
also needs to be ruled out in these developmental contexts, as lipid composition 
of membranes can impact cell signaling (Sunshine and Iruela-Arispe, 2017). 
CTDNEP1 does not control BMP signaling in all tissues; in mouse primordial 
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germ cells, CTDNEP1 does not regulate BMP/Smads (Tanaka et al., 2013). In 
human medulloblastomas, BMP signaling can be upregulated or downregulated, 
though the reason for this is unclear (Caja et al., 2015). It is possible that loss of 
CTDNEP1 leads to attenuation of BMP signaling that might contribute to cancer 
development, although the mechanism for this may not be straightforward. At the 
same time, we have shown that key phenotypes associated with cancer in 
CTDNEP1-depleted cells are suppressed with lipin 1 dephospho-mimic 
overexpression, which is consistent with the idea that CTDNEP1’s role in cancer 
is more related to its role in controlling lipid synthesis. Future studies of 
CTDNEP1 in cancer will clarify if there are multiple roles for CTDNEP1 in 
controlling cancer progression. 
 These findings suggest the existence of a paradox between regulation of cell 
metabolism and chromosomal instability. Limiting membrane synthesis limits a 
cell’s ability to proliferate, but these data show that it also appears to limit 
chromosomal instability, which is detrimental to cell survival at high levels (Giam 
and Rancati, 2015; Sansregret et al., 2017). Why do cancer cells frequently 
exhibit upregulation of lipid synthesis if it could confer a survival disadvantage? It 
is possible that this is the case merely because the benefit of increased 
proliferation overcomes any negative aspects of increased lipid synthesis. It has 
also been proposed that mechanisms that promote chromosomal instability at a 
low level are adaptive for cancer cells because they provide tolerable levels of 
chromosome missegregation that promote genetic heterogeneity (Giam and 
Rancati, 2015). I propose that the solution to this paradox in cancer cells lacking 
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functional CTDNEP1 is that cells having increased membrane lipid synthesis that 
can support proliferation subsequently have increased genetic heterogeneity that 
is adaptive for tumor progression. This conclusion strengthens the case for 
CTDNEP1 as a candidate tumor suppressor in Group 3 medulloblastomas. 
Remaining Questions and Future Directions 
 We have shown that increased lipid synthesis producing excess ER 
membranes can change the physical properties of the cytoplasm in mitotic cells. 
What remains to be seen is whether cytoplasmic viscosity is also increased in 
interphase cells, or whether other properties of the cytoplasm are changed as 
well. It will be interesting to know how ER taking up more space in the cytoplasm 
to increase cytoplasmic viscosity impacts more cell functions, like movements of 
organelles and the cytoskeleton.  
The fatty acid makeup of membranes in CTDNEP1-depleted cells has not 
been studied, as our lipidomic analysis did not include subspecies fatty acid 
chain information. The length and saturation of fatty acids in membrane lipids 
greatly impacts the physical properties of the membrane, so it will be important to 
determine the impact of fatty acid composition in excess membranes in cells 
lacking CTDNEP1. Desaturation of membrane fatty acids is associated with 
membrane fluidity; perhaps more Δ9-unsaturated fatty acids with SCD 
upregulation in CTDNEP1KO cells could make expanded ER membranes more 
fluid and less able to be cleared to the cell periphery in mitosis.   
Lipid synthesis in the ER generates membrane lipids for other organelles 
and performs biogenesis of peroxisomes and lipid droplets (Holthuis and Menon, 
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2014; Thiam et al., 2013; van der Zand et al., 2012). One remaining question is 
whether increased membrane biogenesis in the ER of CTDNEP1-depleted cells 
leads to increased size or altered composition of other organelles. Future studies 
should examine the appearance and function of organelles— like mitochondria, 
endosomes and lysosomes, peroxisomes, lipid droplets, and the plasma 
membrane— that derive lipids from the ER.  
A major future direction for studying roles of CTDNEP1 in human cells will 
be to characterize CTDNEP1 structure and functions on the molecular level. One 
important step will be to optimize purification of CTDNEP1 for antibody synthesis 
and in vitro dephosphorylation assays. Further, another important future direction 
will be to determine all proteins that are dephosphorylated by CTDNEP1 by 
proteomic analysis. Proteins that are determined to be more phosphorylated in 
the absence of CTDNEP1 can be verified by in vitro dephosphorylation of 
peptides or purified proteins. If they are not directly dephosphorylated by 
CTDNEP1, one can determine if their dephosphorylation occurs as a result of 
limiting lipid synthesis by targeting lipin 1 or overexpressing/knocking down 
SREBP1 target genes. CTDNEP1 has a putative transmembrane domain in its N 
terminus; domain-mutation analyses can determine if its transmembrane 
domains and certain residues (outside of the active site) are important for lipin 
dephosphorylation, targeting to the nuclear envelope and ER, and binding with 
NEP1R1.  
Finally, more studies should be performed to elucidate further how control 
of lipid synthesis controls formation of micronuclei. As mentioned previously, 
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tracking membranes in cells in which fatty acid synthesis has been shut off can 
determine if decreasing membranes in mitosis limits chromosome 
missegregation. Nocodazole washout leads to increased formation and 
persistence of merotelic attachments, but upstream of this phenomenon is 
delayed spindle bipolarity and possible imbalance between contributions of 
centrosome-nucleated and chromosome-nucleated microtubules to the spindle 
(Gregan et al., 2011; Silkworth and Cimini, 2012). Future experiments can 
determine if these upstream events can contribute to chromosome 
missegregation in ways other than by increasing merotelic attachments, such as 
by disrupting spindle architecture. Analyses of kinetochore architecture during 
nocodazole washout in mitotic exit in CTDNEP1KO cells can confirm that lagging 
chromosomes are due to merotelic kinetochore attachments. These studies can 
also determine how many chromosomes are contained in nuclei that are not the 
primary nucleus in hyper-micronucleated cells. Average chromosome velocity is 
slower in prometaphase CTDNEP1KO cells; this may reflect slower chromosome 
diffusion in viscous cytoplasm in the presence of uncleared membranes, but it 
could also reflect slower spindle microtubule motions. Further studies of live 
imaging of tubulin can also determine how mitotic spindle growth and movements 
are affected by the presence of excess ER membranes in mitotic cells depleted 
of CTDNEP1.  These studies can cement the role of regulating membrane 
biogenesis in controlling chromosome segregation, which will help our 





 These data have implicated control of membrane lipid synthesis by the lipin 1 
phosphatase CTDNEP1 to control of mitotic error correction to ensure mitotic 
fidelity. This finding represents the first connection between alterations in lipid 
synthesis that can occur in cancer and formation of micronuclei that also 
contribute to cancer progression. These findings and future studies will enlighten 
our understanding of how control of cell metabolism is orchestrated with mitotic 





Figure 6.1 Mechanisms for increased ER membrane lipid synthesis with 
loss of CTDNEP1 
 Schematic of how CTDNEP1 control of lipin 1 at the nuclear envelope controls 
ER membrane biogenesis. With loss of CTDNEP1, lipin 1 is less abundant and 
less active, yet multiple mechanisms feed into increased PC/PE synthesis that lead 
to increased membrane biogenesis. Black boxes, mechanisms increasing 
membrane biogenesis established in this work. Blue boxes, putative mechanisms 






Figure 6.2 CTDNEP1 limits ER membrane abundance to promote proper 
nuclear assembly 
 Schematic for how increased ER membrane biogenesis in the absence of 
CTDNEP1 leads to abnormal nuclear assembly and formation of micronuclei. ER 
membranes, light green; nuclear envelope, dark green; Centrosomes and spindle 





Materials and Methods 
Mammalian cell lines 
U2OS and RPE-1 cells were obtained from ATCC or the source specified. Cells 
were grown at 37°C in 5% CO2 in DMEM low glucose (Gibco 11885) (U2OS), or 
DMEM:F12+HEPES (Gibco 113300)(RPE-1) supplemented with 2 mM L-
glutamine (Sigma 59202C) (RPE-1) supplemented with 10% heat inactivated FBS 
(F4135) and 1% antibiotic-antimycotic (Gibco 15240112). Cells were cultured 
without antibiotics during transfections, RNAi, and treatments for experiments. 
Cells were used for experiments before passage 30 (20 for RPE-1). Cells were 
tested for mycoplasma upon initial thaw and generation of new cell lines (Southern 
Biotech 13100-01), and untreated cells were continuously profiled for 
contamination by assessment of extranuclear DAPI/Hoechst 33258 staining.  
U2OS IBB-GFP H2B-mCherry was generated by transfection of the plasmids using 
Lipofectamine 2000 (Thermo Fisher Scientific 11668), then plated into 10 cm 
dishes at ~100 cells per dish. Dishes were treated with 2 ug/ml puromycin and 400 
ug/ml G418 in antibiotic-free media for 1.5-2 weeks until visible colonies of >100 
cells formed. Non-overlapping colonies were isolated using sterile filter paper discs 
(Bel-Art F37847-0001) dipped in 0.25% trypsin-EDTA (Sigma 59428C or Gibco 
25200) and applied to colonies for 30 s after washing dish with PBS. Isolated 
colonies were grown in 24 well plates under 1 ug/ml puromycin and 200 ug/ml 
G418 selection until confluent, after which colonies were imaged for fluorescence, 
expanded, and frozen down. 
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To generate U2OS GFP-Sec61β H2B-mCherry, U2OS GFP-Sec61β were 
transfected with H2B-mCherry-IRES-puro2v2.0 for 48 hours, then plated into 10 
cm dishes at <100 cells/ml and selected with 0.5 μg/ml puromycin for 2 weeks. 
Colonies were trypsinized and picked with 1/8 in sterile cloning discs (Bel-Art 
F37847-0001) and grown to confluence in a T25 flask before imaging confirmation 
of marker expression. 
Transfection and RNAi 
Most transfections were performed with Lipofectamine 2000 (Thermo Fisher 
Scientific 11668) in Opti-MEM (Gibco 31985) using a 1:2 ratio of 
DNA:lipofectamine with DNA concentrations ranging from 0.05-0.3 μg DNA per 
cm2 of growth surface. Briefly, DNA and lipofectamine were added to 10 μl 
OptiMEM per cm2 of growth surface in separate borosilicate glass tubes (Thermo 
Fisher Scientific STT-13100-S). After 5 minutes incubation, DNA solution was 
added to lipofectamine solution. After 15 minutes, DNA:lipofectamine mix was 
added dropwise to cells plated 16-24 hrs prior to transfection in fresh antibiotic-
free media (1 ml/9.6 cm2 growth surface). Media was exchanged for antibiotic-free 
media after 6 hours. To increase transfection efficiency, plasmids used for live 
imaging were purified using the Zymopure II Plasmid Midi Prep kit, including a 10 
min final elution at 56°C and use of the Zymopure endotoxin removal columns. 
Transfections for lipin 1 overexpression were performed using PolyJet in vitro DNA 
transfection reagent (Signagen SL100688) using a 1:3 ratio of DNA:Polyjet using 
0.1 μg DNA per cm2 of growth surface. Protocol is identical to previous transfection 
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protocol except for using 5 μl OptiMEM per cm2 of growth surface for mixes and 
no incubation before mixing reagents. 
For experiments involving transient CTDNEP1 and/or NEP1R1 overexpression, 
pcDNA3.0 was used as an empty vector negative control. For experiments 
involving phenotype rescue with transient FLAG-lipin 1β construct overexpression, 
GFP-KDEL was used as a co-transfection marker, and untransfected cells within 
the same experiment were used as a negative control for effects of lipin 1β 
overexpression. 
RNAi was performed using Dharmafect 1 (Horizon Discovery T-2001) in Opti-MEM 
according to the manufacturer’s protocol. U2OS Sec61β/H2B-mCherry and U2OS 
IBB-GFP/H2B-mCherry were treated with 40 nM CTDNEP1 single siRNA 
(Dharmacon) or Ambion Silencer negative control 1 for 48 hours; all others were 
treated with 20 nM CTDNEP1 siGENOME SMARTpool or control pool #2 siRNA 
(Horizon Discovery) for 72 hours.  
For RTN1/RTN3 knockdown, cells were treated with either 80 nM Ambion Silencer 
Select negative control #1 siRNA or 40 nM both Silencer Select RTN1 siRNA and 
Silencer Select RTN3 siRNA for 48 hours. 
For SREBP1 or SCD knockdown, cells were treated with 20 nM Silencer Select 
negative control #1 siRNA or 20 nM Silencer Select SREBP1 or SCD siRNA for 72 
hours. For SREBP1/2 knockdown, cells were treated with 40 nM Silencer Select 
negative control #1 siRNA or 20 nM both Silencer Select SREBP1 siRNA and 
Silencer Select SREBP2 siRNA for 72 hours. 
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RNAi knockdown efficiency was determined by qPCR or immunoblot analysis or 
by presence of expanded ER sheets in the RTN4KO RTN1/3 knockdown. 
CRISPR/Cas9 genome editing 
All guide RNA sequences were designed using the online CRISPR tool 
http://crispr.mit.edu and reported no off-target matches. Nup160EN-Halo: 
CACGGGATTTATTATATCGT RTN4KO: CGTTCAAGTACCAGTTCGTG 
CTDNEP1EN-GFP: GGGCATCAGACGGCATCCCA CTDNEP1KO: 
ATGAAGTCAGGAGGCGTACC. The guide RNA sequences were synthesized as 
two oligos with BbsI overhangs and an additional guanidine base 5’ to the 
protospacer sequence, and the oligos were phosphorylated with calf alkaline 
intestine phosphatase (New England BioLabs #M0290) and annealed by heating 
to 95°C and cooling to room temperature. The annealed oligos were cloned into 
pSPCas9(BB)-2A-Puro (PX459) v2.0 (a gift from Feng Zhang, Addgene plasmid 
#62988) that had been digested with BbsI-HF (New England BioLabs #R3539). 
For generation of KO cell lines, the vectors were transfected into U2OS cells using 
Lipofectamine 2000 and selected with 3 ug/ml puromycin (Invitrogen) for 48 hours. 
The remaining cells were grown up and gDNA isolated from the bulk population 
using a QiaAmp DNA Mini kit (Qiagen 51304). Genotyping was performed by 
sequencing and screening for indels using TIDE deconvolution 
(https://www.deskgen.com/landing/tide.html) (Brinkman et al., 2014). Once indels 
were detected in the bulk population, the cells were plated at <100 cells/ml into 10 
cm dishes (RTN4KO) or 96 well plates (CTDNEP1KO) and grown in antibiotic-free 
DMEM with 10% FBS for 2 weeks. Colonies were trypsinized and picked with 1/8 
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in sterile cloning discs (Bel-Art) if in 10 cm dishes. Colonies were grown in 24-well 
plates until more than 10,000 cells could be harvested for gDNA sequencing and 
TIDE analysis to genotype for frameshift mutations. The RTN4KO clonal cell line 
used in experiments showed to have -5bp deletions in >80% of alleles and 0% WT 
alleles as determined by TIDE deconvolution of sequencing and showed no 
expression of RTN4 by immunofluorescence (antigen is upstream of indel). The 
CTDNEP1KO clonal cell line used in experiments showed to have +1 insertions in 
>80% of alleles and 0% WT alleles as determined by TIDE deconvolution. The 
homology-directed repair template for Nup160EN-Halo was generated to add a 5-
glycine linker and HaloTag7 sequence to the 3’ end of the NUP160 gene, fusing 
Halo to the C terminus of all NUP160 isoforms. The HDR template was engineered 
using a 4-piece Gibson assembly: 1) the vector backbone was EGFP-N1 
(Clontech) amplified with oligos (listed below) so that the CMV promoter, MCS, 
and GFP sequence had been removed; 2) the left homology arm was an IDT 
gblock containing 800 bp upstream of the NUP160 stop codon with a silent 
mutation to the PAM sites of 1 potential guide RNA and a 
GGAGGCGGCGGCGGC linker and was flanked by 20-bp overhangs that 
overlapped with the EGFP-N1 backbone and HaloTag7; 3) HaloTag7 was 
amplified from Halo-N1 using oligos listed below (a silent mutation in aspartic acid 
was included in the forward primer to facilitate amplification of the gene); 4) the 
right homology arm was an IDT gblock containing 800 bp downstream of the 
NUP160 stop codon with 2 point mutations in the PAM sites of potential guide 
RNAs that was flanked by 20-bp overlap with HaloTag7 and the EGFP-N1 
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backbone. The CTDNEP1EN-GFP homology-directed repair template was 
generated to add a 6-glycine linker and GFP sequence to the 3’ end of the 
CTDNEP1 gene, fusing GFP to the C terminus of all CTDNEP1 isoforms. The HDR 
template was engineered using a 4-piece Gibson assembly: 1) the vector 
backbone was EGFP-N1 (Clontech) amplified with oligos (listed below) so that the 
CMV promoter, multiple cloning site, and GFP sequences had been removed; 2) 
the left homology arm was an IDT gblock containing 800 bp upstream of the 
CTDNEP1 stop codon with silent mutations to the PAM sites of 2 potential guide 
RNAs and a GGTGGCGGTGGCGGTGGC linker and was flanked by 20-bp 
overhangs that overlapped with the EGFP-N1 backbone and GFP; 3) GFP was 
amplified from EGFP-N1 using oligos listed below 4) the right homology arm was 
an IDT gblock containing 800 bp downstream of the CTDNEP1 stop codon with 2 
point mutations in the PAM sites of potential guide RNAs that was flanked by 20-
bp overlap with GFP and the EGFP-N1 backbone.  
To make endogenously tagged cells, the PX459v2.0 vector containing the guide 
sequences and the HDR templates were transfected into U2OS cells using 
Lipofectamine 2000 and treated with 3 ug/ml puromycin (Invitrogen) in antiobiotic-
free media for 48 hours. The remaining cells were sorted for the top 1-2% of 
fluorescent cells (Nup160EN-Halo cells were labeled with HaloTag TMR ligand 
(Promega). The sorted cells were plated at <100 cells/ml into 10 cm dishes, grown 
in antibiotic-free media for 2 weeks. Colonies were trypsinized and picked with 1/8 
in sterile cloning discs (Bel-Art F37847-0001) and grown to confluence in a T75 
flask, after which the gDNA was harvested using a Qiagen QiaAmp Mini kit.  
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For Nup160EN-Halo clones, the Nup160 region was amplified with combinations of 
primers 1, 2, and 3 to determine correct placement, orientation, and presence of 
wild-type alleles in clonal cell lines. Protein lysates of the bulk and clonal 
populations were run on an 8% polyacrylamide gel and transferred to a 
nitrocellulose membrane for western blot with rabbit anti-HaloTag (Promega 
#G9281) to confirm that the tagged protein is full-length. 
For CTDNEP1EN-GFP clones, the CTDNEP1 region was amplified with the 
specified primer pairs to determine correct placement, orientation, and presence 
of wild-type alleles in clonal cell lines. Regions were additionally amplified and 
sequenced with the specified primers. Clone 1 used for experiments showed 
minimal presence of wild-type CTDNEP1 sequences in sequencing 
chromatograms. CTDNEP1EN-GFP cells treated with 20nM of CTDNEP1 siRNA 
for 48 hours also show reduced nuclear envelope GFP fluorescence compared to 
control siRNA-treated CTDNEP1EN-GFP cells (data not shown). 
Plasmid generation 
GFP-KDEL was modified from pDsRed2-ER (Clontech), which contains a signal 
peptide and ER retention sequence (KDEL), by PCR of GFP with AgeI and HindIII 
sites, digestion of the insert and pDeRed2 with AgeI/HindIII (NEB R0552, R3104), 
and ligation. CTDNEP1-HA was modified from CTDNEP1-v5-His (Han et al., 
2012). pRK5 FLAG-lipin 1β 19xA PAP dead was modified from pRK5 FLAG-lipin 
1β 19xA using Quickchange Mutagenesis to make the following mutations: D712E, 
D714E. For pRK5 FLAG-lipin 1β-NLS and -NES, the NLS of nucleoplasmin or NES 




Early-passage cells were counted by hemocytometer, suspended in PBS at a 
concentration of 3x106 cells/ml, and flash frozen in liquid nitrogen. Triplicate 
samples were submitted for each condition. When noted, corresponding triplicate 
samples were lysed and protein extracted and protein concentration determined 
by Pierce BCA assay. Sample processing and lipidomics were performed and 
obtained at Lipotype GmbH. Samples were spiked with lipid class internal 
standards, and lipids were extracted using chloroform-methanol extraction using a 
Hamilton Robotics STARlet. Samples were infused using an Advion Triversa 
Nanomate automated nano-flow electrospray ion source with positive and negative 
ion mode utilized. Mass spectra were acquired using a Thermo Scientific Q-
Exactive hybrid quadruple/Orbitrap mass spectrometer in MS-only mode and 
tandem MS mode. Lipid species were identified using LipotypeXplorer, and data 
was processed using Lipotype LIMS and LipotypeZoom. Lipid class pmols/mg 
protein was determined using protein concentration and sample volume analyzed 
from each replicate. 
Mitotic shakeoff, micronuclei enrichment, and small molecule inhibitor 
treatment 
For mitotic shakeoff, cells were grown to at least 50% confluence in 75 cm2 flasks. 
Cells were washed with PBS or antibiotic-free media to clear debris, then flasks 
were whacked repeatedly on all sides and tapped on the bottom surface with a 
reflex hammer (DR Instruments S72118) until at least 50% of mitotic cells were 
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dislodged. The cell media was collected and centrifuged at 300xg for 5 min, then 
cells were additionally washed or plated. 
For nocodazole washout, cells at 50-80% confluence in 75 cm2 flasks were 
washed with 37°C PBS to clear debris and then treated with 100 ng/ml nocodazole 
(Sigma M1404) in antibiotic free media for 6 hours (Liu et al., 2018). Cells were 
subject to mitotic shakeoff without washing, then washed 3x with 37°C PBS. After 
the final wash, cells were plated onto acid-washed coverslips (coated with 1 ug/ml 
poly-D-lysine (Sigma P7886) for short-term washout) and incubated for 45 min-60 
min (short-term) or 18-20 hours (long-term) before immunofluorescence 
processing. 
For RO-3306/MPS1i micronuclei enrichment, cells were treated with 9 μM RO-
3306 (Calbiochem 217699) for 19 hours, washed 7 times, then treated with 1 μM 
NMS-P715 (MPS1i) (Calbiochem 475949) for 18 hours before processing for 
immunofluorescence (Liu et al., 2018). Ki values mentioned above were obtained 
from Calbiochem. 
For imaging cells arrested at the G2/M transition, cells in ibidi 8 well plates were 
treated with 9 μM RO-3306 for 18-20 hours and washed 7 times with Fluorobrite 
DMEM + FBS on the microscope stage, then imaged immediately. 
Fatty acid synthesis inhibition and fatty acid supplementation  
To inhibit fatty acid synthesis, cells were treated with 10 μM TOFA (Cayman Chem) 
in DMSO. Cells were treated with TOFA for 24 hours with or without fatty acid 
supplementation for ER and nucleus visualization or for 5-48 hours for ER 
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visualization over time. Cells were treated with TOFA for 48 hours for micronuclei 
quantification. 
For fatty acid supplementation, cells were plated at a density of 200,000 cells/ml 
in 6 well plates. Stocks of oleic acid, linoleic acid, and palmitic acid were made in 
methanol and pipetted into a 50 ml conical vial, then dried with an ambient air 
stream. Pre-warmed DMEM containing 0.5% fatty acid-free BSA (Sigma 
Cat#A8806) was added to a final concentration of 25 μM palmitic acid, 50 μM oleic 
acid, and 25 μM linoleic acid (100 μM total fatty acid concentration; 1:2:1 ratio of 
palmitic:oleic:linoleic acid). The solution was incubated at 37°C for 30 min, then 
held to the bottom of a sonicating bath for 30 s, then incubated at 37°C for 10 min 
until solution was clear. FBS was added to a final concentration of 10% v/v. Cells 
were treated with DMEM with 10% FBS and 0.5% BSA alone or DMEM with 10% 
FBS 0.5% BSA, and 100 μM fatty acids with DMSO or 10 μM TOFA in DMSO for 
24 hrs prior to immunofluorescence processing. 
Quantitative real-time PCR 
RNA was harvested using the RNeasy Mini kit (Qiagen 74104) using the 
manufacturer’s protocol, using Qiashredder columns (Qiagen 79654) for tissue 
homogenization and with additional RNase-free DNase (Qiagen 79254) treatment 
after the first RW1 wash and subsequently adding another RW1 wash. RNA was 
eluted with RNAse-free water and diluted to 50 ng/μl. RNA was subject to reverse 
transcription using the iScript Reverse Transcription Supermix (Bio-Rad 1708840) 
with 400 ng RNA per reaction. The subsequent cDNA was diluted 1:5 for RT-
qPCR. cDNA was analyzed for RT-qPCR using the iTaq universal SYBR Green 
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Supermix (Bio-Rad 1725120). Cycle threshold values were analyzed using the Δ 
ΔCt method. Statistical testing was performed on ΔCt values. 
Immunofluorescence 
Cells were washed 2x with warm PBS and fixed in 4% paraformaldehyde (+0.1% 
glutaraldehyde for ER structure analyses) in PBS for 15 min, permeabilized in 
0.5% Triton X-100 for 5 min, then washed 3 times with PBS and blocked in 3% 
BSA in PBS for 30 min. Samples were transferred to a humidity chamber and 
incubated with primary antibodies in 3% BSA in PBS for 1 hour at room 
temperature with rocking. Samples were washed with PBS 3 times for 5 min, then 
incubated with secondary antibodies in 3% BSA in PBS for 1 hour at room 
temperature in the dark with rocking. Samples were then washed with PBS 3 times 
for 5 min in the dark. For experiments visualizing nuclear structure and/or 
micronuclei, cells were additionally stained with 1 μg/ml Hoechst 33258 (Thermo 
Fisher Scientific H3569) in PBS for 1 min followed by one PBS wash. Coverslips 
were mounted with ProLong Gold Antifade reagent + DAPI (Thermo Fisher 
P36935) and sealed with clear nail polish. For samples treated with goat primary 
antibodies, 5% normal donkey serum (Sigma D9663) was used in place of 3% 
BSA.  
When indicated, cells were fixed and stained to visualize kinetochore microtubules 
(Thompson and Compton, 2011) by extracting in 100 mM PIPES, 1 mM MgCl2, 1 
mM CaCl2, 0.5% Triton X-100, pH 6.8 for 4 min, then fixing in 1% glutaraldehyde 
in PBS for 10 min and quenched 2 times with 0.1% NaBH4 in TBS for 10 min each. 
Cells were washed twice with 10 mM Tris, 150 mM NaCl, 10% BSA and then 
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stained with tubulin antibody for 1.5 hours, washed with PBS, then stained with 
secondary antibody for 1 hour, washed with PBS, then mounted with ProLong Gold 
+ DAPI. 
Immunoblot 
Lysis buffers used were: 1% SDS in 2mM Tris-HCl pH 7.2 (RTN4KO, NUP160); 1% 
NP-40, 150 mM NaCl, and 1 tablet/50 ml cOmplete protease inhibitor cocktail 
(Roche 11836170001) in 20 mM Tris pH 7.5 (calnexin, calreticulin, BiP, RTN4); or 
RIPA buffer (1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 150 mM NaCl, 
and 1 tablet/50 ml cOmplete protease inhibitor cocktail in 25 mM Tris pH 7.4) 
(SREBP1, SREBP2, SCD; protein concentration determination for lipidomic 
analysis). Cell lysates were removed from growth surfaces by scraping with a 
rubber policeman after incubation in lysis buffer or by adding lysis buffer to cell 
pellets collected by trypsinization and centrifugation at 300xg for 5 min followed by 
1-2 PBS washes. Lysates were homogenized by pushing through a 23G needle 
30 times and then centrifuged at >20,000xg for 10 min at 4°C, then protein 
concentration was determined using the Pierce BCA Protein assay kit (Thermo 
Scientific 23225). 10-30 μg of lysates/lane were run on 8-15% polyacrylamide gels 
dependent on target size, and protein was wet transferred to 0.22 μm nitrocellulose 
(<100 kDa) or PVDF (>100 kDa) membranes. For SREBP and SCD knockdown 
assessment, Ponceau S staining was used to visualize transfer efficiency, then 
washed with TBS or DI water. Membranes were blocked in 5% nonfat dry milk or 
BSA in TBS for 1 hour. Membranes were briefly washed in TBS-0.1% Tween 20 
(TBS-T) then incubated with primary antibodies in 5% milk for 1 hour at room 
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temperature or overnight at 4°C with rocking. Membranes were washed 3 times 
for 5 min in TBS-T, then incubated with anti-HRP secondary antibodies in 5% milk 
in TBS-T for 1 hour at room temperature with rocking. Membranes were washed 3 
times for 5 min in TBS-T. Clarity or Clarity Max ECL reagent (Bio-Rad 1705060S, 
1705062S) was used to visualize chemiluminescence, and images were taken with 
a Bio-Rad ChemiDoc or ChemiDoc XRS+ system. Exposure times of images used 
for analysis or presentation were maximum exposure before saturation of pixels 
around or within target bands. 
Live cell imaging  
For live imaging, cells were plated in Willco Wells 35 mm dishes (Willco Wells 
HBST-3522), ibidi 2 well imaging chambers (ibidi 80287) with DIC lid (ibidi 80055); 
or ibidi 8 well imaging chambers (ibidi 80827). Samples were imaged in a CO2-, 
temperature-, and humidity-controlled Tokai Hit Stage Top Incubator. Objectives 
were also heated to 37°C. For CO2-controlled imaging, the imaging media used 
was Fluorobrite DMEM (Gibco A1896701) supplemented with 10% FBS. U2OS 
IBB-GFP/H2B-mCherry and U2OS GFP-Sec61β/H2B-mCherry mitotic cells 
(except cells treated with RO-3306) were imaged using a custom aluminum stage 
insert (P. Forscher) heated to 37°C with heating tape and temperature monitored 
using a Physitemp thermistor (BAT7001H) and probe (IT-18), with objective 
heating and using 140 mM NaCl, 2.5 mM KCl, 1.8 mM CaCl2, 1.0 mM MgCl2, 20 
mM HEPES, 15 mM glucose, pH 7.4 as the live cell imaging solution. When 
indicated, cells were treated with 1 μM SiR-DNA (Cytoskeleton, Inc. CY-SC007) 
for 1 hour prior to imaging and kept in SiR-DNA-containing live imaging media 
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during imaging. For STED imaging, cells were labeled with 0.5 μM 647-SiR (NEB 
S9102S) for 30 min at 37°C, followed by a >15 min washout at 37°C, prior to 
imaging.  
Microscopy 
Samples were imaged on an inverted Nikon Ti microscope equipped with a 
Yokogawa CSU-X1 confocal scanner unit with solid state 100-mW 488-nm and 50-
mW 561-nm lasers, using a 60×1.4 NA plan Apo objective lens (or 10x 0.25 NA 
ADL objective with 1.5x magnification), and a Hamamatsu ORCA R-2 Digital CCD 
Camera. 
Samples with SiR-DNA/GFP-KDEL, FLAG-lipin/calnexin staining, telophase 
nocodazole washout, SREBP depletion, or 20x images were imaged on an 
inverted Nikon Ti Eclipse microscope equipped with a Yokogawa CSU-W1 
confocal scanner unit with solid state 100 mW 405, 488, 514, 594, 561, 594, and 
640 nm lasers, using a 60x 1.4 NA plan Apo objective lens and/or 20x plan Fluor 
0.75 NA multi-immersion objective lens, and a prime BSI sCMOS camera. 
Images for ER sheet/nanohole visualization were imaged on a Leica SP8 gated 
STED 3x with a SuperK Extreme EXW-12 pulsed white light laser (excitation) and 
Onefive Katana-08HP pulsed 775 nm laser (depletion) with a HyD hybrid detector; 
imaging was performed using a 100x plan Apo 1.4 NA oil objective. SiR 
fluorescence was imaged with 633 nm excitation and 775 nm depletion wavelength 
and collected between 650-750 nm with the detector. Pixel size of STED images 





Image analysis was performed using FIJI/ImageJ unless otherwise noted. For 
scoring of ER phenotypes, cells expressing moderate levels of GFP-KDEL with no 
overexpression artifacts (dense fluorescent clumps in ER or nuclei) were included 
for analysis. For scoring of interphase ER expansion, cells with a network of 
peripheral ER tubules visualized with GFP-KDEL or calnexin staining were 
considered “normal”, while cells with ER sheets and tubules extending into the 
periphery with a lack of any tubular network were considered to have “expanded 
ER”. Additionally, cells with the appearance of thin ER tubules, large gaps between 
tubules, and a smaller cluster of perinuclear ER were considered to have “reduced 
ER” with TOFA treatment. These phenotypes were additionally quantified with 
percent abundance of cytoplasmic KDEL/calnexin signal: for cells with the entire 
ER captured within 0.3-0.5 μm interval z stacks, 8-bit maximum intensity 
projections were made of the whole field of view. To ensure the different ER 
morphologies were all accounted for after thresholding, the 8-bit max projections 
were subject to unsharp masking with a radius of 2 and mask of 0.6. The max 
intensity projection was thresholded using the Huang threshold of object fuzziness 
(Huang and Wang, 1995). The cell border and nuclear border for each cell were 
manually traced using ER fluorescent signal, and the percent of KDEL-positive 
pixels per nucleus-free cell area was measured. RPE-1 ER and ER phenotypes in 
SCD-depleted cells were scored blindly. With SCD depletion, cells were 
additionally blindly scored for the presence of GFP-KDEL punctae in the 
perinuclear region that are brighter than the surrounding perinuclear ER. 
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For scoring of intracellular ER membranes in prometaphase cells, whole 75 cm2 
flasks of cells were transfected with GFP-KDEL and imaged 48 hours later after 
mitotic shakeoff and plating into 1 well per flask of an ibidi 8-well imaging chamber. 
Cells expressing GFP-KDEL in prometaphase up until metaphase (determined by 
DIC chromatin appearance) were imaged with 0.5 μm stacks for 20 μm total z 
height. 90x images of cells expressing GFP-KDEL and subject to mitotic shakeoff 
were blindly categorized for presence of a) no intracellular ER membranes 
(“cleared”), (b) few ER tubules within the cell interior (“partially cleared”); or c) large 
(>2 μm length) sheets and/or several tubules within the cell interior (“not cleared”). 
For scoring of intranuclear ER membranes in telophase nuclei, cell nuclei were 
scored 25 m post anaphase onset or in early G1 for presence of membrane 
extensions dimmer than the nuclear rim (extensions the same intensity as the 
nuclear rim were considered invaginations of the INM/ONM that are common in 
control U2OS cells). In analysis of intranuclear membrane extensions including 
categories, “mild” refers to cells with 1-2 extensions, while “severe” cases have 
several intranuclear membrane extensions. 
For scoring of mitotic profiles in control and CTDNEP1KO U2OS cells, 20x images 
of DAPI and tubulin-stained asynchronous, untreated cell populations were 
analyzed. For scoring of mitotic profiles in nocodazole washout (1 hour) control 
and CTDNEP1KO U2OS cells, 60x images of DAPI and tubulin-stained cell 
populations were analyzed. Mitotic cells were identified by DAPI appearance as 
relatively bright mitotic chromatin and tubulin appearance of duplicated 
centrosomes and presence of mitotic spindle. Staging was performed based on 
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the following criteria. Prometaphase: DAPI condensed into visible chromosomes 
not yet aligned into single metaphase plate, centrosomes duplicated and building 
spindle visible (in nocodazole washout, chromosome condensation and lack of 
metaphase-telophase spindle features was used to score prometaphase cells due 
to spindle rebuilding after nocodazole treatment); Metaphase: chromosomes 
aligned on metaphase plate and bipolar mitotic spindle present; Anaphase: visible 
separation of chromosome masses with bipolar mitotic spindle that may be 
elongated; Telophase/cytokinesis: chromosome masses separated into two 
daughter cells with apparent cytokinesis and spindle midzone visible in tubulin 
staining; early G1: chromatin decondensed, cytokinesis nearly complete with 
spindle midbody present. 
For quantification of micronuclei, images taken at 60x were scored for presence of 
micronuclei (DNA fragments encased in an emerin or calnexin-positive rim apart 
from main nucleus <~20% in size of the main nucleus). Severely 
lobulated/partitioned “hypermicronucleated” nuclei (DNA fragments/lobes apart 
from the main nucleus >~20% in size of the main nucleus) and micronuclei were 
scored through oculars or in 60x images of cells with nuclear envelope staining. 
Nuclei with both lobes/partitions and micronuclei were considered 
hypermicronucleated. For quantification of peripheral chromosome/tubulin masses 
in cells subjected to short-term nocodazole washout, 60x images of cells 
processed for immunofluorescence without non-kinetochore microtubule 
depolymerization were scored for the presence of chromosome masses with 
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microtubules extending to them that were to away to the cell periphery compared 
to the primary nuclei chromosome masses. 
Nuclear solidity was quantified as described (Fonseca et al., 2019). Briefly, 
DAPI/Hoechst images were thresholded with the ImageJ default setting, then the 
magic wand tool was used to select segmented nuclei. Nuclei that were unable to 
be segmented due to poor signal:noise, adjacent nuclei touching, or presence of 
a micronucleus touching the main nucleus were not included in the analysis. 
Segmented and selected nuclei were measured using the ImageJ shape 
descriptors measurement metric. Data were expressed as % of nuclei with a 
solidity value less than the control U2OS average minus 1 standard deviation. 
To quantify the percent of mitotic cell diameter that is occupied by ER membranes 
in cells expressing GFP-Sec61β/H2B-mCherry or GFP-KDEL/SiR-DNA, 60x 
image stacks of cells at anaphase onset (determined by first frame of visible 
chromatid separation) were obtained. Image background was subtracted using the 
average value of 3 boxes from surrounding the cell (but not within adjacent cells). 
A 10-pixel thick line was drawn encompassing the cell diameter along the 
metaphase plate (in the center of the dividing chromatin masses, along the division 
plane), and a profile plot was generated. The local maxima of theSec61β/KDEL 
peaks for each side of the cell was determined, and the width of the half maxima 
for each of the 2 Sec61β/KDEL peaks was quantified and added together. This 
value was divided by the diameter of the cell (determined by the bounds of the 
Sec61β/KDEL half maxima) to determine the % of the cell diameter occupied by 
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ER signal. For representation, plot profiles shown are normalized to minimum and 
maximum of ER and DNA signal. 
For quantification of nuclear import/size during mitotic exit with CTDNEP1 RNAi in 
U2OS IBB-GFP/H2B/mCherry cells,15x time lapse images were taken. Cells that 
were not overlapping, were fully in the imaging plane in z, had bright enough signal 
to distinguish from background, and did not experience z drift were included for 
analysis. IBB background intensity was taken from the first frame of the time lapse 
from a box in a cell-free area and subtracted from all frames. Nuclear size over 
time after anaphase onset was measured using the thresholded H2B-positive 
regions (using imageJ default algorithm) every 30 sec 3-30 min after anaphase 
onset. Integrated IBB-GFP intensity was measured for the entire thresholded 
chromatin (H2B positive) mass every 30 sec from 3-30 min after anaphase onset. 
IBB values were normalized to the minimum and maximum measured values for 
integrated intensity and size, then divided by the value at 3 min to be expressed 
as fold change. Values from both nuclei per daughter cell were averaged when 
applicable.  
To quantify lagging chromosomes in U2OS GFP-Centrin2/GFP-CENPA/mCherry-
α tubulin cells, cells were imaged immediately after mitotic shakeoff. 60x image 
stacks encompassing the whole cell volume of late anaphase and telophase cells 
expressing all markers and lacking large open vacuoles (an overexpression 
artifact) were included for analysis. Cell images were blindly categorized as having 
GFP punctae apart from the segregating chromosome masses that did not have 
associated bright tubulin (which would indicate a Centrin2 puncta). Metaphase cell 
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images were taken at the same time for spindle pole-pole distance measurements. 
To measure spindle pole-pole distance in U2OS GFP-Centrin2/GFP-
CENPA/mCherry-α tubulin cells, 60x images stacks encompassing the whole cell 
volume of metaphase cells that had no spindle tilt were analyzed to determine the 
central z plane to take measurements. A line was drawn from the center of the 
Centrin2 punctae (or brightest tubulin punctae if Centrin2 not expressed) and used 
to measure the pole-pole distance.  
Statistical analysis 
GraphPad Prism 8 was used for all statistical analysis. Continuous data was tested 
for normality using a Shapiro-Wilk test. For experimental setups in which > 10 
samples (n) per experimental replicate (N) were able to be collected consistently, 
continuous data was measured with paired t tests of experimental replicate means. 
Superplot format was used for representing percent of ER-positive pixels in 
cytoplasm area (Lord et al., 2020). Experimental replicates of discrete data were 
plotted with shapes indicating separate replicates to display reproducibility, and 
incidences between groups (replicates pooled) were tested for significance using 
Fisher’s exact test (2 categories) or Chi square test (>2 categories). Statistical tests 
used, sample sizes, definitions of n and N, and p values (p<0.05 as significance 
cutoff) are reported in figures and/or figure legends. For quantification of all data 
where >10 samples could be gathered within an experimental repeat, sample size 
calculations using the online tool (https://clincalc.com/stats/samplesize.aspx) 
determined the adequate sample size for number of cells to analyze for sufficient 
(80%) power.  
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Key Resources Table 
 
Plasmid or siRNA Source notes 
EGFP-N1 Takara Bio, Inc. 6085-1  
Halo-N1 Bewersdorf lab  
pSPCas9(BB)-2A-
Puro (PX459) v2.0 
Addgene #62988  
GFP-KDEL (Merta et al., 2021) (L.K. 
Schroeder) 
ssGFP-KDEL 
SNAP-KDEL (Schroeder et al., 2018)  
IBB-eGFP EUROSCARF P30631  
pH2B_mCherry_IRE
S_puro2 
Addgene 21045  
pRK5 FLAG-lipin 1β 
(Mm) 
(Peterson et al., 2011) Addgene #32005 
pRK5 FLAG-lipin 1β 
19xA 
(Peterson et al., 2011) Addgene #32007 
pRK5 FLAG-lipin 1β 
19xA PAP dead 





This study (S. Lee)  
pRK5 FLAG-NES-
lipin 1β 
This study  
CTDNEP1-HA (Merta et al., 2021) (M. 
Deline) 
 
CTDNEP1 D67E-HA (Merta et al., 2021) (C.L. 
Hu) 
 






















control siRNA #1 




Life Technologies 4390843 
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Antibody Source notes 
Mouse α-tubulin 
DM1A 
Millipore Sigma 05-829 1:5000 IB, 1:1000 IF 
mouse α FLAG Sigma F3165 1:4000 IB, 1:1000 IF 
Rabbit α HA Cell Signaling 
Technologies 3724T 
1:1000 IB, 1:800 IF 
Goat α Rtn4/NogoA Santa Cruz sc-11032 
(discontinued) 
1:200 
Mouse α RTN4 Santa Cruz sc-271878 1:200 
Rabbit α-HaloTag Promega G9281 1:1000 
Rabbit α-emerin Proteintech 10351 1:200 
Rabbit anti-calnexin Abcam Ab22595 1:1000 
Rabbit anti-
calreticulin 
Abcam Ab2907 1:1000 
Goat α GFP Hyman lab 1:1000 
Rabbit anti-PCNA Proteintech 10205-2-AP 1:5000 
Mouse anti-GAPDH GeneTex GTX28245 1:1000-1:2000 
Rabbit anti-BiP 
(Grp78) 
Abcam Ab21685 1:400 
Rabbit α SREBP1 
(2A4) 
Santa Cruz sc-13551X 1:250 
Rabbit α SREBP2 Abcam ab30682  
Mouse anti-goat 
IgG-HRP 
Santa Cruz sc-2354 1:2500 
Goat anti mouse 
IgG-HRP 
Thermo Fisher 31430 1:10000 
Goat anti rabbit IgG-
HRP 
Thermo Fisher 31460 1:10000 
Rhodamine RedX 






























Alexa Fluor 488 





Alexa Fluor 647 goat 




Cell lines Source notes 
U2OS Slack lab N/A 
RPE-1 Breslow lab N/A 
U2OS GFP-Sec61β Rapoport lab N/A 
U2OS GFP-Sec61β 
H2B-mCherry 
(Merta et al., 2021) N/A 
U2OS IBB-GFP 
H2B-mCherry 




(Yu et al., 2019) N/A 
U2OS CTDNEP1KO (Merta et al., 2021) N/A 
U2OS CTDNEP1KO 
CTDNEP1-HAstable 
(Merta et al., 2021) (J.W. 
Carrasquillo Rodríguez) 
N/A 
U2OS RTN4KO (Schroeder et al., 2018)  
U2OS CTDNEP1EN-
GFP 
This study N/A 
U2OS NUP160EN-
Halo 






Nocodazole Sigma  Cat#M1404 
RO-3306 EMD Millipore  Cat#217699 
TOFA Cayman Chemicals  Cat#10005263 
NMS-P715 EMD Millipore  Cat#475949 
SiR-DNA Cytoskeleton, Inc.  Cat#CY-SC007 
Puromycin HCl Thermo Fisher  Cat#A1113803 
G418 EMD Millipore  Cat#345810 
Blasticidin Sigma  Cat#R21001 
Palmitic acid Sigma  Cat#P0500 
Oleic acid Sigma  Cat#O1008 
Linoleic acid Sigma  Cat#L5900 
SNAP-Cell 647-SiR NEB Cat# S9102S 




Zymopure II plasmid 
Midi prep kit 
Zymogen  Cat#D4200 
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Pierce BCA Protein 
Assay kit 
Thermo Scientific  Cat#23225 
Software   
FIJI (Schindelin et al., 2012) https://imagej.net/Fiji 
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